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ABSTRACT  
The shape of glucose response and one hour (1-hr) glucose during an oral glucose 
tolerance test (OGTT) are emerging biomarkers for type 2 diabetes. The purpose of this 
study was two-fold: (1) to investigate the utility of these novel biomakers to differentiate 
type 2 diabetes risk in Latino youth, and (2) to examine the genetic determinants in a 
Latino population. 
Data from the ASU Arizona Insulin Registry (AIR) registry and the USC Study of 
Latino Adolescents at Risk for diabetes project were used to test the cross-sectional and 
prospective utility of novel biomarkers to identify youth at risk for type 2 diabetes. 
Pediatric and adult data from the ASU AIR registry were assessed to examine the 
association of single nucleotide polymorphisms (SNPs) with type 2 diabetes risk. Three 
KCNQ1 SNPs (rs151290; rs2237892; rs2237895) were examined as novel genetic 
variants for type 2 diabetes in Latinos. 
Latino youth with a biphasic response in the AIR registry exhibited significantly 
better β-cell function (P < 0.05) compared to youth with a monophasic response. 
Additionally, Latino youth with a 1-hr glucose ≥155 mg/dL exhibited a significantly 
greater decline in β-cell function over 8 years compared with the <155 mg/dL group (β=-
327.8±126.2, P = 0.01). Moreover, a 1-hr glucose ≥155 mg/dL was associated with a 2.5 
times greater risk for developing prediabetes over time (P = 0.0001). 1-hr glucose was the 
most powerful predictor of prediabetes (area under the receiver operating characteristic 
curve=0.73) when compared to the traditional biomarkers including HbA1c (0.58), 
fasting (0.67), and 2-hr glucose (0.64). Two KCNQ1 SNPs (rs151290 and rs2237892) 
exhibited significant associations with type 2 diabetes risk factors. For the novel 
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glycemic markers, 15 SNPs were associated with the glucose response curve, while 18 
SNPs were associated with 1-hr glucose. 
These data suggest that glucose response curve and 1-hr glucose during an OGTT 
independently differentiate type 2 diabetes risk among Latino youth. Furthermore, it was 
successful to replicate the association of type 2 diabetes risk with 2 KCNQ1 SNPs in a 
Latino population. Data suggest that novel glycemic biomarkers are influenced by genetic 
background in this high-risk population. 
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CHAPTER 1: GENERAL INTRODUCTION 
Obesity has reached epidemic proportions in the US with approximately 32% of 
adolescents and two-thirds of adults classified as either overweight or obese (Ogden, 
Carroll, Kit, & Flegal, 2014). In the context of a widespread obesity epidemic, the burden 
of metabolic abnormalities (i.e., metabolic syndrome and type 2 diabetes) is of clinical 
and public health concern in both youth and adults (Fagot-Campagna, 2000; Ford, Li, & 
Zhao, 2010). 
In order to diagnose disorders of glucose metabolism (i.e., prediabetes and type 2 
diabetes), the oral glucose tolerance test (OGTT) has been used in the clinical practice. 
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (The 
Expert Committee on the, Diagnosis, & Classification of Diabetes, Mellitus, 1997; 2003) 
announced specific criteria for diagnosing new onset of type 2 diabetes based on the 
fasting and 2-hr glucose levels that are obtained from the OGTT. In addition, impaired 
fasting glucose (IFG) and impaired glucose tolerance (IGT) were introduced as 
intermediate stages in the natural history of type 2 diabetes. Individuals with prediabetes 
(i.e., IFG and/or IGT) have been referred to as exhibiting relatively high risk for the 
future development of type 2 diabetes (The Expert Committee on the, Diagnosis, & 
Classification of Diabetes, Mellitus, 2003). 
However, epidemiological studies in adults demonstrate the limitations of fasting 
and 2-hr post challenge glucose in predicting risk for type 2 diabetes, as only 50% of 
patients with prediabetes eventually convert to diabetes (Gerstein et al., 2007; Unwin, 
Shaw, Zimmet, & Alberti, 2002). These findings indicate that approximately half of 
individuals with new onset of type 2 diabetes are considered as maintaining their normal 
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glucose tolerance (NGT) status prior to the diagnosis of type 2 diabetes. In the pediatric 
populations, relatively rapid progression to overt type 2 diabetes has been observed 
compared to adults, as obese youth with IGT decompensate to frank type 2 diabetes over 
a mean follow-up of 20 months (Weiss et al. 2005). It has been clearly shown that 
impairment of β-cell function, which is a hallmark feature of type 2 diabetes and is 
considered one of the earliest indicators of diabetes risk (Bergman, Ader, Huecking, & 
Van Citters, 2002; DeFronzo, 2009; Tfayli, Lee, & Arslanian, 2010), starts even in NGT 
in both youth and adults. For this reason, in addition to the traditional glycemic markers 
(i.e., fasting and 2-hr glucose), there is a substantial interest in gaining individuals’ 
metabolic information from the OGTT. This effort leads to further examine novel 
biomarkers to accurately identify high-risk individuals for the future development of type 
2 diabetes. 
In an effort to find an accurate identification tool for future type 2 diabetes, recent 
studies in adults recommended using a simple shape index during OGTT (Abdul-Ghani, 
Lyssenko, Tuomi, DeFronzo, & Groop, 2010; Fuchigami, Nakano, Oba, Metori, 1994; 
Kanauchi, M., Kimura, Kanauchi, K., & Saito, 2005; Trujillo-Arriaga & Roman-Ramos, 
2008; Tschritter et al., 2003; Tura et al., 2011). They commonly found that individuals 
with a monophasic response (inverted U shape) during an OGTT exhibit greater insulin 
resistance and decreased β-cell function compared to individuals with a biphasic response 
(a second rise of plasma glucose after first decline). Further, Abdul-Ghani et al. (2010) 
revealed that prediabetic adults with a monophasic glucose response to an OGTT 
exhibited nearly double the risk of developing type 2 diabetes over a 7-8 year follow-up 
compared to prediabetics with a biphasic response. To our knowledge, whether the shape 
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of the glucose response curve is associated with type 2 diabetes risk in younger 
populations has not been determined. Therefore, our group tested the utility of this 
phenotype and confirmed that the biphasic phenotype is associated with lower risk of 
type 2 diabetes independent of traditional glycemic markers (i.e., fasting and 2-hr 
glucose) in Latino youth, potentially due to higher insulin sensitivity and better β-cell 
function (Kim, Coletta, Mandarino, & Shaibi, 2012). 
In addition to glucose response shape index, one hour (1-hr) plasma glucose 
concentration during an OGTT has been shown an independent predictor of type 2 
diabetes in adults (Abdul-Ghani, Williams, DeFronzo, & Stern, 2007; Abdul-Ghani M, 
Abdul-Ghani T, Ali, & DeFronzo, 2008; Abdul-Ghani, Lyssenko, Tuomi, DeFronzo, & 
Groop, 2009) and in youth (Tfayli, Lee, Bacha, & Arslanian, 2011). Especially, Abdul-
Ghani et al. (2008) compared predictive power of glycemic indicators and found that 1-hr 
glucose of 155mg/dL was a better predictor of type 2 diabetes than either fasting or 2-hr 
glucose concentrations yielding the maximal sum of sensitivity (0.75) and specificity 
(0.79). However, little is known about longitudinal changes in metabolic health based on 
this cutoff value in younger population. Therefore, we examined the threshold of 1-hr 
glucose concentration (155 mg/dL) and confirmed this finding in Latino youth, 
suggesting that 1-hr glucose predicts the development of prediabetes and β-cell 
dysfunction over the 8 years follow-up period (Kim et al., 2013). Moreover, similar to the 
prospective study in adults, this emerging biomarker was more powerful to predict type 2 
diabetes risk (i.e., development of prediabetes) than traditional glycemic indicators 
including HbA1c, fasting, and 2-hr glucose (Kim, Goran, Toledo‐Corral, Weigensberg, 
& Shaibi, 2014). 
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In order to understand the pathogenesis of type 2 diabetes, a growing number of 
studies have examined environmental factors such as diet or exercise (Ershow, 2009) 
and/or genetic factors, which contribute to the development of type 2 diabetes. 
Specifically, significant progress has been made with regards to identifying the genetic 
causes or single nucleotide polymorphisms (SNPs) since genome-wide association 
studies (GWAS) and large-scale meta-analysis have been widely performed. To date, 
GWAS have identified over 60 susceptibility loci which have been associated with type 2 
diabetes risk (Brunetti, Chiefari, & Foti, 2014; Dupuis et al., 2010; McCarthy, 2010; 
Morris et al., 2012; Saxena et al, 2012). Moreover, ongoing efforts on the physiologic 
characterization of diabetes-related chronic disease risk factors such as obesity, 
dyslipidemia, hypertension, and glucose homeostasis have led to a better understanding 
of the pathogenesis of type 2 diabetes (Ingelsson et al., 2010). 
Although previous data showed that similar physiological contributors 
(impairment of insulin release and action) seem to be involved in the monophasic glucose 
response and higher 1-hr glucose (Kim et al., 2012; Kim et al., 2013), it is still unknown 
whether there are genetic involvements in these novel phenotypic characteristics. To our 
knowledge, no studies have examined genetic determinants of glucose response curve or 
1-hr glucose. Although we recently have replicated GWAS SNPs (n=28) that are related 
to type 2 diabetes risk in a Latino population (DeMenna et al., 2014), we did not examine 
genetic association with these emerging biomarkers. Therefore, in addition to the 
verification of the utility of novel biomarkers for predicting type 2 diabetes risk, it is 
necessary to examine the genetic association with these novel markers (e.g., glucose 
response curve and 1-hr glucose) to expand the understanding of novel markers. 
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To date, the majority of type 2 diabetes susceptibility loci have been associated 
with β-cell function while a limited number of genes related to insulin action have been 
identified (Saxena et al., 2012). For example, transcription factor 7-like 2 (TCF7L2) 
genetic variants have a substantially stronger effect on the impairment of insulin secretion 
as compared to insulin action (Grant et al., 2006; Morris et al., 2012). Since it is well 
established that obesity is also linked to the risk for future type 2 diabetes (Kahn, Hull, & 
Utzschneider, 2006), fat mass and obesity-associated (FTO) became a widely-replicated 
gene and numerous studies have confirmed the association between FTO SNPs and 
obesity-related phenotypes such as BMI and waist circumference in several populations 
(Dina et al., 2007; Kilpeläinen et al., 2011; Scuteri et al., 2007). However, these SNPs 
found via GWAS have shown modest effect sizes and collectively explain only 10% for 
the variance in type 2 diabetes risk (Imamura & Maeda, 2011; McCarthy & Zeggini, 
2009; Morris et al., 2012; Voight et al., 2010). The limitations of current GWAS to date 
may be due to the involvement of novel (or not fully replicated) SNPs (Brunetti et al., 
2014; Thomsen & Gloyn, 2014). It is possible that detailed physiological characterization 
of these SNPs may help clarify their associations with and/or role in type 2 diabetes risk 
(Ingelsson et al., 2010). 
Compared to the genetic variants in TCF7L2 or FTO, some genes and SNPs were 
not widely replicated in various populations despite exhibiting a relatively high effect 
size. Moreover, the majority of genetic studies were performed on Europeans and little is 
known about the genetic influences on type 2 diabetes risk in Latino populations. For 
example, KCNQ1 has been associated with impaired β-cell function (Unoki et al., 2008; 
Yasuda et al., 2008) and its effect size is similar with that of TCF7L2 (Prokopenko, 
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McCarthy, & Lindgren, 2008). However, approximately 90% of genetic studies were 
performed among East Asian or Caucasian populations according to the meta-analysis of 
the effect of KCNQ1 SNPs on the type 2 diabetes risk (Liu et al., 2013). Therefore, it is 
necessary to replicate the study of genetic variants of KCNQ1 in Latino population. To 
our knowledge, two studies examined KCNQ1 SNP (rs2237892) in the Mexican 
population and exhibited significant association with susceptibility to type 2 diabetes 
(Gamboa-Meléndez et al., 2012; Parra et al., 2011). Further replication studies of 
KCNQ1 effects on type 2 diabetes risk are warranted in this population by recruiting 
more SNPs (e.g., rs2237895 and rs151290) in this gene, which have been studied in other 
populations. Collectively, more candidate SNPs along with non-traditional phenotypic 
markers for dysglycemia are critical to expand the genetic contributions to type 2 
diabetes. Therefore, we examined genetic determinants of novel glycemic biomarkers 
(i.e., glucose response curve and 1-hr glucose) as well as included more SNPs (KCNQ1 
genetic variants) in the genetic association analysis. 
The overall purpose of this dissertation was two-fold; (1) to examine the utility of 
novel glycemic markers for predicting the type 2 diabetes risks, and (2) to examine 
genetic determinants of novel glycemic markers. To be specific, this dissertation 
explores: (1) the association of the glucose response curve during an OGTT with type 2 
diabetes risk factors in Latino youth, (2) the utility of 1-hr glucose level to predict type 2 
diabetes risk in obese Latino youth, (3) the predictive power of the 1-hr glucose level 
compared to traditional glycemic markers, and (4) genetic determinants of novel 
glycemic biomarkers as well as genetic influences of type 2 diabetes susceptibility genes 
including KCNQ1 in Latino population.  
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The explicit aims of the dissertation are outlined below. 
Aim 1: To compare type 2 diabetes risk factors in Latino adolescents characterized by 
either a monophasic or biphasic glucose response during an OGTT. 
Aim 2: To examine the utility of elevated 1-hr glucose levels to prospectively predict 
deterioration in β-cell function and the development of prediabetes in high-risk youth. 
Aim 3: To compare the predictive power of 1-hr glucose to traditional glycemic markers 
(i.e., HbA1c, fasting, and 2-hr glucose) for prospectively identifying prediabetes in high-
risk youth. 
Aim 4: To examine genetic determinants of novel glycemic biomarkers (i.e., glucose 
response curve and 1-hr glucose level) and traditional clinical markers of type 2 diabetes 
risk (i.e., adiposity, lipid profile, fasting glucose, HbA1c, and OGTT-derived insulin 
release and resistance measures). 
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CHAPTER 2: GLUCOSE RESPONSE CURVE AND TYPE 2 DIABETES RISK IN 
LATINO ADOLESCENTS. 
 
Joon Young Kim, Dawn K. Coletta, Lawrence J. Mandarino, and Gabriel Q. Shaibi 
 
Abstract 
Objective 
In adults, the shape of the glucose response during an oral glucose tolerance test 
(OGTT) prospectively and independently predicts type 2 diabetes. However, no reports 
have described the utility of this indicator in younger populations. The purpose of this 
study was to compare type 2 diabetes risk factors in Latino adolescents characterized by 
either a monophasic or biphasic glucose response during an OGTT. 
Research Design and Methods 
A total of 156 nondiabetic Latino adolescents completed a 2-hr OGTT. 
Monophasic and biphasic groups were compared for the following type 2 diabetes risk 
factors: fasting and 2-hr glucose, HbA1c, glucose area under the curve (AUC), insulin 
sensitivity (Matsuda index), insulin secretion (insulinogenic index), and β-cell function as 
measured by the disposition index (insulin sensitivity × insulin secretion). 
Results 
Of the participants, 107 youth were categorized as monophasic and 49 were 
biphasic. Compared with the monophasic group, participants with a biphasic response 
exhibited lower HbA1c (5.4 ± 0.3 vs. 5.6 ± 0.3%, P < 0.01) and lower glucose AUC 
(14,205 ± 2,382 vs. 16,230 ± 2,537 mg*dL-1*h-1, P < 0.001) with higher insulin 
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sensitivity (5.4 ± 3.2 vs. 4.6 ± 3.4, P ≤ 0.05), higher insulin secretion (2.1 ± 1.3 vs. 1.8 ± 
1.3, P = 0.05), and better β-cell function (10.3 ± 7.8 vs. 6.0 ± 3.6, P < 0.001). Differences 
persisted after adjusting for age, sex, and BMI. 
Conclusions 
These data suggest that the glycemic response to an OGTT may differentiate risk 
for type 2 diabetes in youth. This response may be an early marker of type 2 diabetes risk 
among high-risk youth. 
Introduction 
In parallel with the current pediatric obesity epidemic, type 2 diabetes has 
emerged as a critical health concern among obese adolescents (Fagot-Campagna, 2000; 
Ogden, Flegal, Carroll, & Johnson, 2002). Although type 1 diabetes is more prevalent in 
the pediatric population, data from the SEARCH for Diabetes in Youth Study highlight a 
disproportionate distribution of type 2 diabetes among certain subpopulations of 
adolescents (Dabela et al., 2007). It is notable that for Hispanic females aged 15–19 
years, the incidence of type 2 diabetes exceeds that of type 1 diabetes (Lawrence et al., 
2009). 
An important issue for the medical and research communities is to identify Latino 
youth at increased risk for premature type 2 diabetes so that appropriate prevention 
strategies may be initiated. In 1997, the Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus (The expert committee on the diagnosis and 
classification of diabetes mellitus, 1997) introduced impaired fasting glucose (IFG) and 
impaired glucose tolerance (IGT) as intermediate stages in the natural history of type 2 
diabetes. In adults, pre- diabetes precedes frank type 2 diabetes by 5–10 years (Edelstein 
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et al, 1997; Saad et al, 1988); however, similar data are limited in younger populations. 
Weiss et al. (2005) have noted that obese youth with IGT decompensate to frank type 2 
diabetes over a mean follow-up of 20 months. These data support the potential for a rapid 
progression to overt type 2 diabetes in youth, which may be exacerbated by pubertal 
insulin resistance (Goran & Gower, 2001; Gungor, Bacha, Saad, Janosky, & Arslanian, 
2005). In contrast, Goran, Lane, Toledo-Corral, and Weigensberg (2008) have shown that 
obese Latino youth may vacillate between normal glucose tolerance (NGT) and IFG/IGT 
over time. Therefore, in addition to pre- diabetes, other markers of type 2 diabetes risk 
may be necessary. 
Several recent studies in adults use the shape of the glucose curve during an oral 
glucose tolerance test (OGTT) to identify metabolic dysregulation and the potential risk 
for future type 2 diabetes (Abdul-Ghani, Lyssenko, Tuomi, DeFronzo, & Groop, 2010; 
Fuchigami, Nakano, Oba, & Metori, 1994; Kanauchi, M., Kimura, Kanauchi, K., & Saito, 
2005; Morbiducci et al, 2014; Trujillo-Arriaga, & Roman-Ramos, 2008; Tschritter et al., 
2003; Tura et al., 2011). Using a simple shape index, individuals with a monophasic 
response (inverted U shape) during an OGTT exhibit greater insulin resistance and 
decreased β-cell function compared with individuals with a biphasic response (a second 
rise of plasma glucose after first decline). A recent prospective study demonstrates that 
independent of fasting and/or post-challenge glucose concentrations, individuals with a 
monophasic response developed type 2 diabetes at a higher rate than those with a 
biphasic response (Abdul-Ghani et al., 2010). 
Since our group tested the utility of the glucose response curve obtained from the 
OGTT for differentiating the risk for type 2 diabetes in a Latino youth, more attempts to 
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confirm previous findings in younger population have been made. Nolfe, Spreghini, 
Sforza, Morino, and Manco (2012) described the morphology of glucose response curve 
during an OGTT in Caucasian obese children and adolescents (N=553). More 
sophisticated classification criteria for the glucose response curve was used (i.e., 
monophasic, biphasic, triphasic, and upward monotonous). They found that, within a 
normoglycemic individuals (n=522), monophasic was most prevalent type of glucose 
response to an OGTT (n=285, 54%) and represented high risk for type 2 diabetes in 
terms of glucose intolerance, insulin resistance, and impairment of insulin secretion. 
Further, they discussed that more accurate metabolic information (i.e., type 2 diabetes 
risk) can be extracted when the glucose response curve was analyzed with morphologies 
of insulin curve or time of glucose peak. More recently, Bervoets, Mewis, and Massa 
(2014) examined the shape of plasma glucose response curve in relation to insulin 
sensitivity, insulin secretion, and other metabolic phenotypes in end-pubertal girls. A 
total 81 end-pubertal obese girls completed a standard 2-hr OGTT and divided into four 
types of the glucose response curves using a threshold of 2 mg/dL as follows: 
monophasic, biphasic, triphasic, and unclassified. Individuals with monophasic glucose 
response exhibited higher area under the curve for glucose, lower early-phase insulin 
secretion, and poorer β-cell function relative to insulin sensitivity compared to the 
participants with biphasic and triphasic glucose response. Collectively, aforementioned 
two studies further tested and confirmed the utility of the glucose response curve during 
an OGTT in the cross-sectional dataset. To our knowledge, our study was the first to 
examine the association of the glucose response curve with type 2 diabetes risk in 
younger populations. The purpose of this study was to compare diabetes risk factors in 
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Latino youth characterized by either a monophasic or biphasic glucose response during a 
2-hr OGTT.  
Research Design and Methods 
Data from 156 nondiabetic Latino adolescents (aged 12–21 years) who 
participated in a community- based diabetes registry were used in the present analysis. 
Participants arrived at the Arizona State University Clinical Research Unit after an 
overnight fast. Anthropometric measurements included height, weight and BMI, waist 
and hip circumference, and seated blood pressure. A blood sample (~20 mL) was taken 
under fasting conditions to measure HbA1c and lipid profile, including total cholesterol, 
triglyceride, HDL, LDL, and VLDL. All laboratory tests were performed by a Clinical 
Laboratory Improvement Amendments–certified commercial laboratory (Sonora Quest 
Laboratories, Phoenix, AZ). 
Oral Glucose Tolerance Test (OGTT) 
Participants underwent a 2-hr OGTT following a 10-hr overnight fast. Subjects 
ingested a solution containing 75 g dextrose (1.75 g/kg), and venous blood samples were 
obtained at 0, 30, 60, 90, and 120 min for determination of plasma glucose and insulin 
concentrations. Plasma glucose was measured by the glucose oxidase method using a YSI 
2300 STAT plus (YSI, Inc., Yellow Springs, OH), and insulin was measured in duplicate 
by ELISA (ALPCO Diagnostics, Windham, NH). 
Classification of Response Curve 
Glucose response phenotype (i.e., monophasic or biphasic) was classified 
according to previous studies (Abdul-Ghani et al., 2010; Kanauchi et al., 2005; Trujillo-
Arriaga, & Roman-Ramos, 2008; Tschritter et al., 2003), with a glucose threshold of 4.5 
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mg/dL as described by Tschritter et al. (2013) to minimize fluctuations in glucose 
concentrations that may be caused by the method of glucose analysis rather than 
physiological reasons. A monophasic response was characterized by a gradual rise in 
plasma glucose concentrations until a peak was reached followed by a subsequent 
decrease until 120 min. A biphasic response was characterized by a gradual rise in 
glucose, followed by a ≥ 4.5 mg/dL fall, with a second rise of glucose of at least 4.5 
mg/dL at a subsequent time point. Participants who exhibited a gradual increase in 
plasma glucose after glucose ingestion without a corresponding fall were deemed 
“unclassified” (n = 2) and were excluded for the present analysis (Tschritter et al., 2013). 
Variables and Calculation 
Type 2 diabetes risk factors included fasting plasma glucose and insulin, 2-hr 
plasma glucose and insulin, HbA1c, and glucose and insulin area under the curve (AUC). 
Total AUC for plasma glucose and insulin during the OGTT were calculated by the 
trapezoidal method using 30-min sampling time points (Matthews, Altman, Campbell, & 
Royston, 1990). In addition to these indicators, insulin action was estimated by the 
homeostasis model assessment (HOMA) for insulin resistance (HOMA-IR) (Matthews et 
al., 1985) and the whole-body insulin sensitivity index of Matsuda and DeFronzo (1999), 
and insulin secretion was estimated by the insulinogenic index calculated using fasting 
and 30-min insulin and glucose concentrations (Phillips, Clark, Hales, & Osmond, 1994). 
β-cell function was estimated by the disposition index as the product of insulin action 
Matsuda index (Matsuda & DeFronzo, 1999) and insulin secretion insulinogenic index 
(Phillips et al, 1994). 
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Statistical Analysis 
Independent sample t tests and χ2 analyses were used to compare characteristics 
between glucose phenotypes. Two-way repeated-measures ANOVA was used to assess 
differences in the glucose and insulin levels at each time point during the OGTT. 
Analysis of covariance was used to compare phenotypes after adjusting for the potential 
confounding effects of age, sex, and BMI on type 2 diabetes risk factors. Data that did 
not meet the assumptions for normality (glucose values at 30 and 90 min and insulin 
values at each time point from the OGTT, HbA1c, and all indices for insulin sensitivity, 
secretion, and β-cell function) were log10 transformed; untransformed data are presented 
for ease of interpretation. Data were analyzed using PASW 18.0 statistical software 
package with significance set at P ≤ 0.05. 
Results 
Descriptive characteristics of participants are presented in Table 2-1. No 
differences in sex, BMI categories (lean vs. overweight vs. obese), or glycemic status 
(NGT vs. prediabetes) were noted between glucose phenotypes. In addition, no 
significant differences were noted for age, anthropometrics (BMI and waist and hip 
circumference), lipids, or blood pressure. 
Two-way repeated-measures ANOVA for plasma glucose concentrations during 
the OGTT demonstrated significant effects for group and time as well as group 3 time 
interaction, indicating differences between groups over the course of the OGTT (all P < 
0.0001). Glucose and insulin concentrations for each OGTT time point are presented in 
Fig. 2-1.  
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Figure 2-1. Glucose (A) and Insulin (B) Response Curves During OGTT in Monophasic 
(white circles and dashed line) and Biphasic (black circles and solid line). 
Within each glucose phenotype, all time points across the OGTT (i.e., 0, 30, 60, 
90, and 120) were significantly different from each other (P < 0.0001). The monophasic 
group exhibited significantly higher blood glucose levels at 30, 60, and 90 min compared 
with the biphasic group, while no differences were noted for either fasting or 2-hr glucose 
concentrations between groups. In terms of insulin response during the OGTT, there were 
significant effects for time (P < 0.0001) but not for group. The monophasic group had 
significantly higher insulin values at 60 and 90 min compared with the biphasic group. 
Measures of glycemia are presented in Table 2-2. Participants with a monophasic 
response exhibited slightly but significantly higher HbA1c than biphasic participants, and 
these differences remained significant after adjusting for sex, BMI, and age. Glucose 
AUC in the monophasic group was 14.3% higher than in the bi- phasic group, and these 
differences were in- dependent of sex, age, or BMI (Table 2-2). 
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Table 2-2. Measures of Insulin and Glucose Homeostasis and β-cell Function 
 Mean  ±  SD 
Variables 
Monophasic Biphasic 
(n=107) (n=49) 
HbA1C (%) 5.55 ± 0.3 5.41 ± 0.27* 
Glucose AUC (mg*dL-1*h-1) 16229.73 ± 2537.15 14205.31 ± 2382.49** 
Insulin AUC(µU*mL-1*h-1) 11113.33 ± 7280.4 9026.45 ± 5528.69 
HOMA-IR 2.59 ± 2.08 2.03 ± 1.24 
Matsuda Index 4.59 ± 3.38 5.43 ± 3.18* 
Insulinogenic Index 1.75 ± 1.32 2.1 ± 1.32* 
Disposition Index 6.03 ± 3.59 10.28 ± 7.8** 
NOTE: *P < 0.05, **P < 0.001, All significances remained after adjusting gender and 
BMI or gender, BMI, and age. Insulin data were not available on 19 of the 156 
participants (mono vs. biphasic, 93 vs. 44) 
 
Insulin measures are presented in Table 2-2. No significant differences between 
groups were noted for insulin AUC or HOMA-IR. However, insulin sensitivity as 
measured by the Matsuda index and insulin secretion as measured by the insulinogenic 
index were both significantly higher in youth exhibiting the biphasic phenotype. β-cell 
function as measured by the disposition index was 42% higher in the biphasic group, and 
this difference remained significant after adjusting for covariates. Figure 2-2 displays the 
hyperbolic relationship between insulin sensitivity and insulin secretion for each group 
using the product of the Matsuda index and insulinogenic index. The best-fit line derived 
from the individual points of the monophasic group is shifted toward the origin (down 
and to the left) compared with the biphasic group (Fig. 2-2). 
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Figure 2-2. Hyperbolic Relationship Between Insulin Sensitivity and Insulin Secretion in 
Monophasic (white circles and dashed line) and Biphasic (black circles and solid line). 
Conclusions 
In the current study, we demonstrated that the shape of the plasma glucose 
response during an OGTT differentiates diabetes risk factors in Latino adolescents. 
Participants with a biphasic response exhibited lower glucose AUC and HbA1c, higher 
whole-body insulin sensitivity (Matsuda index) and insulin secretion, and better β-cell 
function compared with individuals with a monophasic response. These data extend 
previous studies in adults and suggest that the glucose response curve may be an early 
indicator of type 2 diabetes risk in adolescents. 
Studies in adults have established that the shape of the glucose curve is related to 
both type 2 diabetes risk factors (Fuchigami et al., 1994; Kanauchi et al., 2005; Trujillo-
Arriaga, & Roman-Ramos, 2008; Tschritter et al., 2003; Tura et al., 2011) and the 
development of type 2 diabetes (Abdul-Ghani et al., 2010). Tschritter et al. (2003) 
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studied glucose curves from 551 nondiabetic Caucasian adults and found that the bi- 
phasic response was associated with lower BMI, younger age, and higher insulin 
sensitivity and disposition index. The authors also reported that females and individuals 
with NGT were more likely to be characterized by a biphasic response. These findings 
were confirmed and expanded upon by Tura et al. (2011) who used glucose excursions 
during 3-hr OGTTs from nearly 600 Austrian women screened for gestational diabetes. 
The authors noted that a 3-hr OGTT captured even greater variations in glucose response, 
with some individuals exhibiting up to five phases. Greater complexity of the glucose 
curve (i.e., increasing number of phases) was associated with a healthier metabolic 
profile as indicated by higher insulin sensitivity and β-cell function as well as a lower 
prevalence of prediabetes and type 2 diabetes. These cross-sectional studies were 
confirmed prospectively where prediabetic adults with a monophasic glucose response 
during an OGTT exhibited nearly double the risk of developing type 2 diabetes during a 
7- to 8-year follow-up compared with prediabetic subjects with a biphasic response 
(Abdul-Ghani et al., 2010). These studies suggest that the bi- phasic phenotype is 
associated with lower risk of type 2 diabetes potentially as a result of higher insulin 
sensitivity and better β-cell function. 
In adults, insulin resistance and insulin secretory dysfunction are independently 
and interactively related to type 2 diabetes risk (Haffner, Miettinen, Gaskill, & Stern, 
1995; Lillioja et al., 1993; Weyer, Bogardus, Mott, & Pratley, 1999). Specifically, the 
inability of the β-cell to compensate for insulin resistance is a primary determinant of 
type 2 diabetes (Bergman, Ader, Huecking, & Van Citters, 2002; Weyer et al., 1999). 
Compared with what is known in adults, the natural history of type 2 diabetes in youth is 
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less well understood. Recent studies support β-cell dysfunction as a key feature of type 2 
diabetes in adolescents (Arslanian, 2002; Weiss & Gillis, 2008). 
Not only does β-cell dysfunction contribute to type 2 diabetes in adolescents but it 
also was recently noted that Latino children and adolescents with prediabetes exhibit 
significantly lower β-cell function compared with their normoglycemic peers (Goran et 
al., 2004; Weigensberg, Ball, Shaibi, Cruz, & Goran, 2005). These data suggest that β-
cell dysfunction contributes to prediabetes and type 2 diabetes in children and 
adolescents. 
Taken together, our results extend findings on glucose response patterns in adults 
and type 2 diabetes pathophysiology in adults and youth to suggest that a monophasic 
glucose response may be associated with an increased risk for type 2 diabetes. This 
seemingly increased risk is evidenced by a lower disposition index that is due to 
significantly lower insulin sensitivity and secretion. When the disposition index of each 
group is plotted on the same graph (Fig. 2-2), the best-fit line representing the disposition 
index for the monophasic group is shifted closer to the origin (i.e., down and to the left) 
compared with that for the biphasic group. This shift is a hallmark feature of type 2 
diabetes and is considered one of the earliest indicators of β-cell dysfunction (Bergman et 
al., 2002). It is important to note that the lower disposition index among the monophasic 
group was independent of BMI and, therefore, may confer additional type 2 diabetes risk 
beyond that of obesity. Furthermore, despite the lower disposition index observed in the 
monophasic group, neither the levels of fasting and 2-hr glucose nor the percentage of 
prediabetic subjects were significantly different between groups. When the dataset was 
restricted to only those participants with NGT, the disposition index in the monophasic 
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group remained significantly lower than that of the biphasic group (P ≤ 0.05). 
Collectively, these findings suggest that the shape of the glucose response curve may be a 
very early marker of glucose dysregulation and type 2 diabetes risk and is detectable even 
before traditional indicators of hyperglycemia (The expert committee on the diagnosis 
and classification of diabetes mellitus, 2003). Whether the shape of the glucose curve is 
similarly predictive of the development of type 2 diabetes as traditional diabetes risk 
factors is an important question that should be addressed in future studies. 
The physiological mechanisms responsible for the various glucose response 
curves are poorly understood. Although we found lower β-cell function (lower insulin 
sensitivity and secretion) in the monophasic group, we do not know whether this 
represents a cause or an effect of the phenotype or whether there are common biologic or 
genetic pathways linking these phenotypic characteristics. It may be that higher insulin 
sensitivity and secretion contribute to the biphasic response through more efficient and 
faster glucose clearance compared with the monophasic response. It is also possible that 
the timing of the insulin response may contribute to differences in the shape of the 
glucose response curve. Therefore, we divided individuals into either early (30-min) or 
late (≥ 60-min) responders based on the timing of peak insulin concentrations. The 
biphasic group exhibited a higher percentage of “early responders” compared with the 
monophasic group (57 vs. 32%; P < 0.01); however, including insulin timing as a 
covariate in the final models did not change the results (data not shown). In addition, it is 
possible that an early return of plasma glucose concentrations toward baseline may 
stimulate a subtle counterregulatory response (Kanauchi, 2005; Trujillo-Arriaga, 2008), 
leading to a second rise in plasma glucose at 60 or 90 min. Another possible explanation 
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may be prolonged or delayed gastric emptying among monophasic individuals. Previous 
studies suggest that delayed gastric emptying is more common among adults with type 2 
diabetes compared with control subjects, and prolonged gastric emptying is positively 
correlated with plasma glucose concentration (Horowitz et al., 1989). Among nondiabetic 
individuals, the incretin response following an oral glucose challenge is directly related to 
the rate of gastric emptying, which is inversely associated with postchallenge glucose and 
insulin concentrations (Horowitz, Edelbroek, Wishart, & Straathof, 1993). Taken 
together, it is possible that differences in gastric emptying as well as alterations in the 
incretin response may be associated with a monophasic glucose response and, ultimately, 
increases in type 2 diabetes risk with this phenotype. 
To our knowledge, this is the first study to examine the shape of the glucose 
response curve in relation to type 2 diabetes risk among the pediatric population. We 
focused on Latino adolescents because this group represents a vulnerable population at 
increased risk for developing type 2 diabetes. We used defined glucose thresholds based 
on objective criteria to identify when and if more than one glucose peak was achieved. 
Very few researchers have published specific glucose thresholds for identifying 
differences between time points, and we believe using rigid criteria (i.e., a minimum of 
4.5 mg/dL glucose excursion between a peak and a subsequent trough) rather than simply 
characterizing glucose curves through observation will minimize misclassification. When 
we analyzed our data using a previously published relative threshold of ≥ 2% difference 
between consecutive glucose time points (Tura et al., 2011), the overall results and 
interpretations were not affected. Despite these strengths, we acknowledge potential 
limitations in our data that should be considered. 
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First, we based our phenotype on the response to a single OGTT, which may have 
limited reproducibility in youth. Libman, Barinas-Mitchell, Bartucci, Robertson, & 
Arslanian (2008) demonstrated poor reproducibility of the OGTT in overweight youth in 
terms of identifying hyperglycemia. In addition, Kramer, Vuksan, Choi, Zinman, and 
Retnakaran (2014) evaluated the reproducibility of novel parameters of the insulin and 
glucose response during the OGTT. They reported 40% agreement on the shape of 
glucose response among three series of OGTT results. However, it is still unknown 
whether the shape of the glucose response is an inherent and, hence, reproducible 
biological process warrants further examination before using this assessment in 
longitudinal in youth. In addition, our classification of glucose phenotype was derived 
from the 2-hr OGTT. By using a longer OGTT (i.e., 3-hr OGTT) and/or more frequent 
sampling intervals (i.e., every 10 min) it is possible to capture more sophisticated curve 
types that will provide greater information on type 2 diabetes risk (Trujillo-Arriaga, 
2008; Tura et al., 2011). Second, family history of diabetes, expo- sure to gestational 
diabetes in utero, and pubertal stage were not available for our analysis. It is well 
established that family history of diabetes is a strong risk factor for type 2 diabetes in 
both adults and youth (Arslanian, Bacha, Saad, & Gungor, 2005; Kelly et al., 2007; Kuo, 
C., Lin, Yu, Chang, & Kuo, H., 2010) and exposure to gestational diabetes in utero is a 
hypothesized risk factor for type 2 diabetes in youth (Fetita, Sobngwi, Serradas, Calvo, & 
Gautier, 2006). In addition, cross-sectional and longitudinal studies show that puberty is 
associated with insulin resistance, which may further contribute to type 2 diabetes risk 
(Ball et al., 2006; Goran, & Gower, 2001; Reinehr et al., 2009). Although we did not 
assess pubertal status in the current study, we did attempt to minimize the confounding 
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effects by adjusting for age. Nonetheless, age is not an ideal surrogate for pubertal stage, 
and we further acknowledge the relatively wide spectrum of age in our heterogeneous 
sample that should be addressed in future studies. Third, the utility of HbA1c as a 
potential type 2 diabetes risk factor in youth has not been well established (Lee, Wu, 
Tarini, Herman, & Yoon, 2011). It is also not clear whether this result is of clinical 
significance because differences were subtle. Lastly, the cross-sectional nature of our 
study precludes the ability to draw causal inferences about the shape of the glucose curve 
and type 2 diabetes risk. Given that type 2 diabetes is a progressive, chronic disease and 
typically presents in adulthood, examining markers that may identify risk in younger 
cohorts can offer temporal insight into the pathophysiological mechanisms of diabetes. It 
is interesting to note that previous studies suggest that adults with a biphasic response are 
characterized by younger age compared with those with a monophasic response 
(Fuchigami et al., 1994; Tschritter et al, 2003). In our cohort, .31% of the participants 
exhibited a biphasic response, which is slightly higher than the prevalence of biphasic in 
adult cohorts (AbdulGhani et al., 2010; Fuchigami et al., 1994; Kanauchi et al., 2005; 
Trujillo-Arriaga, & Roman-Ramos, 2008; Tschritter et al., 2003; Tura et al., 2011). 
Interestingly, similar prevalences of monophasic and biphasic glucose response were 
observed in recent two studies in younger population (Bervoets et al., 2014; Nolfe et al., 
2012). To date, there are six studies in adults and two studies in youth (Table 2-3) 
describing the glucose response curve and suggest that the monophasic response is the 
dominant phenotype in adults (mean prevalence of monophasic response = 69%, range = 
45 – 84%). From our data and those described above, it is difficult to determine whether 
this dominant state is indeed the "normal state" and whether the prevalence of different 
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glucose response curve phenotypes differs by age, gender, race/ethnicity or some other 
contributing factors (e.g., glycemic status). Given our findings and focus on a high-risk 
population, it is plausible that the proportion of youth with a monophasic response may 
be less in adolescents from a lower risk population (e.g., lean or Caucasian). 
 
Table 2-3. Prevalence of Mono vs. Biphasic Glucose Response Curve From The 
Published Studies to Date in Adults and Youths 
Study Population Total N (age) 
Mono vs. Biphasic vs. 
(Unclassified) 
Fuchigami (1994) Japanese 70 (NA) 61 vs. 33% vs. (6%) 
Tschritter (2003) Caucasian 551 (36 yrs) 45 vs. 35% vs. (20%) 
Kanauchi (2005) Japanese 583 (62 yrs) 73 vs. 21% vs. (6%) 
Trujillo-Arriaga (2008) Mexican 100 (30 yrs) 84 vs. 16% 
Abdul-Ghani (2010) Finnish 2445 (46 yrs) 82 vs. 18% 
Tura (2011) Austrian women 475 (35 yrs) 69 vs. 31% 
Nolfe et al (2012) Caucasian 553 (4 to 18 yrs) 55 vs. 33% vs. (12%) 
Bervoets et al. (2014) Belgium (native 
and non-native) 
81 (11 to 18 yrs) 35 vs. 37% vs. (28%) 
 
Although our data supported that youth with a monophasic response are at higher 
risk for the type 2 diabetes, it is important to note that our data were cross-sectional and it 
is difficult to know whether those with a monophasic response will develop diabetes at 
either a higher or faster rate than those with a biphasic phenotype. If a monophasic 
response indicates a declining or insufficient β-cell response, it is physiologically 
reasonable to assume that those youth with a monophasic response will develop type 2 
diabetes at either a higher rate or younger age (or both). Therefore, longitudinal data on 
the development of type 2 diabetes in younger populations should be analyzed in relation 
to the glucose response curve phenotypes and future studies focusing on the predictive 
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power of the shape of glucose response curve during the OGTT for identifying future 
type 2 diabetes are warranted. 
In summary, the pattern of plasma glucose response during an OGTT may 
provide an early marker of type 2 diabetes risk in youth. We have demonstrated that 
participants with a biphasic response have significantly better β-cell function secondary 
to higher insulin sensitivity and secretion as well as lower glucose AUC and HbA1c. 
Moreover, our data suggest that the shape of the glucose curve may differentiate type 2 
diabetes risk independent of obesity and before dysregulation of fasting or 2-hr glucose. 
Longitudinal studies to investigate whether glucose response phenotypes prospectively 
predict the development of type 2 diabetes in younger populations are warranted.  
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CHAPTER 3: ONE-HOUR GLUCOSE DURING AN ORAL GLUCOSE CHALLENGE 
PROSPECTIVELY PREDICTS β-CELL DETERIORATION AND PREDIABETES IN 
OBESE HISPANIC YOUTH 
 
Joon Young Kim, Michael I. Goran, Claudia M. Toledo-Corral, Marc J. Weigensberg, 
Myunghan Choi, and Gabriel Q. Shaibi 
 
Abstract 
Objective 
In adults, 1-hr glucose during an oral glucose tolerance test (OGTT) predicts the 
development of type 2 diabetes independent of fasting and 2-hr glucose concentrations. 
The purpose of the current investigation was to examine the utility of elevated 1-hr 
glucose levels to prospectively predict deterioration in β-cell function and the 
development of prediabetes in high-risk youth. 
Research Design and Methods 
Obese Latino youth with a family history of type 2 diabetes (133 male and 100 
female; age 11.1 ± 1.7 years) completed a baseline OGTT and were divided into two 
groups based upon a 1-hr glucose threshold of 155 mg/dL (<155 mg/dL, n = 151, or ≥155 
mg/dL, n = 82). Youth were followed annually for up to 8 years for assessment of 
glucose tolerance, body composition by dual-energy X-ray absorptiometry, and insulin 
sensitivity, insulin secretion, and the disposition index by the frequently sampled 
intravenous glucose tolerance test. 
Results 
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Over time, the ≥155 mg/dL group exhibited a significantly greater decline in β-
cell function compared with youth with a 1-hr glucose <155 mg/dL (β=-327.8 ± 126.2, P 
= 0.01). Moreover, this decline was independent of fasting or 2-hr glucose and body 
composition. When the data were restricted to only participants with normal glucose 
tolerance at baseline, a 1-hr glucose ≥155 mg/dL was independently associated with a 2.5 
times greater likelihood of developing prediabetes during follow-up (95% CI 1.6–4.1, P = 
0.0001). 
Conclusions 
These data suggest that a 1-hr glucose ≥155 mg/dL during an OGTT is an 
independent predictor of β-cell deterioration and progression to prediabetes among obese 
Latino youth. 
Introduction 
Once thought to be an adult disease, type 2 diabetes has emerged as an 
increasingly prevalent health condition in younger populations (Ogden, Flegal, Carroll, & 
Johnson, 2002). Estimates from the SEARCH for Diabetes in Youth Study suggest that 
the incidence rates of type 2 diabetes among adolescents are as high as 17.0–
49.4/100,000 person-years and, among certain ethnic minority groups, may exceed rates 
of type 1 diabetes (Dabelea et al., 2007; Lawrence et al., 2009). Cohort studies of high-
risk obese youth portray a more troubling picture where as many as 30% of these youth 
exhibit impairments in glucose regulation (Goran et al., 2004; Sinha et al., 2002). These 
data support the potential for a rapid progression to overt type 2 diabetes in youth, which 
may be exacerbated by pubertal insulin resistance (Goran & Gower, 2001; Gungor, 
Bacha, Saad, Janosky, & Arslanian, 2005). As such, identification of youth at highest risk 
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for premature type 2 diabetes is critical in order to initiate appropriate prevention 
strategies. 
In 1997, the Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus introduced the term pre- diabetes to mean either impaired fasting glucose (IFG) 
or impaired glucose tolerance (IGT) to indicate intermediate stages in the natural history 
of type 2 diabetes (The expert committee on the diagnosis and classification of diabetes 
mellitus, 1997). However, prospective epidemiological studies in adults demonstrate the 
limitations of IFG and IGT in predicting risk, as only one-half of patients with 
prediabetes eventually convert to diabetes (Gerstein et al., 2007; Unwin, Shaw, Zimmet, 
& Alberti, 2002). These data are supported by pediatric studies where children and 
adolescents often vacillate between normal glucose tolerance (NGT) and prediabetes 
(Goran, Lane, Toledo-Corral, & Weigensberg, 2008; Weiss et al., 2005). Therefore, in 
addition to prediabetes, other markers may be necessary to accurately identify those at 
highest risk for developing type 2 diabetes. 
Recently, 1-hr plasma glucose concentration during an oral glucose tolerance test 
(OGTT) has been shown to be an independent predictor of type 2 diabetes in adults. In a 
series of analyses, Abdul-Ghani, M., Abdul-Ghani, T., Ali, and DeFronzo, (2008), and 
Abdul-Ghani, Lyssenko, Tuomi, DeFronzo, and Groop (2009), and Abdul-Ghani, 
Williams, DeFronzo, and Stern (2007) found that a 1-hr glucose concentration of ≥155 
mg/dL predicts the development of type 2 diabetes in two independent cohorts. 
Moreover, Abdul-Ghani et al. (2009) and Manco et al. (2010) found that 1-hr glucose of 
155 mg/dL was a better predictor of type 2 diabetes than either fasting or 2-hr glucose 
concentrations yielding the maximal sum of sensitivity (0.75) and specificity (0.79). 
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Recently, Alyass et al. (2015) also supported previous findings as they reported the 
predictive power of 1-hr glucose (area under the receiver operating characteristic 
curve=0.80 in the Botnia study and 0.70 in the Malmo Prevention Project).  
In addition, it is well established that a 1-hr glucose concentration of ≥155 mg/dL 
was associated with a high risk for (1) type 2 diabetes (Bardini, Dicembrini, Cresci, & 
Rotella, 2010; Bianchi et al., 2013; Cubeddu & Hoffmann, 2010; Joshipura, Andriankaja, 
Hu, & Ritchie, 2011; Marini et al., 2012), (2) metabolic syndrome (Cubeddu & 
Hoffmann, 2010), and (3) cardiovascular disease (Bianchi et al., 2013). 
A recent cross-sectional study (Tfayli, Lee, Bacha, & Arslanian, 2011) of 
overweight/obese youth found that those with 1-hr glucose ≥155 mg/dL were more likely 
to exhibit IGT; however, independent of glucose tolerance status, those with 1-hr glucose 
≥155 mg/dL exhibited lower insulin secretion relative to insulin sensitivity (i.e., 
disposition index [DI]) compared with those with 1-hr glucose<155 mg/dL. 
Unfortunately, the cross-sectional nature of that study limits the ability to draw predictive 
conclusions about the utility of this threshold over time. Given that conversion from 
prediabetes to overt type 2 diabetes in youth may occur rapidly (Weiss et al., 2005), the 
identification of sensitive and specific markers for type 2 diabetes is an important 
question that remains unanswered. Therefore, the purpose of this study was to examine 
whether a 1-hr glucose concentration ≥155 mg/dL can prospectively predict change in 
type 2 diabetes risk among high-risk youth. We tested the hypotheses that (1) obese youth 
with 1-hr glucose concentration ≥155 mg/dL exhibit a deterioration of β-cell function 
over time and (2) NGT obese youth with 1-hr glucose concentration ≥155 mg/dL have a 
greater likelihood of developing prediabetes over time. 
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Research Design and Methods 
Data from 233 obese Latino children (133 male and 100 female; 11.1 ±1.7 years 
old at initial visit) who participated in the Study of Latino Adolescents at Risk (SOLAR) 
diabetes project at the University of Southern California (USC) were used in the present 
analysis. The SOLAR project is an ongoing longitudinal study in which participants are 
followed annually for determination of the natural history of type 2 diabetes in high-risk 
youth. To date, 201 participants had at least one follow-up visit, with some being 
followed for up to 8 years. Details of the study have previously been published (Goran et 
al., 2004). Briefly, children were required to meet the following study entry inclusion 
criteria: (1) age 8–13 years, (2) BMI ≥85th percentile for age and sex, (3) Latino ancestry 
(all four grandparents reporting to be Hispanic), and (4) a family history of type 2 
diabetes (at least one parent, sibling, or grandparent). Participants were excluded if they 
were already diagnosed with type 1 or type 2 diabetes or if they were taking medications 
known to affect body composition or glucose homeostasis. Written informed consent and 
assent were obtained from parents and children, respectively. The institutional review 
board of the USC approved this study. 
Outpatient Visit 
Children arrived at the USC General Clinical Research Center (GCRC) at ~8:00 
A.M. after an overnight fast. Weight and height were measured to determine BMI and 
BMI percentiles, waist circumference was assessed, and a physical examination including 
Tanner staging based on breast development in girls (Marshall & Tanner, 1969) and 
pubic hair in boys (Marshall & Tanner, 1970) was performed. A fasting sample was 
collected for determination of lipid profile (HDL, LDL, and VLDL, triglyceride, and total 
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cholesterol), and a 2-hr OGTT using a dose of 1.75 g glucose/kg body wt to a maximum 
of 75 g was performed. Blood samples were obtained at 0, 30, 60, and 120 min for 
determination of plasma glucose and insulin concentrations. Glucose tolerance was 
determined according to the American Diabetes Association (2010) as NGT (fasting 
glucose <100 mg/dL and 2-hr glucose <140 mg/dL), IFG (fasting glucose between 100 
and 125 mg/dL), and IGT (2-hr glucose ≥140 mg/dL). 
Inpatient Visit 
Children were admitted to the GCRC for an overnight stay for determination of 
total body composition by dual-energy X-ray absorptiometry, body fat distribution by 
magnetic resonance imaging, and insulin sensitivity (SI) using an insulin- modified 
frequently sampled intravenous glucose tolerance test (FSIVGTT). Fasting samples were 
collected at 215 and 25 min prior to administration of glucose (25% dextrose, 0.3 g/kg 
body wt) at time 0. Subsequent blood samples were collected at time points 2, 4, 8, 19, 
22, 30, 40, 50, 70, 100, and 180 min. Insulin (0.02 units/kg body wt, Humulin R [regular 
insulin for human injection]; Eli Lilly, Indianapolis, IN) was intravenously injected at 20 
min. Values for glucose (glucose oxidase method Yellow Springs Instrument 2700 
Analyzer; YSI, Yellow Springs, OH) and insulin (ELISA; Linco, St. Charles, MO) were 
entered into the MINMOD Millennium 2002 computer program (version 5.16) for 
determination of SI, insulin secretion using the acute insulin response (AIR), and DI as 
the product of SI and AIR (Bergman, Phillips, & Cobelli, 1981). 
Statistical Analysis 
Participants were divided into two groups based upon 1-hr glucose concentrations 
at their initial baseline visit (N = 233, <155 or ≥155 mg/dL). Independent-sample t tests 
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were used to compare anthropometry and body composition at baseline between the two 
groups (<155 group vs. ≥155 group). Baseline analysis included comparisons between 
groups for proportions of sex, Tanner stage, and prediabetes status using χ2 tests and by 
ANCOVA for SI, AIR, and DI adjusting for age, sex, Tanner stage, body composition, 
and fasting and 2-hr glucose from the OGTT. Data that did not meet the assumptions for 
normality were log10 transformed; untransformed data are presented for ease of 
interpretation. 
For longitudinal data analyses (n = 201), a hierarchical linear mixed model with a 
fixed-effects and a random-effects approach (Singer, 1998; West, 2009) was used to (1) 
evaluate the impact of 1-hr glucose ≥155 mg/dL at baseline on changes in DI over time 
and (2) estimate the main effects of group assignment (<155 vs. ≥155 group) after con- 
trolling for age, sex, Tanner stage, body composition, fasting and 2-hr glucose, and 
baseline DI on changes in DI over time. The grouping variable (<155 vs. ≥155 group) 
was modeled as a fixed predictor with adjustments made for the variation between 
individuals in the number of follow-up visits (i.e., random effects). In this model, “visit 
number” equals “follow- up years.” β-Coefficients generated represent the unit changes 
of DI over time. 
Generalized estimating equation model analysis (Zeger, Liang, & Albert, 1988) 
was used to predict the likelihood of developing prediabetes by group (<155 vs. ≥155 
group) in only participants who were NGT at baseline (n = 125). Sequential models were 
developed to adjust for potential confounding effects of age, sex, Tanner stage, body 
composition, and fasting and 2-hr glucose. All data were analyzed using SPSS 20.0 with 
significance level set at P ≤ 0.05. 
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Results 
Cross-Sectional Analysis 
Descriptive characteristics of the 233 participants at baseline were compared 
between those above or below 1-hr glucose of 155 mg/dL (Table 3-1). No differences in 
age, weight status (overweight vs. obese), or Tanner stage were noted. There was a 
significantly higher proportion of males in the <155 group compared with the ≥155 group 
(P = 0.007). Furthermore, prediabetes (IFG or IGT) was more commonly observed 
among those in the ≥155 group compared with those in the <155 group (P = 0.0002). 
Additionally, anthropometrics, lipids, and body composition and distribution measures 
were not different between groups. 
Measures of glucose homeostasis and insulin dynamics from the baseline OGTT 
and FSIVGTT are presented in Table 3-1. Participants in the <155 group exhibited a 
healthier metabolic profile, as indicated by significantly lower HbA1c, 2-hr glucose, 2-hr 
insulin, area under the curve (AUC) for glucose and insulin, and higher DI compared 
with those in the ≥155 group. These differences persisted after adjustment for age, sex, 
Tanner stage, and body composition. 
Longitudinal Analysis 
A total of 201 participants had follow-up data and were included in the 
longitudinal linear mixed-model analysis. Participants were followed for up to 8 years 
(4.7 ± 2.7 years), accounting for a total of 1,145 observations. Those with 1-hr glucose 
≥155 mg/dL at baseline exhibited a significantly lower β-coefficient for DI, indicating 
greater deterioration of β-cell function over time (model 1 [Table 3-2]).  
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Table 3-1. Characteristics of Participants by 1-hour Glucose at Study Entry 
Variables <155 (n=151) ≥155 (n=82) P-value 
Descriptive characteristics 
Sex (Male/Female) 96 (64%) / 55 (36%) 37 (45%) / 45 (55%) 0.007 
Tanner stage    0.59 
1 63 (42%) 33 (40%)  
2 45 (30%) 20 (25%)  
3 14 (9%) 7 (9%)  
4 18 (12%) 11 (13%)  
5 11 (7%) 11 (13%)  
Overweight/Obese 27 (18%) / 124 (82%) 12 (15%) / 70 (85%) 0.53 
NGT/Prediabetes (IFG and/or 
IGT) 
115 (76%) / 36 (24%) 42 (52%) / 39 (48%) 0.0002 
Age (y) 11.1 ± 1.6 11.1 ± 1.8 1.00 
BMI (kg/m2) 28.9 ± 5.8 28.3 ± 4.8 0.52 
BMI percentile (%) 97.1 ± 3.3 97.2 ± 2.9 0.82 
Waist (cm) 89.7 ± 13.9 87.1 ± 12.2 0.19 
SBP (mmHg) 109.4 ± 13.0 111.7 ± 11.7 0.18 
DBP (mmHg) 62.5 ± 6.9 64.4 ± 6.2 0.04 
SAAT (cm2) 345.9 ± 157.4 333.1 ± 124.4 0.82 
IAAT (cm2) 49.8 ± 23.6 47.3 ± 17.6 0.56 
Lean tissue mass (kg) 38.0 ± 10.3 35.8 ± 9.7 0.11 
Fat mass (kg) 26.1 ± 11.0 24.1 ± 9.0 0.25 
TAG (mg/dL) 110.3 ± 56.6 107.5 ± 61.3 0.57 
HDL (mg/dL) 36.8 ± 8.8 38.3 ± 8.0 0.13 
LDL (md/dL) 94.6 ± 21.9 93.4 ± 20.7 0.72 
VLDL (mg/dL) 22.2 ± 11.3 21.5 ± 12.3 0.53 
Cholesterol (md/dL) 153.5 ± 26.0 153.3 ± 26.0 0.96 
HbA1c (%) 5.5 ± 0.3 5.6 ± 0.3 0.05 
Fasting glucose (mg/dL) 89.3 ± 6.2 89.1 ± 6.4 0.85 
1-hour glucose (mg/dL) 130 ± 15.9 171.5 ± 15.6 < 0.0001 
2-hour glucose (mg/dL) 118.7 ± 15 132.8 ± 17.3 < 0.0001 
Glucose AUC (mg*dL-1*h-1) 14948.3 ± 1266.1 17723.6 ± 1385.4 < 0.0001 
Fasting insulin (µU/mL) 17.2 ± 10.2 15.7 ± 9.4 0.34 
1-hour insulin (µU/mL) 161.4 ± 124.1 232.7 ± 149.6 0.02 
2-hour insulin (µU/mL) 144.7 ± 129.4 186.7 ± 132.8 0.003 
Insulin AUC (µU*mL-1*h-1) 17992.3 ± 11574.2 22248.8 ± 13173.7 0.003 
SI (×10-4min-1*µU*mL-1) 2.1 ± 1.5 2.1 ± 1.3 0.64 
AIR (µU/mL) 1848.2 ± 1246.4 1572.9 ± 1292.7 0.03 
DI (×10-4min-1) 2708.4 ± 1162.4 2321 ± 1034 0.006 
 
Data are means ± SD, n (%), NGT=normal glucose tolerance; IFG=impaired fasting glucose; 
IGT=impaired glucose tolerance; BMI=body mass index; SBP=systolic blood pressure; 
DBP=diastolic blood pressure; SAAT=subcutaneous abdominal adipose tissue; IAAT=intra-
abdominal adipose tissue TAG=triglyceride; HDL=high-density lipoprotein; LDL=low-density 
lipoprotein; VLDL=very low-density lipoprotein; AUC=area under the curve; SI=insulin 
sensitivity; AIR=acute insulin response; DI=disposition index. 
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These findings persisted after age, sex, Tanner stage, body composition, and 
fasting and 2-hr glucose were con- trolled for (models 2–4 [Table 3-2]). The pattern of 
change for the ≥155 group was characterized by a steady decline in DI resulting in a 
54.8% decrease by year 8. In contrast, the <155 group was characterized by an initial 
decrease followed by a subsequent increase in DI, which resulted in a 28.6% higher DI 
than that at baseline (Fig. 3-1)  
 
Table 3-2. Linear Mixed Models of Disposition Index (DI) Over Time by One Hour 
Glucose at Baseline 
Dependent Variable Effect β ± SE P-value 
Model 1: Intercept 2078.5 ± 111.3 < 0.0001 
DI (unadjusted) 1-hour glucose (<155) 341.5 ± 137.9 0.01 
    
Model 2: Intercept 3563.3 ± 370.2 < 0.0001 
DI (adjusted) 1-hour glucose (<155) 279.5 ± 130.0 0.03 
 Age -53.4 ± 27.6 0.05 
 Sex -201.8 ± 133.6 0.13 
 Tanner stage -146.2 ± 47.8 0.002 
    
Model 3: Intercept 3957.2 ± 395.6 < 0.0001 
DI (adjusted) 1-hour glucose (<155) 338.8 ± 126.6 0.008 
 Age 24.9 ± 31.2 0.43 
 Sex -334.6 ± 155.7 0.03 
 Tanner stage -85.2 ± 57.6 0.14 
 Lean tissue mass (kg) -0.022 ± 0.008 0.008 
 Fat mass (kg) -0.018 ± 0.006 0.009 
    
Model 4: Intercept 5672.7 ± 747.2 < 0.0001 
DI (adjusted) 1-hour glucose (<155) 327.8 ± 126.2 0.01 
 Age 19.8 ± 31.2 0.53 
 Sex -373.7 ± 155.8 0.02 
 Tanner stage -83.8 ± 57.9 0.15 
 Lean tissue mass (kg) -0.022 ± 0.008 0.007 
 Fat mass (kg) -0.014 ± 0.006 0.03 
 Fasting glucose (mg/dL) -14.5 ± 6.9 0.04 
 2-hour glucose (mg/dL) -2.9 ± 2.2 0.19 
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Figure 3-1. Changes in Disposition Index (DI) Over Time in Below155 and Above 155 
 
Hierarchical generalized estimating equations were used to examine the odds of 
developing prediabetes (IFG or IGT) by group among participants with NGT at baseline 
(n = 125; 747 total observations). NGT participants with 1-hr glucose concentrations 
≥155 mg/dL at baseline were 2.54 times more likely to develop prediabetes over time 
(model 1 [Table 3-3]). These findings persisted after controlling for age, sex, Tanner 
stage, body composition, and fasting and 2-hr glucose concentrations (models 2–4 [Table 
3-3]). Fifty-eight percent of those in the <155 group maintained NGT status throughout 
follow-up compared with only 28% of those in the ≥155 group (P = 0.004). 
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Table 3-3. Multivariable Adjusted Odds Ratios and 95% Confidence Intervals (CI) for 
Developing Prediabetes for NGT at Baseline 
 Odds Ratio (95% CI) P-value 
Model 1   
<155 1  
≥155 2.5 (1.6- 4.1) 0.0001 
Model 2a   
<155 1  
≥155 2.6 (1.6 - 4.2) 0.0001 
Model 3b   
<155 1  
≥155 3.1 (1.9 - 4.9) < 0.0001 
Model 4c   
<155 1  
≥155 2.4 (1.4 - 4.2) 0.0015 
aModel 2 adjusted for age, sex, and Tanner stage 
bModel 3 adjusted for age, sex, Tanner, stage, lean tissue mass and fat mass 
cModel 4 adjusted for age, sex, Tanner, stage, lean tissue mass, fat mass, fasting 
glucose and 2-hour glucose. 
 
Conclusions 
In the current study, we demonstrate that a 1-hr glucose concentration during an 
OGTT differentiates diabetes risks and prospectively predicts deterioration in β-cell 
function and progression to prediabetes among obese Latino youth. These data extend 
previous cross- sectional studies in youth and support the potential prospective utility of 
1-hr glucose concentrations during an OGTT to identify youth at highest risk for 
developing type 2 diabetes. Furthermore, these findings are independent of traditional 
risk factors for type 2 diabetes. 
Longitudinal epidemiological studies in adults (Abdul-Ghani et al., 2008; Abdul-
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Ghani et al., 2009; Abdul-Ghani et al., 2007) have established a cutoff value (155 mg/dL) 
for 1-hr plasma glucose concentration during an OGTT as a strong, independent predictor 
of type 2 diabetes. Abdul-Ghani et al. (2009) reported that the rate of conversion to 
diabetes over 8 years was significantly greater in NGT participants with 1-hr glucose 
concentrations ≥155 mg/dL compared with individuals whose 1-hr glucose concentration 
did not exceed 155 mg/dL (8.5 vs. 1.3%). Further- more, the predictive ability of 1-hr 
glucose concentrations was significantly stronger than either fasting or 2-hr glucose 
levels. The authors suggested that, while individuals with NGT are typically considered 
at low risk for the development of type 2 diabetes, a subgroup of those reaching a 1-hr 
threshold of 155 mg/dL during an OGTT may be at increased risk for future type 2 
diabetes. Although the specific threshold identified by Abdul-Ghani et al. has been 
confirmed in two separate cohorts, others have identified alternative 1-hr glucose 
thresholds that may confer increase risk for type 2 diabetes. In a cross-sectional analysis, 
Manco et al. (2010) identified 161 mg/dL as a 1-hr threshold for differentiating type 2 
diabetes risk factors including IGT, insulin resistance, and β-cell dysfunction among 
European adults. Only two cross-sectional studies in the pediatric population have tested 
the utility of 1-hr glucose concentration during an OGTT to identify diabetes risk (Manco 
et al., 2012; Tfayli et al., 2011). Tfayli et al. (2011) examined a biracial group (African 
American and Caucasian) of over- weight and obese youth and found that, independent of 
adiposity and glucose tolerance status, children with 1-hr glucose concentration ≥155 
mg/dL exhibited 41% lower DI compared with those with a 1-hr glucose value below this 
threshold. A second cross-sectional study in youth by Manco et al. (2012) used receiver 
operating characteristic analysis to try to establish and validate the best 1-hr glucose 
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threshold for identifying diabetes risk. The authors reported that a cutoff value of 132.5 
mg/dL identified IGT with 80.8% sensitivity and 74.3% specificity. Both of the 
aforementioned pediatric studies used cross-sectional designs, which have inherent 
limitations that are exacerbated by growth-related changes in children and adolescents. 
The present findings extend these previous studies to show that a 1-hr glucose 
concentration of ≥155 mg/dL does indeed predict diabetes risk over time and that the 
predictive ability is independent of other known risk factors. Of interest, when we 
modeled 1-hr glucose based on the threshold identified by Manco et al. (132.5 mg/dL), 
we observed a significant association with changes in DI that was similar in magnitude to 
the effect for the 155 threshold (β = -329.1, P = 0.02). However, this threshold was not 
associated with increased odds of developing prediabetes in our cohort (odds ratio 1.5, P 
= 0.19). It is plausible that population variation in terms of age, sex, or race/ethnicity may 
impact the predictive utility of various thresholds, as these factors have been shown to 
affect diabetes risk in youth (Goran & Gower, 2001; Lewy, Danadian, Witchel, & 
Arslanian, 2001; Goran, Bergman, Cruz, & Watanabe, 2002).  
Little is known about the natural history of type 2 diabetes in youth. Most studies 
to date examining the pathophysiology of type 2 diabetes in youth have been cross-
sectional in nature. Similar to findings in adult studies (Bergman, Ader, Huecking, & Van 
Citters, 2002; Weyer, Bogardus, Mott, & Pratley, 1999), β-cell dysfunction is thought to 
be a key feature in the development of type 2 diabetes (Elder, Woo, & D'Alessio, 2010; 
Gungor et al., 2005). Using cross-sectional data from this cohort, we previously observed 
that both IFG and IGT were associated with impaired β-cell function (Goran et al., 2004; 
Weigensberg, Ball, Shaibi, Cruz, & Goran, 2005). Furthermore, recent studies suggest 
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that obese youth with glucose levels toward the upper limit of the normal range (i.e., 
fasting glucose between 90 and 100 mg/dL and 2-hr glucose between 120 and 140 
mg/dL) exhibited lower β-cell function compared with youth whose fasting and 2-hr 
glucose concentrations are <90 mg/dL and 120 mg/dL, respectively (Burns et al., 2011; 
Tfayli, Lee, & Arslanian, 2010). These findings have been confirmed longitudinally 
(Giannini et al., 2012), where obese NGT youth with 2-hr glucose concentrations 
between 120 and 139 mg/dL exhibited a significantly greater likelihood of developing 
IGT than obese NGT youth with 2-hr glucose levels between 100 and 119 mg/dL (42 vs. 
21%, respectively). Collectively, these reports support impaired β-cell function as an 
important pathophysiologic process underlying prediabetes and overt diabetes in youth. 
The current results build upon these previous findings to indicate that independent of 
fasting or 2-hr glucose levels, a higher 1-hr glucose concentration is associated with β-
cell dysfunction and the development of prediabetes. 
Although it remains unclear whether the primary defect underlying type 2 
diabetes in youth is related to insulin action or secretion, using β-cell function may offer 
the most robust risk measure. Recent studies in adults suggest that early defects in insulin 
secretion play a pivotal role in the pathophysiology of type 2 diabetes (Abdul-Ghani, 
Jenkinson, Richardson, Tripathy, & DeFronzo, 2006). A large prospective study reported 
that the impairment of first-phase insulin secretion (measured by the insulinogenic index 
during an OGTT) is a common characteristic of both IFG and IGT. Similarly, recent 
studies in youth (Bacha, Lee, Gungor, & Arslanian, 2010; Weiss et al., 2005) suggest that 
obese adolescents with prediabetes (IFG or IGT) exhibit primary defects in insulin 
secretion (commonly in first- phase insulin secretion) rather than insulin resistance. 
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However, these studies focused exclusively on obese adolescents who presumably 
already had some degree of insulin resistance. It is possible that higher 1-hr glucose 
reflects impairments in the first- phase insulin secretion and that elevation in 2-hr glucose 
reflects second- or late-phase insulin secretion. Our cross-sectional results suggest that 
differences in DI between the ≥155 group and the <155 group were the result of insulin 
secretion rather than SI, as the latter was not different between groups. If we model our 
longitudinal data with either SI or insulin secretion as the dependent variable, secretion 
rather than sensitivity appears to be the differentiating factor between groups over time. 
Independent of the mechanism, our data suggest that 1-hr glucose concentrations of at 
least 155 mg/dL during an OGTT may identify children at high risk for developing type 2 
diabetes and who could benefit from focused and intensive prevention efforts. Moreover, 
the predictive ability of 1-hr glucose was independent of fasting markers of diabetes risk 
including IFG or an HbA1c ≥5.7%. Given that pediatricians often have to make clinical 
decisions about patients based upon a single visit, including a 1-hr glucose measure 
during a standard 2-hr OGTT may help identify those in need of more aggressive or 
closer follow-up. 
To our knowledge, this was the first longitudinal study in youth to examine the 
threshold of 1-hr glucose concentration (155 mg/dL) in relation to changes in type 2 
diabetes risk and development of prediabetes over time. We focused on a high-risk 
cohort, assessed diabetes risk using robust measures of insulin sensitivity and secretion 
from the FSIVGTT to estimate β-cell function, controlled for the potential confounding 
effects of maturation and body composition, and used powerful statistical modeling 
techniques to account for the variance component across time. Despite these strengths, 
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we acknowledge potential limitations that should be considered. First, we analyzed the 
data based on a single OGTT at baseline. Libman, Barinas-Mitchell, Bartucci, Robertson, 
and Arslanian (2008) demonstrated poor reproducibility of the OGTT in over- weight 
youth, with 2-hr glucose being less reproducible than fasting glucose. It would be 
worthwhile to examine whether the reproducibility of 1-hr glucose more closely 
resembles that of fasting or 2-hr measures and whether repeated measures of 1-hr glucose 
≥155 mg/dL are more consistently associated with diabetes risk than is repeated IFG or 
IGT status. Second, given the longitudinal nature of the study, not all participants were 
available for every year of testing, so controlling for missing data by linear mixed 
modeling was necessary. Third, owing to the low conversion rate to overt type 2 diabetes, 
we opted to focus on changes in diabetes risk factors (β-cell dysfunction and prediabetes). 
There were only three cases of newly diagnosed type 2 diabetes over time (2 from the 1-
hr glucose <155 group and 1 from the 1-hr glucose ≥155 group for overall conversion 
rates of 1.3% and 1.2%, respectively). The low overall conversion rate renders it difficult 
to make any reliable comparisons between two groups. When we separately examined the 
development of IFG and/or IGT over time, the results are outlined in Table 3-4. 
Table 3-4. Change of Glycemic Status During The Follow-up Periods 
Within NGT at 
baseline (N=125) 
Maintain 
NGT  
n (%) 
IFG 
n (%) 
IGT 
n (%) 
IFG + IGT 
n (%) 
Total 
Prediabetes 
n (%) 
Below 155 
(n=93) 
54 (58%) 10 (11%) 14 (15%) 15 (16%) 39 (42%) 
Above 155 
(n=32) 
9 (28%) 5 (16%) 13 (40%) 5 (16%) 23 (72%) 
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 Future studies will need to recruit much larger cohorts followed over longer 
periods to definitively test the utility of 1-hr glucose concentrations to predict the 
development of overt diabetes in youth. Lastly, we applied a single cutoff point of 1-hr 
glucose based upon adult studies to prospectively identify changes in diabetes risk 
factors. Future studies should use receiver operating characteristic analysis to identify the 
maximum sensitivity and specificity of a 1-hr glucose concentration to predict the 
development of type 2 diabetes across representative pediatric populations. These studies 
will not only allow for optimization of the best 1-hr glucose threshold but may also be 
used to compare the predictive power of this risk marker with other established diabetes 
risk factors such as fasting and postchallenge glucose concentrations as well as HbA1c. 
In summary, a glucose concentration ≥155 mg/dL at 1-hr during an OGTT may be 
an early independent marker of future type 2 diabetes risk as measured by deterioration in 
β-cell function and progression to prediabetes in overweight and obese Latino youth with 
a family history of type 2 diabetes. 
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CHAPTER 4: COMPARING GLYCEMIC INDICATORS OF PREDIABETES: A 
PROSPECTIVE STUDY OF OBESE LATINO YOUTH 
 
Joon Young Kim, Michael I. Goran, Claudia M. Toledo-Corral, Marc J. Weigensberg, 
and Gabriel Q. Shaibi 
 
Abstract 
Objective 
One hour (1-hr) glucose during an oral glucose tolerance test (OGTT) is an 
emerging biomarker for type 2 diabetes. We compared the predictive power of 1-hr 
glucose to traditional glycemic markers for prospectively identifying prediabetes in 
youth. 
Research Design and Methods 
Obese normoglycemic Latino youth (N = 116) were assessed at baseline for 
glycated hemoglobin (HbA1c), fasting, 1-hr, and 2-hr glucose during an OGTT and were 
followed for up to 8 yr for the development of prediabetes. Receiver operating 
characteristic (ROC) curves were used and a multivariable prediction model was 
developed. 
Results 
The area under the 1-hr glucose ROC curve was the most powerful predictor of 
prediabetes over time [0.73, 95% confidence interval (CI) = 0.64 – 0.83]. However, 
combining all indicators into a single model was superior to individual marker models 
(0.77, 95% CI = 0.690.86). Conclusions: These results further support the utility of 1-hr 
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glucose during an OGTT as a prospective marker of diabetes risk in youth. 
Introduction 
Early identification of youth at greatest risk for developing type 2 diabetes is a 
critical step for delivering targeted prevention strategies. In addition to traditional 
markers of hyperglycemia [glycated hemoglobin (HbA1c), fasting glucose, and 2-hr 
glucose following an oral glucose tolerance test (OGTT)], several recent studies have 
shown that 1-hr glucose is an emerging biomarker for type 2 diabetes risk in children 
(Kim et al., 2013; Manco et al., 2012; Tfayli, Lee, Bacha, & Arslanian, 2011) and adults 
(Abdul-Ghani, M., Abdul-Ghani, T., Ali, & DeFronzo, 2008; Abdul-Ghani, Lyssenko, 
Tuomi, DeFronzo, & Groop, 2009; Abdul-Ghani, Williams, DeFronzo, & Stern, 2007; 
Manco et al., 2010). Recently, Alyass et al. (2015) compared the predictive power 1-hr 
plasma glucose with traditional risk factors for future type 2 diabetes. They revealed that 
1-hr glucose concentraion from the OGTT showed fair/good predictive power (area under 
the receiver operating characteristic [ROC] curve=0.80), indicating that it was more 
powerful than HbA1c (area under the ROC curve=0.69). To our knowledge there were no 
longitudinal studies in younger population. Therefore, the purpose of this study was to 
prospectively compare the predictive power of 1-hr glucose to HbA1c, fasting, and 2-hr 
glucose for identifying progression to prediabetes in obese Latino youth. In addition, we 
combined predictors into a multivariate model to examine whether combining indicators 
improved the predictive power. 
Research design and methods 
Participants 
Baseline data from 116 overweight/obese [body mass index (BMI) for age and 
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sex ≥85th percentile] Latino youth with a family history of type 2 diabetes (67 male/49 
female; 11.5 ± 1.9 yr old) who participated in the USC Study of Latino Adolescents at 
Risk (SOLAR) diabetes project were used in this study. Data were restricted to 
participants with normal glucose tolerance (NGT) at baseline who were followed for at 
least 1 yr and up to 8 yr. The institutional review board of the USC approved this study. 
Normoglycemic vs. Dysglycemic 
Two groups were created based upon glycemic status during follow-up. 
Participants in the normoglycemic group maintained their NGT status over time while 
participants in the dysglycemic group met the American Diabetes Association (2010) 
criteria for prediabetes during at least one follow-up visit. Participants whose glycemic 
status fluctuated between NGT and pre- diabetes across follow-up periods (intermittent 
prediabetes), were classified as dysglycemic and data from their latest visit corresponding 
to a prediabetic state were used for analysis. 
Measurements 
Participants completed a fasting blood draw followed by a standard 2-hr OGTT. 
HbA1c as well as fasting, 1- hr, and 2-hr plasma glucose obtained during the OGTT was 
analyzed at the Los Angeles County-USC Medical Center Core Laboratory with the 
Hexokinase method (Dade Behring, Deerfield, IL, USA). HbA1c was measured by high-
performance liquid chromatography (model 11c 2.2 HLC-723; Tosoh, Tokyo, Japan). 
Statistical Analysis.  
Independent sample t-tests and chi-square analysis were used to compare clinical 
features at baseline between glycemic groups. Non-normally distributed data were log10 
transformed. PASW 20.0 statistical software package was used. Receiver operating 
65 
characteristic (ROC) curves were used to estimate the predictive power (i.e. area under 
the ROC curve) of each glycemic indicator to identify progression to prediabetes over 
time. In addition, a complete multivariable prediction model combining all glycemic 
indicators was developed and compared against the individual models. The algorithm 
developed by DeLong, E., DeLong, D., and Clarke-Pearson (1988) was used to compare 
the areas under the ROC curves. Statistical analyses related to predictive power of 
parameters were performed with the sas statistical software package. 
Results 
Of the 116 overweight/obese normoglycemic Latino youth at baseline, 57 
participants (49.1%) experienced progression to prediabetes whereas 59 participants 
(52.9%) maintained their NGT status throughout follow-up. Among the dysglycemic 
group, 10 exhibited persistent prediabetes, 10 exhibited intermittent dysglycemia and 
were prediabetic at their last visit, and 37 exhibited prediabetes at least one time but 
reverted back to NGT at the last visit. No significant baseline differences in age, sex, 
BMI, waist circumference, visceral fat, total body fat mass, or HbA1c were noted 
between two groups. However, participants in the dysglycemic group exhibited 
significantly higher plasma glucose level at fasting (89.4±4.7 vs. 86.8±4.8mg/dL), 1- hr 
(149.8 ± 20.9 vs. 132.1 ± 21.2 mg/dL) and 2-hr (120.4 ± 12.3 vs. 114.2 ± 11.3 mg/dL), 
time points during the OGTT (all P < 0.01).  
The comparison of area under the ROC curve was used to identify the model with 
the highest predictive powerful for prospectively identifying progression to prediabetes 
based on baseline glycemic measures (Table 4-1). Of the individual glycemic indicators, 
the highest predictive power was for 1-hr glucose (73.4%), followed by fasting glucose 
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(66.9%), 2-hr glucose (63.6%), and HbA1c (58.1%). Adding BMI as a covariate to each 
model had no effect on predictive power. When predictive powers were compared pair- 
wise, only 1-hr glucose and HbA1c were statistically different (P < 0.05). The area under 
the ROC curve for the complete model (HbA1c, fasting, 1-hr, and 2-hr glucose) was 
significantly better than any of the individual models for predicting progression to 
prediabetes with the exception of that for 1-hr glucose (77.0% vs. 73.0%, P = 0.26). 
Table 4-1. Comparing Areas Under The ROC Curve Among Individual Parameters and A 
Multivariate Prediction Model 
Parameter ROC AUC 95 % CI 
Compared to  
1-hr glucose  
P-value 
Compared to  
Full modela  
P-value 
Fasting glucose 0.67 0.57 - 0.77 0.35 0.03 
1-hr glucose 0.73 0.64 - 0.83 - 0.26 
2-hr glucose 0.64 0.53 - 0.74 0.12 0.01 
HbA1c 0.58 0.48 - 0.69 0.04 < 0.01 
Full model a 0.77 0.69 - 0.86 0.26 - 
a Full model: HbA1c, fasting, 1-hr, and 2-hr glucose  
ROC, Receiver Operator Characteristic; AUC, Area Under the Curve; CI, Confidence 
Interval. 
 
Conclusions 
In the current longitudinal study, we showed that 1-hr glucose is the single best 
predictor for identifying future prediabetes among normoglycemic overweight/obese 
Latino youth. However, combining indicators into a multivariate model that included 
HbA1c, fasting, 1-hr, and 2-hr glucose was superior to any individual model. 
Although standard clinical glycemic indicators (i.e. HbA1c, fasting, and 2-hr 
glucose) are currently used for the identification of prediabetes and diagnosis of type 2 
diabetes, longitudinal epidemiological studies in adults show that these indicators do not 
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optimally predict future risk of type 2 diabetes (Gerstein et al., 2007; Unwin, Shaw, 
Zimmet, & Alberti, 2002). In addition, the utility of HbA1c as a screening tool for 
diabetes risk in youth remains controversial (Chan et al., 2014; Love-Osborne et al., 
2013). For these reasons, studies continue to search for better biomarkers and/or models 
in youth and adults (Reinehr et al, 2009; Stern, Williams, & Haffner, 2002). Recent 
studies in adults support the utility of 1-hr glucose during an OGTT for identifying type 2 
diabetes risk and Abdul-Ghani et al. verified that the predictive ability of 1-hr glucose 
was significantly better than traditional glycemic markers (Abdul-Ghani et al., 2008; 
Abdul-Ghani et al., 2009; Abdul-Ghani et al., 2007).  
In the pediatric population, Tfayli et al. (2011) confirmed the previous findings in 
overweight/obese African American and Caucasian youth. Our group also reported that 
Latino youth with a higher 1-hr glucose exhibited greater deterioration of β-cell function 
and higher risk for developing prediabetes over time (Kim et al., 2013). Although both of 
the aforementioned studies tested the utility of 1-hr glucose for identifying type 2 
diabetes risk, no study has compared this marker to traditional markers for predicting 
diabetes risk in youth. 
To our knowledge, this is the first longitudinal study in youth to examine the 
predictive power of 1-hr glucose during the OGTT for predicting future prediabetes. We 
focused on Latino overweight/obese Latino youth with a family history of type 2 diabetes 
who experience disproportionate risk for developing type 2 diabetes relatively early in 
life. Our data support the utility of 1-hr glucose concentrations as a useful predictor for 
type 2 diabetes risk and suggest that this novel marker may be more powerful than 
traditional glycemic indicators. Interestingly, the complete multivariate model that 
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included fasting, 1-hr, 2-hr glucose, and HbA1c was not statistically better than 1-hr 
glucose alone. All other indicators were statistically less powerful than the combined 
model. When additional indicators (age, sex, BMI, visceral fat, total fat mass, fasting 
insulin, and 1-hr insulin) were added to the complete multivariate glycemic model the 
predictive power was slightly increased, but it was not significantly different (0.81 vs. 
0.77, P = 0.10). 
There are potential limitations of our study. Given the longitudinal nature of the 
study, not all participants were available for every year of testing. We attempted to define 
dysglycemia as those participants who experienced at least one instance of a prediabetes 
over time (Table 4-2). We acknowledge that this approach may overestimate the true 
incidence of prediabetes as the OGTT is not always reproducible and 65% of youth in the 
dysglycemic group did indeed convert back to NGT in subsequent years.  
Table 4-2. Classification of Dysglycemic 
 
Baseline 
visit 
Follow-up 
visits 
Last visit 
# of 
participants 
Classification 
Case 1 NGT Prediabetes Prediabetes 10 (17.5%) Dysglycemic 
Case 2 NGT NGT Prediabetes 10 (17.5%) Dysglycemic 
Case 3 NGT Prediabetes NGT 37 [20]* (65%) Dysglycemic 
Note. Case 2 and 3 are classified as participants who had intermittent prediabetes. In Case 3, 
latest visit (among “Follow-up visits”) corresponding to a pediabetic state was used for our 
analysis. *Of 37 participants in the Case 3, while 17 youth experienced one instance of a 
prediabetes over time, 20 participants exhibited more than 2 times of development of prediabetes 
before the last visit (even though their glycemic status were reverted back to NGT at the last 
visit).  
 
However, given that previous research in obese youth suggests that youth with 
intermittent prediabetes may be at greatest metabolic risk (Libman, Barinas-Mitchell, 
Bartucci, Robertson, & Arslanian, 2008), we included these youth as dysglycemic in our 
analyses. Longer follow-up periods and larger samples are needed to (1) definitively test 
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the predictive power of 1-hr glucose compared with traditional glycemic markers, and (2) 
identify a threshold for 1-hr glucose that best discriminates youth at highest risk for 
developing type 2 diabetes. In addition, the complex nature of type 2 diabetes warrants 
that other potential risk factors such as ethnicity, family history of diabetes, degree of 
obesity, or pubertal development should be considered in these analyses (Ek, Rossner, 
Hagman, & Marcus, 2014; Reiner et al., 2009). 
In conclusion, this study highlights 1-hr glucose concentrations during an OGTT 
as an important biomarker of diabetes risk in youth. Among individual glycemic 
indicators, 1-hr glucose exhibited the highest predictive power for identifying future 
prediabetes. 
Acknowledgements 
We are grateful to the children and their families who have participated in the 
USC SOLAR Diabetes Project. We thank the staff of the GCRC for their help with 
enrolling and testing participants. This study has been supported by National Institutes of 
Health Grant R01-DK-59211 to Dr. Michael I. Goran and General Clinical Research 
Center, National Center for Research Resources Grant MO1-RR-00043. 
J. Y. K. analyzed data and wrote the manuscript. M. I. G. researched data and 
reviewed/edited the manuscript. M. J. W. researched data and reviewed/edited the 
manuscript. C. T.-C. researched data and reviewed/edited the manuscript. G. Q. S 
researched data and reviewed/edited the manuscript, assisted in writing the manuscript. 
G. Q. S. is the guarantor of this work and, as such, takes responsibility for the integrity of 
the data and the accuracy of the data analysis. 
Parts of this study were presented in abstract from at the 73rd Scientific Sessions 
70 
of the American Diabetes Association, Chicago, IL, 21–25 June 2013. 
Conflict of interest 
The authors have declared no conflicting interests.  
71 
References 
Abdul-Ghani, M. A., Abdul-Ghani, T., Ali, N., & Defronzo, R. A. (2008). One-hour 
plasma glucose concentration and the metabolic syndrome identify subjects at 
high risk for future type 2 diabetes. Diabetes Care, 31(8), 1650-1655. doi: 
10.2337/dc08-0225 
Abdul-Ghani, M. A., Lyssenko, V., Tuomi, T., DeFronzo, R. A., & Groop, L. (2009). 
Fasting versus postload plasma glucose concentration and the risk for future type 
2 diabetes: results from the Botnia Study. Diabetes Care, 32(2), 281-286. doi: 
10.2337/dc08-1264 
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. (2007). What is the 
best predictor of future type 2 diabetes? Diabetes Care, 30(6), 1544-1548. doi: 
10.2337/dc06-1331 
Alyass, A., Almgren, P., Akerlund, M., Dushoff, J., Isomaa, B., Nilsson, P., … Meyre, D. 
(2015). Modelling of OGTT curve identifies 1 h plasma glucose level as a strong 
predictor of incident type 2 diabetes: results from two prospective cohorts. 
Diabetologia, 58(1), 87-97. 
American Diabetes, Association. (2010). Diagnosis and classification of diabetes 
mellitus. Diabetes Care, 33(Suppl 1), S62-69. doi: 10.2337/dc10-S062 
Chan, C. L., McFann, K., Newnes, L., Nadeau, K. J., Zeitler, P. S., & Kelsey, M. (2014). 
Hemoglobin A1c assay variations and implications for diabetes screening in obese 
youth. Pediatric Diabetes, 15(8), 557-563. doi: 10.1111/pedi.12132 
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas 
under two or more correlated receiver operating characteristic curves: a 
nonparametric approach. Biometrics, 44(3), 837-845.  
Ek, A. E., Rossner, S. M., Hagman, E., & Marcus, C. (2014). High prevalence of 
prediabetes in a Swedish cohort of severely obese children. Pediatric Diabetes. 
doi: 10.1111/pedi.12136 
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., … 
Booker, L. (2007). Annual incidence and relative risk of diabetes in people with 
various categories of dysglycemia: a systematic overview and meta-analysis of 
prospective studies. Diabetes Research and Clinical Practice, 78(3), 305-312. 
doi: 10.1016/j.diabres.2007.05.004 
72 
Kim, J. Y., Goran, M. I., Toledo-Corral, C. M., Weigensberg, M. J., Choi, M., & Shaibi, 
G. Q. (2013). One-hour glucose during an oral glucose challenge prospectively 
predicts β-cell deterioration and prediabetes in obese Hispanic youth. Diabetes 
Care, 36(6), 1681-1686. 
Libman, I. M., Barinas-Mitchell, E., Bartucci, A., Robertson, R., & Arslanian, S. (2008). 
Reproducibility of the oral glucose tolerance test in overweight children. The 
Journal of Clinical Endocrinology & Metabolism, 93(11), 4231-4237. 
Love-Osborne, K. A., Sheeder, J., Svircev, A., Chan, C., Zeitler, P., & Nadeau, K. J. 
(2013). Use of glycosylated hemoglobin increases diabetes screening for at-risk 
adolescents in primary care settings. Pediatric Diabetes, 14(7), 512-518. doi: 
10.1111/pedi.12037 
Manco, M., Miraglia Del Giudice, E., Spreghini, M. R., Cappa, M., Perrone, L., Brufani, 
C., … Caprio, S. (2012). 1-Hour plasma glucose in obese youth. Acta 
Diabetologica, 49(6), 435-443. doi: 10.1007/s00592-012-0384-3 
Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., … 
Cardiovascular Risk, Consortium. (2010). One-hour plasma glucose identifies 
insulin resistance and beta-cell dysfunction in individuals with normal glucose 
tolerance: cross-sectional data from the Relationship between Insulin Sensitivity 
and Cardiovascular Risk (RISC) study. Diabetes Care, 33(9), 2090-2097. doi: 
10.2337/dc09-2261 
Reinehr, T., Wabitsch, M., Kleber, M., de Sousa, G., Denzer, C., & Toschke, A. M. 
(2009). Parental diabetes, pubertal stage, and extreme obesity are the main risk 
factors for prediabetes in children and adolescents: a simple risk score to identify 
children at risk for prediabetes. Pediatric Diabetes, 10(6), 395-400. doi: 
10.1111/j.1399-5448.2008.00492.x 
Stern, M. P., Williams, K., & Haffner, S. M. (2002). Identification of persons at high risk 
for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Annals of 
Internal Medicine, 136(8), 575-581.  
Tfayli, H., Lee, S. J., Bacha, F., & Arslanian, S. (2011). One-hour plasma glucose 
concentration during the OGTT: what does it tell about beta-cell function relative 
to insulin sensitivity in overweight/obese children? Pediatric Diabetes, 12(6), 
572-579. doi: 10.1111/j.1399-5448.2011.00745.x 
73 
Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. (2002). Impaired glucose tolerance 
and impaired fasting glycaemia: the current status on definition and intervention. 
Diabetic Medicine, 19(9), 708-723. 
  
74 
CHAPTER 5: ASSOCIATION OF GENETIC VARIANTS FOR SUSCEPTIBILITY TO 
TYPE 2 DIABETES WITH NOVEL GLYCEMIC MARKERS IN LATINOS 
 
Joon Young Kim, Dawn K. Coletta, Elena A. De Filippis, Lawrence J. Mandarino, and 
Gabriel Q. Shaibi 
 
Abstract 
Objective 
Type 2 diabetes has emerged as a critical public health concern in youth and 
adults. Despite significant progress in identifying the genetic causes on type 2 diabetes, 
data related to new promising genes such as KQT-like subfamily member (KCNQ1) are 
lacking. Given that novel type 2 diabetes risk markers including glucose response curve 
and 1-hr glucose level were verified in both youth and adults, the purpose of our study 
was to examine whether these novel type 2 diabetes biomarkers are associated with 
common 59 SNPs (representing 31 genes including KCNQ1) in the Latino population. 
Research Design and Methods 
Data from the Arizona Insulin Resistance registry were used in this study. 
Metabolic, anthropometric, demographic and medical history information were obtained 
from 667 Latino youth and adults. Genotypes and cardiometabolic phenotypes were 
analyzed to examine the associations of genetic variants of interested susceptibility gene 
with phenotypes (i.e., adiposity, lipid profile, glycemic parameters, and measures of 
insulin dynamics) using software package Sequential Oligogenic Linkage Analysis 
Routines. 
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Results 
Among 59 common SNPs, 15 SNPs (representing 8 genes/loci) were associated 
with the glucose response curve and 18 genetic variants (representing 9 genes/loci) were 
associated with 1-hr glucose. In both novel markers, rs11605924/CRY2 exhibited that the 
major allele was significantly associated with increased prevalence of the monophasic 
response and an elevated 1-hr glucose concentration. These findings indicate that these 
major alleles are risk alleles for early indicators of type 2 diabetes. The minor allele of 
rs4766415 and rs10735003/ADIPOR2 showed a significant association with increased 
prevalence of the monophasic response and an elevated 1-hr glucose level, indicating that 
these minor alleles were considered as risk alleles. For the KCNQ1 SNPs (n=3), fasting 
and 2-hr glucose, prediabetes, Matsuda Index, insulinogenic Index, and disposition index 
were significantly associated with both SNPs (rs151290 and rs2237892). SNP rs2237892 
was significantly associated with 1-hr glucose concentration.  
Conclusions 
This study found that there were significant associations between KCNQ1 SNPs 
(rs151290 and rs2237892) and diabetes-related phenotypes. In addition, genetic 
associations of novel glycemic markers found multiple genetic variants that were 
associated with either the glucose response curve or 1-hr glucose level from an OGTT. 
Introduction 
Obesity has reached epidemic proportions in the US with approximately 32% of 
adolescents and two-thirds of adults classified as either overweight or obese (Ogden, 
Carroll, Kit, & Flegal, 2014). In the context of a widespread obesity epidemic, the burden 
of metabolic abnormalities (i.e., metabolic syndrome and type 2 diabetes) is of clinical 
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and public health concern in both youth and adults (Fagot-Campagna, 2010; Ford, Li, & 
Zhao, 2010). Due to the complex nature of metabolic impairments, the avenues by which 
type 2 diabetes has been studied are varied. In addition to environmental factors such as 
diet or exercise (Ershow, 2009), there is compelling evidence that genetic factors are also 
involved in the development of type 2 diabetes. To date, genome-wide association studies 
(GWAS) and large-scale meta-analysis have identified more than 60 single nucleotide 
polymorphisms (SNPs) that are associated with type 2 diabetes risk (Brunetti, Chiefari, & 
Foti, 2014; Dupuis et al., 2010; McCarthy, 2010; Saxena et al., 2012). However, these 
SNPs have shown modest effect sizes and collectively explain only 10% for the variance 
in type 2 diabetes risk (McCarthy & Zeggini, 2009; Morris et al., 2012; Imamura & 
Maeda, 2011; Voight et al., 2010). For this reason, ongoing efforts are needed to further 
identify genetic variants in relation to type 2 diabetes risk (Brunetti et al., 2014; Grarup, 
Sandholt, Hansen, & Pedersen, 2014; Thomsen & Gloyn, 2014). 
It is important to note that, in addition to case-control analyses (Prokopenko, 
McCarthy, & Lindgren, 2008; Saxena et al., 2012, Scott et al., 2007; Zeggini et al., 
2008), most susceptibility genes are examined in relation to traditional type 2 diabetes 
risk factors such as fasting and 2 hour (2-hr) glucose during an oral glucose tolerance test 
(OGTT) (Dupuis et al., 2010; Ingelsson et al., 2010; Saxena et al., 2010). However, 
longitudinal studies in adults demonstrated that these traditional type 2 diabetes risk 
markers do not optimally predict future development of type 2 diabetes (Gerstein et al., 
2007; Unwin, Shaw, Zimmet, & Alberti, 2002). In order to more accurately identify 
individuals at highest risk for type 2 diabetes, clinical studies continue to search for novel 
biomarkers (Abdul-Ghani, Williams, DeFronzo, & Stern, 2007; Stern, Williams, & 
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Haffner, 2002). Our group observed that two different phenotypes of glucose response 
(mono- vs. bi-phasic) emerge by plotting glucose concentrations during an OGTT (Kim, 
Coletta, Mandarino, & Shaibi, 2012). Moreover, compared to a monophasic response, 
adults who exhibit a biphasic response may be at lower risk for developing type 2 
diabetes as evidenced by Abdul-Ghani, Lyssenko, DeFronzo, and Groop (2010). In 
addition to this marker, we also observed that one hour (1-hr) glucose predicts the 
development of prediabetes and β-cell dysfunction among obese Latino youth (Kim et al., 
2013). Moreover, 1-hr glucose may be more powerful than traditional glycemic 
indicators including fasting and 2-hr glucose for predicting type 2 diabetes risk (Kim, 
Goran, Toledo-Corral, Weigensberg, & Shaibi, 2014). Overall, our data suggest that the 
glucose response curve and 1-hr glucose concentration during an OGTT represent novel 
biomarkers for type 2 diabetes risk that are independent of traditional type 2 diabetes risk 
factors (Kim et al., 2012, 2013, 2014). 
To our knowledge, no studies have examined genetic determinants for the glucose 
response curve or 1-hr glucose. Although we recently have replicated GWAS SNPs 
(n=28) that are related to type 2 diabetes risk in a Latino population (DeMenna et al., 
2014), we did not examine genetic association with these emerging biomarkers. 
Collectively, more candidate SNPs along with non-traditional phenotypic markers for 
dysglycemia are critical to expand the current level of understanding of the genetic 
contributions to type 2 diabetes. Since these novel markers are associated with 
differential physiological risk in terms of insulin action and secretion, it is necessarily to 
identify unique SNPs in relation to insulin dynamics. In addition to our candidate SNPs 
study (DeMenna et al., 2014), we currently have included genetic variants in the 
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potassium voltage-gated channel, KQT-like subfamily member 1 (KCNQ1) that exhibit 
relatively higher effect size compared to other candidate SNPs in other ethnicities (Hu et 
al., 2009; Qi et al., 2009; van Vliet-Ostaptchouk et al., 2012). This gene is mainly 
expressed in a number of tissues, including heart, pancreas, kidneys, and intestine (Unoki 
et al., 2008; Yasuda et al., 2008) and thought to be related to β-cell dysfunction by 
regulating either glucose-stimulated (Ullrich et al., 2005) or incretin-stimulated insulin 
secretion (Mussig et al., 2009; Vallon et al., 2005). However, only two studies examined 
KCNQ1 SNP (rs2237892) in the Mexican population and exhibited significant 
association with susceptibility to type 2 diabetes (Gamboa-Melendez et al., 2012; Parra et 
al., 2011), while approximately 90% of genetic studies were performed among East 
Asian or Caucasian (Liu et al., 2013). Given that Latinos are disproportionately impacted 
by obesity and type 2 diabetes (Lawrence et al., 2009), further genetic studies related to 
KCNQ1 are warranted in this high-risk population. 
Therefore, the overall purpose of this study was to examine the associations of 
KCNQ1 genetic variants with traditional and novel glycemic biomarkers (i.e., glucose 
response curve and 1-hr glucose level) in the Arizona Insulin Resistance (AIR) registry. 
Specific aims are two-fold: 1) to determine the association between KCNQ1 SNPs 
(rs2237892; rs2237895; rs151290) and traditional diabetes-related risk factors (i.e., 
adiposity, lipid profile, fasting glucose, HbA1c, and OGTT-derived insulin release and 
resistance measures) in 667 Latino population, and 2) to examine whether the novel 
biomarkers (i.e., glucose response curve and 1-hr glucose) are associated with 59 
candidate SNPs including KCNQ1 SNPs from the AIR registry. 
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Research Design and Methods 
Participants 
A total of 667 Latino children and adults (aged 7-84 years) were enrolled with 
97% consenting to the AIR registry. The primary purpose of this registry project was to 
examine cardiometabolic disease risk in the Latino community of Phoenix, Arizona 
(Shaibi, Coletta, Vital, & Mandarino, 2013). Of the 667 participants enrolled in the study, 
365 were distributed across 92 families from the AIR registry. The 365 participants from 
92 families generated 723 relative pairs that were distributed across fourteen relative-pair 
categories. The remaining 302 participants are represented as single individuals. Consent 
was obtained for banking of serum, DNA, and RNA for the examination of molecular 
mechanisms underlying type 2 diabetes. 
Phenotypic Characterization and Measurements 
Brief Medical History and Physical Examination. Participants arrived at the 
Arizona State University Clinical Research Unit after an overnight fast followed by 
screening of their medical history. Anthropometric measurements included height, 
weight, body mass index (BMI), hip and waist circumference (HC and WC, respectively), 
and systolic and diastolic blood pressure (SBP and DBP, respectively). Body composition 
(fat mass) was determined via bioelectrical impedance. 
Metabolic Testing. The study included an OGTT in individuals with no known 
history of type 2 diabetes. Participants underwent a standard 2-hr OGTT following a 10-
hr overnight fast. Subjects ingested a solution containing 75 g dextrose (1.75 g/kg), and 
venous blood samples were obtained at 0, 30, 60, 90, and 120 minutes for determination 
of plasma glucose and insulin concentrations. Plasma glucose was measured by the 
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glucose oxidase method using a YSI 2300 STAT plus (YSI, Inc., Yellow Springs, OH), 
and insulin was measured in duplicate by ELISA (ALPCO Diagnostics, Windham, NH). 
In addition, a blood sample (~20 mL) was taken under fasting conditions to measure 
hemoglobin A1C (HbA1c) and lipid profile (total cholesterol, triglyceride, high density 
lipoprotein [HDL], low density lipoprotein [LDL], and very low density lipoprotein 
[VLDL]), and liver enzymes (alanine aminotransferase [ALT] and aspartate 
aminotransferase [AST]). All laboratory tests were performed by a Clinical Laboratory 
Improvement Amendments–certified commercial laboratory (Sonora Quest Laboratories, 
Phoenix, AZ). 
Classification of Glycemic Status. Glucose tolerance was determined according 
to the American Diabetes Association (2010) as prediabetes (impaired fasting glucose 
[IFG]: fasting glucose between 100-125 mg/dL and/or impaired glucose tolerance [IGT]: 
2-hr glucose between 140-199 mg/dL) and type 2 diabetes (fasting glucose ≥126 mg/dL 
and/or 2-hr glucose ≥200mg/dL). 
OGTT-derived Indices. Insulin action was estimated by the homeostasis model 
assessment for insulin resistance (HOMA-IR) (Matthews et al, 1985) and the whole-body 
insulin sensitivity index of Matsuda and DeFronzo (1999). Insulin secretion was 
estimated by the insulinogenic index calculated using fasting and 30 minute insulin and 
glucose concentrations (Phillips, Clark, Hales, & Osmond, 1994). The β-cell function 
relative to the degree of insulin resistance was estimated by the disposition index as the 
product of insulin action and insulin secretion. Validation studies of these indices driven 
from OGTT by comparing to the gold standards (e.g., insulinogenic clamp or intravenous 
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glucose tolerance test) are presented in Table 5-1. It is important to note that all indices 
listed in Table 5-1 were validated to be used in Latino population across age groups. 
 
Table 5-1. Validation of OGTT-derived Indices in Latinos 
Index Estimate Validation  Reference 
HOMA-IR Insulin resistance 
Inversely correlated 
with insulin 
sensitivity obtained 
from the IVGTT (r=-
0.81 p<0.01) 
Conwell, Trost, 
Brown, & Batch, 
2004; Haffner, 
Kennedy, 
Gonzalez, Stern, & 
Miettinen, 1996; 
Matthews et al., 
1985 
Matsuda Index Insulin sensitivity 
Correlated with 
insulin sensitivity 
obtained from the 
hyperinsulinemic-
euglycemic clamp 
(r=0.78, p<0.0005) 
Matsuda & 
DeFronzo, 1999; 
Yeckel et al., 2004 
Insulinogenic Index Insulin secretion 
Correlated with 1st 
phase insulin 
secretion obtained 
from the 
hyperglycemic 
clamp (r=.068, 
p<0.001) 
Phillips et al., 
1994; Wareham, 
Byrne, Hales &, 
Phillips, 1995; 
Weiss et al., 2005 
Disposition Index 
β-cell function 
relative to the 
degree of insulin 
resistance 
Correlated with 
disposition index 
obtained from the 
IVGTT (r=0.21, 
p=0.003) 
Retnakaran, Qi, 
Goran, & 
Hamilton, 2009 
 
Classification of Glucose Response Curve. Glucose response phenotype (i.e., 
monophasic or biphasic) was classified according to previous study by Tschritter et al. 
(2003) with a glucose threshold of 4.5 mg/dL used to minimize fluctuations in glucose 
concentrations that may be due to the method of glucose analysis rather than 
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physiological reasons. A monophasic response was characterized by a gradual rise in 
plasma glucose concentrations until a peak is reached followed by a subsequent decrease 
over a 2-hr period. A biphasic response was characterized by a gradual rise in glucose, 
followed by a ≥4.5 mg/dL fall, with a second rise of glucose of at least 4.5 mg/dL at a 
subsequent time point. Participants who exhibit a gradual increase in plasma glucose after 
glucose ingestion without a corresponding fall was deemed “unclassified” and was 
excluded for this study. 
SNP Genotyping 
For the genotyping, a robust screening assay was designed for each SNP. Our 
method of choice was Taqman-based allelic discrimination polymerase chain reaction 
(AD-PCR), using Taqman SNP Genotyping Assays (Applied Biosystems, Foster City, 
CA, USA). In this approach, two alternative probes were designed to anneal to the PCR 
product, covering the SNP of interest. The probe binded to the target template upstream 
from one of the primers and was displaced with cleavage when encountered by Taq 
polymerase during primer extension. Cleavage of the probe generated a signal (Gibson, 
2006). Mismatched probes from energetically less stable duplexed with the target 
sequence and provided a greatly attenuated intensity signal. Reporter dye intensity was 
measured in a “real time” PCR-Fluorometer (Applied Biosystems; 7900HT sequence 
detector). Eventually, alleles were scored using the allelic discrimination software 
Sequence Detection System v2.1 (Applied Biosystems). 
KCNQ1 SNPs Genotyping. Isolated genomic DNA from whole blood using the 
PAXgene Blood DNA procedure, per the manufacturer’s instructions (Qiagen, CA, USA) 
were used in this study. Stored DNA samples were quantified and performed quality 
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check by using the ND-1000 Spectrophotometer (Nanodrop Technologies; Rockland, 
DE). KCNQ1 SNPs (rs2237892; rs2237895; rs151290) were obtained by the Assay-by-
Design service (Applied Biosystems, CA, USA). Briefly, in a 384-well plate, 2 μL of 
purified genomic DNA (2 ng/ μL) was incubated with primers and probes with the 
KCNQ1 SNPs (0.09 μL), 3.5 μL of TaqMan Universal Polymerase Chain Reaction 
Master Mix–No AmpErase UNG, and 1.14 μL distilled water. Samples were polymerase 
chain reaction-amplified on the Applied Biosystems 9700HT Thermal Cycler under the 
following conditions; denatured for 10 minutes at 95°C, denatured, annealed, and 
extended for 40 cycles of 15 seconds at 92°C, and 1 minute at 60°C. The 384-well 
microplates were scanned for fluorescence emission using a 7900HT sequence detector 
(Applied Biosystems) and alleles were scored using the allelic discrimination software 
Sequence Detection System v2.3 (Applied Biosystems). For all SNPs genotyped in this 
study, our mean rate of success for genotyping was > 99%. 
Statistical Genetic Analysis 
The software package Sequential Oligogenic Linkage Analysis Routines 
(SOLAR) (http:// www.sfbr.org/solar) was used for testing our study hypotheses. A 
complete description of participants’ characteristics after excluding outliers for each 
phenotype (if individual value is lower or greater than mean ± 4 x standard deviation) 
was described in Table 5-2. Heritability of the phenotypes (n=25) after controlling for 
age and sex effects which were used in this study was estimated and presented in Table 5-
3. Association analysis using the measured genotype approach (MGA) within the 
variance components (VC) analytical framework was used and it allowed us to account 
for the non-independence among family members (Almasy & Blangero, 1998; 
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Boerwinkle, Chakraborty, & Sing, 1986). In this analytical framework, VCs were 
modeled as random effects (e.g., additive genetic effects and random environmental 
effects) and the mean effects of measured covariates (i.e., age and sex) were modeled as 
fixed effects on the trait mean. In MGA, generally, the marker genotypes were 
incorporated in the mean effects model as a measured covariate assuming additive allelic 
effects. The VCs, association parameters, and mean covariate effects were 
simultaneously estimated using maximum likelihood-based methods. Before performing 
MGA, the quantitative transmission disequilibrium test (QTDT) was performed to 
evaluate population stratification. With the presence of population stratification, the 
QTDT procedure was employed to assess association which is robust in the presence of 
stratification. A likelihood function based on multivariate normal density was 
numerically maximized to obtain parameter estimates. For the purposes of the exploration 
of the relationship between genetic variants (previously selected 56 SNPs and 3 KCNQ1 
SNPs) and type 2 diabetes-related traits (traditional and novel biomarkers), we used a 
nominal P value of 0.05 as our threshold for statistical significance. Deviations from 
Hardy-Weinberg Equilibrium (HWE) was tested based on the calculated allele 
frequencies by the SOLAR program.  
Phenotypes for Genetic Analysis. Twenty-five diabetes and metabolic 
phenotypes including indices of insulin action and secretion were used for the analysis: 
BMI, WC, HC, total cholesterol, HDL, LDL, VLDL, triglyceride, SBP, DBP, ALT, AST, 
fasting plasma glucose (FPG), 2-hr glucose, HbA1c, fasting plasma insulin (FPI), 
HOMA-IR, Matsuda index, insulinogenic index, disposition index, pre-diabetes status, 
and diabetes status. The formulas and references of indices of insulin action, secretion 
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and β-cell function, which are derived from the OGTT, were described previously (Kim 
et al., 2012). To normalize the trait distributions for genetic analyses, with exception of 
total cholesterol and SBP, all phenotypes were transformed using inverse normalization.  
Results 
The descriptive characteristics of the Arizona Insulin Resistance (AIR) subjects 
are shown in Table 5-2. Briefly, among 667 participants with mean age of 31.7 ± 13.4 
(aged 7-85 years old), 61% (n=407) were female and 80% of the study population were 
adults (>18 years old). The prevalence of diabetes in our population was 12.3% (n=77) 
and 34% of the participants were classified with prediabetes (IFG or IGT; n=187). For 
the novel markers of type 2 diabetes risk, the prevalence of monophasic glucose response 
phenotype was 74.5% (n=435) while 25.5% (n=149) of our study population was 
characterized by having biphasic glucose response to an OGTT. The average of 1-hr 
glucose concentrations obtained from the OGTT was 150.2 ± 66.9 (mg/dL). Prior to 
determining genetic determinants of these novel glycemic markers, the utility of each 
biomarker was tested in youth, adults, and combined groups (youth and adults) in the 
AIR registry, respectively. For the glucose response curve, individuals with a monophasic 
response exhibited deleterious metabolic characteristics across age groups when 
compared to individuals with a biphasic response (Appendix A and B). In addition, a total 
of 609 participants had available data of 1-hr glucose level in the AIR registry and we 
confirmed the utility of this threshold (≥155 mg/dL). A glucose concentration ≥155 
mg/dL at 1-hr during an OGTT exhibited higher risk for type 2 diabetes (Appendix C-E).  
Heritability estimates (h2) for the phenotypes after adjusting for age and sex were 
determined using SOLAR (Table 5-3). All of the phenotypes measured showed moderate 
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to high in magnitude (range 0.24-0.78) and were significant (all P < 0.05), with the 
exception of the glucose response curve, diabetes status, and prediabetes status.  
Table 5-2. Characteristics of the Arizona Insulin Resistance (AIR) Registry Subjects 
Phenotype Sample Size Mean ± SD or n (%) 
Age (years) 667 31.7 ± 13.4 
Sex (male/female) 667 260 (39.0%) / 407 (61.0%) 
BMI (kg/m2) 662 28.7 ± 6.5 
WC (cm) 660 95.3 ± 16.1 
HC (cm) 660 106.1 ± 13.5 
Fat mass (kg) 662 22.6 ± 11.7 
Total cholesterol (mg/dL) 657 168.5 ± 35.7 
Triglycerides (mg/dL) 655 126.9 ± 75.6 
HDL (mg/dL) 659 44.4 ± 11.0 
LDL  (mg/dL) 646 102.3 ± 29.2 
VLDL (mg/dL) 644 20.4 ± 10.6 
SBP (mmHg) 664 118.1 ± 14.8 
DBP (mmHg) 666 74.5 ± 10.1 
ALT (U/L) 647 24.7 ± 16.6 
AST (U/L) 650 23.8 ± 10.2 
HbAIc (%) 567 5.6 ± 0.3 
FPI (uIU/mL) 491 9.2 ± 6.5 
FPG (mg/dL) 626 94.7 ± 14.3 
1-hr glucose (mg/dL) 609 150.2 ± 66.9 
2-hr glucose (mg/dL) 551 121.8 ± 30.3 
HOMA-IR 514 2.2 ± 1.6 
Matsuda Index 480 5.1 ± 3.6 
Insulinogenic Index 494 1.4 ± 1.1 
Disposition Index 495 6.2 ± 5.4 
Glucose response curve (mono/bi) 584 435 (74.5%) / 149 (25.5%) 
Diabetes Status (non-diabetic/diabetic) 628 551 (87.7%) / 77 (12.3%) 
Prediabetes Status (NGT/IFG and IGT) 551 54.6 (66.1%) / 187 (33.9%) 
BMI , body mass index; WC, waist circumference; HC, hip circumference; HDL, high density 
lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; ALT; alanine aminotransferase, AST, aspartate 
transaminase; HbA1c, hemoglobin A1c; FPI, fasting plasma insulin; HOMA-IR, homeostatis 
assessment of insulin resistance; FPG, fasting plasma glucose; NGT, normal glucose tolerance; 
IFG, impaired fasting glucose; IGT, impaired  glucose tolerance. 
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Table 5-3. Heritability (h2) Estimates for Diabetes and Metabolic Phenotypes 
 
 
Phenotype h2 ± SE (%) P-value 
BMI 37 ± 10 < 0.0001 
WC 39 ± 10 < 0.0001 
HC 34 ± 10 < 0.001 
Fat mass 39 ± 11 < 0.0001 
Total cholesterol 46 ± 12  < 0.0001 
Triglycerides 58 ± 12 < 0.0001 
HDL 78 ± 10 < 0.0001 
LDL 31 ± 13 0.005 
VLDL 46 ± 13 < 0.0001 
SBP 36 ± 13 0.001 
DBP 20 ± 11 0.024 
ALT 34 ± 14 0.005 
AST 29 ± 14 0.009 
HbA1c 49 ± 11 < 0.0001 
FPI 47 ± 14 < 0.001 
HOMA-IR 51 ± 12 < 0.0001 
Matsuda Index 50 ± 14 < 0.001 
Insulinogenic Index 24 ± 14 0.042 
Disposition Index 27 ± 13 0.019 
FPG 41 ± 14 0.001 
1-hr glucose 47 ± 12 < 0.001 
2-hr glucose 28 ± 16 0.033 
Glucose response curve 17 ± 25 0.256 
Diabetes status 69 ± 51 0.100 
Prediabetes status 39 ± 32 0.067 
Phenotypes were inverse normalized for genetic analyses. 
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We genotyped 59 common SNPs (representing 31 genes/loci) and all were 
polymorphic and in HWE (P > 0.05). Minor allele frequencies of the SNPs ranged from 
5% to 49% (Table 5-4), indicating that the SNPs were common in the AIR registry.  
 
Table 5-4. Allele Frequency Distribution of Candidate SNPs (n=59) Studied in the AIR 
Registry  
Gene or nearest 
gene 
SNP ID 
Chromos
ome 
Major 
allele 
Major 
allele 
frequency 
Minor 
allele 
Minor 
allele 
frequency 
NOTCH2 rs10923931 1 G 0.9322 T 0.0678 
PROX1 rs340874 1 T 0.6140 C 0.3860 
GCKR rs780094 2 C 0.6797 T 0.3203 
G6PC2 rs560887 2 C 0.8726 T 0.1274 
THADA rs7578597 2 T 0.9450 C 0.0550 
ADAMTS9 rs4607103 3 C 0.6647 T 0.3353 
ADCY5 rs11708067 3 A 0.6902 G 0.3098 
IGF2BP2 rs4402960 3 G 0.7187 T 0.2813 
SLC2A2 rs11920090 3 T 0.8746 A 0.1254 
WFS1 rs10010131 4 G 0.7187 A 0.2813 
CDKAL1 rs10946398 6 A 0.7058 C 0.2942 
GCK rs4607517 7 G 0.7902 A 0.2098 
JAZF1 rs864745 7 T 0.6609 C 0.3391 
LOC100128217 rs2191349 7 G 0.5957 T 0.4043 
SLC30A8 rs13266634a 8 C 0.7777 T 0.2223 
SLC30A8 rs11558471a 8 A 0.7610 G 0.2390 
CDKN2A/B rs10811661 9 T 0.8740 C 0.1260 
GLIS3 rs7034200 9 A 0.5685 C 0.4315 
HHEX rs1111875 10 C 0.6342 T 0.3658 
LOC100420392 rs10885122 10 G 0.8548 T 0.1452 
TCF7L2 rs7901695b 10 T 0.7413 C 0.2587 
TCF7L2 rs4506565b 10 A 0.7392 T 0.2608 
TCF7L2 rs7903146b 10 C 0.7610 T 0.2390 
TCF7L2 
rs12243326
b 
10 T 0.8094 C 0.1906 
TCF7L2 
rs12255372
b 
10 G 0.8048 T 0.1952 
CRY2 rs11605924 11 A 0.5026 C 0.4974 
FADS1 rs174550 11 C 0.6137 T 0.3863 
KCNJ11 rs5215 11 T 0.6392 C 0.3608 
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MADD rs7944584 11 A 0.8586 T 0.1414 
MTNR1B rs10830963 11 C 0.7689 G 0.2311 
KCNQ1 rs151290 11 C 0.6369 A 0.3631 
KCNQ1 rs2237892 11 C 0.7226 T 0.2774 
KCNQ1 rs2237895 11 A 0.5235 C 0.4765 
ADIPOR2 rs12342c 12 G 0.5164 A 0.4836 
ADIPOR2 rs767870 12 T 0.8916 C 0.1084 
ADIPOR2 rs929434c 12 C 0.5148 T 0.4852 
ADIPOR2 rs1029629c 12 A 0.5459 C 0.4541 
ADIPOR2 rs1044471 12 C 0.5837 T 0.4163 
ADIPOR2 rs1058322 12 C 0.6848 T 0.3152 
ADIPOR2 rs1468491 12 G 0.9381 C 0.0619 
ADIPOR2 rs2058033 12 A 0.7808 C 0.2192 
ADIPOR2 rs2068491 12 A 0.5825 G 0.4175 
ADIPOR2 rs2286380 12 A 0.9361 T 0.0639 
ADIPOR2 rs3809266c 12 C 0.5164 A 0.4836 
ADIPOR2 rs4140992 12 C 0.6155 T 0.3845 
ADIPOR2 rs4766415 12 T 0.6061 A 0.3939 
ADIPOR2 rs9805042 12 C 0.9068 T 0.0932 
ADIPOR2 rs10735003 12 C 0.5994 T 0.4006 
ADIPOR2 rs10848569c 12 G 0.5148 A 0.4852 
ADIPOR2 rs12582624c 12 G 0.5583 C 0.4417 
IGF1 rs35767 12 G 0.7888 A 0.2112 
TSPAN8 rs7961581 12 T 0.8237 C 0.1763 
FTO rs8050136d 16 C 0.7435 A 0.2565 
FTO rs3751812d 16 G 0.7704 T 0.2296 
FTO rs9939609d 16 T 0.7435 A 0.2565 
FTO rs17818902 16 T 0.7456 G 0.2544 
FTO rs7203051 16 G 0.5962 C 0.4038 
FTO rs1075888 16 T 0.5212 G 0.4788 
HNF1B rs4430796 17 A 0.5927 G 0.4073 
aTwo SNPs in the SLC30A8 gene are in strong linkage disequilibrium with r2=9.0 
bFive SNPs in the TCF7L2 gene are in strong linkage disequilibrium with r2 ranging 
from 0.88 to 0.99 
cSix SNPs in ADIPOR2 gene are in strong linkage disequilibrium with r2 ranging from 
0.81 to 0.89 
dThree SNPs in the FTO gene are in strong linkage disequilibrium with r2 ranging from 
0.86 to 0.98 
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Association Between Candidate SNPs (n=39) and Traditional Clinical Phenotypes 
The Associations of candidate SNPs with diabetes and metabolic phenotypes have 
been reported in our previous study (DeMenna et al., 2014), with the exception of genetic 
variants in KCNQ1 and ADIPOR2 genes. Briefly, our previous study found that there 
were 28 SNPs (representing 19 genes/loci) that exhibited nominal associations with either 
anthropometrics/lipids or glucose regulation/insulin dynamics-related phenotypes. Of 
them, 5 SNPs from 5 genes exhibited the most powerful and significant association with 
anthropometrics, lipids, and glucose/insulin dynamics (rs3751812/FTO: BMI, HC; 
rs13266634/ SLC30A8: BMI; rs4607517/GCK: FPG, HbA1c; rs10830963/MTNR1B: 
VLDL; rs7578597/THADA: Cholesterol, LDL).  
Association Between KCNQ1 SNPs and Traditional Clinical Phenotypes 
Three KCNQ1 SNPs (rs151290, rs2237892, rs2237895) were included in this 
analysis. Of them, 2 SNPs (rs151290 and rs2237892) exhibited nominal (P < 0.05) 
associations with multiple phenotypes, while rs2237895 was not associated with any of 
the phenotypes. Specific mean values for the phenotypes that were associated with each 
KCNQ1 SNP are shown in Table 5-5 and 5-6. Specifically, rs151290 was significantly 
associated with total cholesterol, LDL, DBP, FPG, prediabetes status, Matsuda index, 
insulinogenic index, and disposition index (all P < 0.05). Consistent direction of 
increased risk in each phenotype was observed with the exception of FPI and Matsuda 
index, indicating that major allele C was considered as a risk allele while minor allele A 
was protective. In addition, there were trends toward significance in the association 
between rs151290 and FPI and 2-hr glucose. Similarly, rs2237892 was significantly 
associated with SBP, FPG, 2-hr glucose, HbA1c, prediabetes status, Matsuda index, 
91 
insulinogenic index, and disposition index (all P < 0.05). Direction of increased risk in 
the SNP rs2237892 was consistent except Matsuda index. For the rs2237892, major allele 
C was considered as a risk allele while minor allele T was protective.  
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Association Between Candidate SNPs (n=59) and Glucose Response Curve 
Among 59 genetic variants (representing 31 genes/loci), 15 SNPs (representing 8 
genes/loci) were associated with the glucose response curve (Table 5-7). Major allele of 
rs10923931/NOTCH2, rs780094/GCKR, rs13266634/SLC30A8, rs12243326/TCF7L2, 
rs11605924/CRY2, and rs2058033/ADIPOR2 exhibited significant association with 
increased prevalence of the monophasic response, indicating that these major allele were 
considered as risk allele. Moreover, minor allele of rs10830963/MTNR1B, rs3809266, 
rs3809266, rs4766415, rs767870, rs10735003/ADIPOR2, and rs8050136, rs1075888, 
rs9939609/FTO showed significant association with increased prevalence of the 
monophasic response, indicating that these minor allele were considered as risk alleles.   
Association Between Candidate SNPs (n=59) and 1-hr Glucose 
Among 59 candidate SNPs (representing 31 genes/loci), 18 genetic variants 
(representing 9 genes/loci) were associated with 1-hr glucose (Table 5-8). Major allele of 
rs4402960/IGF2BP2, rs4607517/GCK, rs11605924/CRY2, rs2237892/KCNQ1, and 
rs12342, rs1058322/ADIPOR2 exhibited a significant association with an elevated 1-hr 
glucose concentration, indicating that these major alleles were considered as risk alleles. 
Moreover, minor allele of rs340874/PROX1, rs1111875/HHEX, 
rs2191349/LOC100420392, rs274550/FADS1, and rs929434, rs1029629, rs2068491, 
rs4766415, rs10735003, rs10848569, rs12582624/ADIPOR2 showed a significant 
association with an elevated 1-hr glucose level, indicating that these minor alleles were 
considered as risk alleles.   
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Conclusions 
This study described the genetic contributions to novel markers of dysglycemia 
(i.e., glucose response curve and 1-hr glucose) in the AIR registry. In the present study, 
we first demonstrated that there were significant associations between KCNQ1 SNPs 
(rs151290 and rs2237892) and diabetes-related phenotypes including β-cell function, a 
hallmark feature of type 2 diabetes, which is considered one of the earliest indicators of 
diabetes risk. Second, we described the genetic determinants of novel glycemic markers 
and found multiple genetic variants that were associated with either the glucose response 
curve or 1-hr glucose level from an OGTT. 
KCNQ1 is a gene encoding the pore-forming subunit of a voltage-gate K+ 
channel that is expressed in a number of tissues, including heart, pancreas, kidneys, and 
intestine (Unoki et al., 2008; Yasuda et al., 2008). Since it is well established that this 
encoded protein plays an important role in the electrical depolarization of the cell 
membrane in the heart and presumably in pancreatic β-cells, an increasing number of 
studies have examined its polymorphisms in relation to type 2 diabetes risk (Liu et al., 
2013; Morris et al., 2012). Although it is not clear whether the genetic variants of 
KCNQ1 affect its gene expression, functional investigations have shown that selective 
blockades of this K+ channel stimulates insulin secretion through alterations in the 
membrane repolarization potential of the pancreatic β-cells (Ullrich et al., 2005). 
Furthermore, KCNQ1 is involved in hormone and electrolyte transport, suggesting that it 
may affect incretin secretion in the gastrointestinal tract (Vallon et al., 2005). Müssig et 
al. (2009) confirmed its effects on incretin-stimulated insulin secretion by measuring 
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differences in plasma GLP-1 and GIP levels along with insulin secretion during the 
OGTT among 3 genotyping groups in rs151290. 
The association between KCNQ1 genetic variants and type 2 diabetes risk has 
been increasingly replicated, but the majority of these studies (around 90% of KCNQ1 
SNP studies) have focused on those of Caucasian or East Asian descent (Liu et al., 2013). 
A growing number of studies have provided evidence that KCNQ1 genetic variants 
(mostly rs2237892 and rs2237895) were associated with clinical phenotypes including 
fasting glucose, first and second phases of insulin secretion, and homeostatic model 
assessment of β-cell function (Hu et al., 2009; Qi et al., 2009; van Vliet-Ostaptchouk et 
al., 2012). To our knowledge, two studies examined KCNQ1 SNP (rs2237892) in the 
Mexican population and exhibited significant association with susceptibility to type 2 
diabetes, as odds ratio for developing type 2 diabetes ranged from 1.20 to 1.36 (Gamboa-
Melendez et al., 2012; Parra et al., 2011).  
Our data from a Latino cohort exhibited that 2 (rs151290 and rs2237892) out of 
the 3 KCNQ1 SNPs examined were associated with type 2 diabetes risk factors including 
prediabetes status, insulin resistance, impairment of insulin secretion, and β-cell function. 
These data suggest that major allele C for both SNPs is considered a risk allele and our 
findings were concordant with previous findings (Hu et al., 2009; Qi et al., 2009; van 
Vliet-Ostaptchouk et al., 2012). Unexpectedly, for both rs151290 and rs2237892, the 
major allele C (i.e., risk allele) was associated with a slightly higher Matsuda index 
(indicates insulin sensitivity) than the minor allele (rs151290 [A] and rs2237892 [T], i.e., 
protective allele). However, when the disposition index (i.e., insulin secretion x insulin 
sensitivity) was examined across genotypes, risk allele C was associated with lower β-
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cell function relative to the degree of insulin resistance. It is because major allele C 
exhibited significant association with the impairment of insulin secretion (i.e., lower 
insulinogenic index). Given the fact that the prevalence of overweight and obesity was 
50% in children and 81% in adults in the AIR registry, we expected that our study 
participants were already affected by a certain degree of insulin resistance (e.g., 
regardless of their given genotypes). In this respect, it may physiologically explain that 
the protective allele in these SNPs were associated with higher insulin secretion (to 
compensate given certain degree of insulin resistance), which leads to a higher 
disposition index. It is important to note that consistent patterns of protective or 
deleterious allele for the risk variables were detected for two SNPs (rs151290 and 
rs2237892) and they were found to replicate the same association direction (i.e., same 
risk allele) as the one identified in the original GWAS and candidate gene studies (Hu et 
al., 2009; Qi et al., 2009; van Vliet-Ostaptchouk et al., 2012). 
More importantly, although continuous efforts have been conducted to further 
physiologically characterize candidate SNPs, the majority of type 2 diabetes 
susceptibility loci have been replicated with traditional clinical markers such as fasting 
and 2-hr glucose (Ingelsson et al., 2010). To our knowledge, no studies have examined 
genetic determinants of either the glucose response curve or 1-hr glucose concentration 
from an OGTT. We first reported the heritability estimates of the novel glycemic makers 
in this study. It is important to note that there is considerable loss of power observed for 
discrete variables due to the low prevalence of the biphasic response (Williams & 
Blangero 2004). Moreover, since it is also possible that heritability can be age dependent, 
the heritability estimate of the glucose response curve may be underestimated (i.e., age 
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effect was significant (P = 0.0023) when the heritability was estimated in the model of 
the glucose response curve). Interestingly, the heritability estimate of 1-hr glucose was 
significant and it was higher than that of either fasting or 2-hr glucose.  
We identified 15 SNPs nominally associated with the glucose response curve. Of 
these, associations of rs3809266 in adiponectin receptor 2 (ADIPOR2) gene and 
rs9939609 in the fat mass and obesity-associated (FTO) gene with the glucose response 
curve exhibited the most powerful and significant effect in our dataset (all P < 0.01). 
ADIPOR2 was first cloned by Yamauchi et al. (2003) and it has been characterized as 
enhancing fatty acid oxidation, increasing glucose uptake, increased adenosine 5’-
monophosphate-activated protein kinase activity, and interacting with peroxisome 
proliferator-activated receptor pathways (Yamauchi et al., 2002). The studies of 
adiponectin receptor gene expression in relation to type 2 diabetes risk further supported 
above function (Civitarese et al., 2004; Debard et al., 2004). Interestingly, out of the total 
15 SNPs in ADIPOR2 in our dataset, 6 SNPs were found to be associated with the 
glucose response curve. It is important to note that all 6 SNPs were not in strong linkage 
disequilibrium, indicating that they are not sharing the same genetic information. 
Moreover, minor alleles for the 5 SNPs were consistently associated with a higher 
prevalence of monophasic, indicating that those are risk alleles. However, these trends of 
deleterious alleles were not concordant with previous findings from the San Antonio 
Family Diabetes Study, exhibiting that the majority of the minor alleles for the ADIPOR2 
SNPs were associated with decreased fasting triglyceride levels (Richardson et al, 2006). 
Given that a handful of studies have reported genetic associations of adiponectin 
receptors with cardiometabolic risk and these results were also inconsistent in various 
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populations (Broedl et al., 2006; Cohen et al., 2011; Hara et al., 2005; Peters et al., 2013; 
Vaxillaire et al., 2006), further population specific examination of this relationship is still 
warranted. 
Another strong association with the glucose response curve was observed in 
rs9939609 in the FTO gene. FTO is the fat mass and obesity-associated protein and 
physiological function of FTO has been continuously and widely examined. Recent 
studies have demonstrated that the FTO gene may play an important role in energy 
homeostasis by regulating either energy expenditure or energy intake in humans (Cecil, 
Tavendale, Watt, Hetherington, & Palmer, 2008; Fredriksson et al, 2008; Haupt et al., 
2009) and animals (Church et al., 2009; Fischer et al., 2009). In addition, FTO has been 
described as a regulator of adipose tissue metabolism (i.e. lipolysis), as it contributes to 
the regulation of fat mass (Jacobsson, Schioth, & Fredriksson, 2012; Wåhlén, Sjölin, & 
Hoffstedt, 2008). Based on our data, 3 SNPs in FTO exhibited a consistent direction of 
increased prevalence of monophasic glucose response (i.e., minor alleles were associated 
with increased type 2 diabetes risk). It is important to note that these results are 
concordant with our previous findings, which showed that minor alleles for these 3 SNPs 
were associated with increased BMI, waist circumference, hip circumference, FPI, and 
HOMA-IR (DeMenna et al., 2014). 
In addition to the aforementioned SNPs/genes, we have further nominally 
identified genetic variants in neurogenic locus notch homolog protein 2 (NOTCH2), 
glucokinase regulator (GCKR), solute carrier family 30 (zinc transporter), member 8 
(SLC30A8), transcription factor 7-like 2 (TCF7L2), cryptochrome circadian clock 2 
(CRY2), and melatonin receptor 1B (MTNR1B) that were found to be associated with the 
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glucose response curve. Briefly, NOTCH2 is a type 1 transmembrane receptor and a 
genetic association study exhibited an odds of 1.13 (95% CI=1.08–1.17) for type 2 
diabetes (Zeggini et al., 2008). From the Botnia study focused on the Finnish population, 
major allele G in NOTCH2 was associated with islet function measured by elevated 
fasting and 2-hr glucagon concentrations obtained from the OGTT (Jonsson et al., 2013). 
GCKR is an important regulator of glucokinase activity, which is a key glucose 
phosphorylation enzyme responsible for the first rate-limiting step in the glycolysis 
pathway and regulates glucose-stimulated insulin secretion from pancreatic β-cells and 
glucose metabolism in the liver (Chu et al., 2004; Matschinsky, 1996). Dupuis et al. 
(2010) observed that the major allele C in GCKR was associated with elevated fasting 
glucose and fasting insulin or HOMA-IR. SLC30A8 gene is exclusively expressed in 
pancreas (mainly in β-cells) and it is localized to insulin secretory granules, implicating 
that it plays an important role in the storage and maturation of insulin in the granules of 
the β-cell (Chimienti, Devergnas, Favier, & Seve, 2004; Chimienti et al., 2006). 
Commone genetic varitant (rs13266634) in SLC30A8 was associated with odds of 1.15 
for type 2 diabetes (Dupuis et al., 2010) TCF7L2 codes for a transcription factor involved 
in the Wnt signaling pathway and genetic variants have been associated with type 2 
diabetes risk (Grant et al., 2006; Saxena et al., 2007; Dupuis et al., 2010). Major allele T 
in TCF7L2 was associated with impaired insulin secretion, insulin sensitivity, and 
enhanced rate of hepatic glucose production in various ethnic groups (Damcott et al., 
2006; Elbein et al., 2007, Lyssenko et al., 2007; Musso et al., 2009). Lastly, CRY2 and 
MTNR1B regulate circadian rhythm regulation (Kume et al., 1999) and the odds of type 
2 diabetes were 1.04 (95% CI=1.02–1.06) and 1.09 (95% 1.06-1.12), respectively 
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(Dupuis et al., 2010). Taken together, we confirmed that directions of increased 
prevalence of monophasic response for aforementioned SNPs are concordant with either 
Dupuis et al. (2010), or our previous study (DeMenna et al., 2014). 
Compared to the genetic determinants of the glucose response curve, the majority 
of associations with 1-hr glucose was stronger. This result may be affected by the 
moderate and significant heritability estimate of 1-hr glucose (h2=47±12). A total of 20 
SNPs were found to be associated with 1-hr glucose level. Notably, 10 SNPs in 
ADIPOR2 were observed in the genetic association analysis and 8 SNPs exhibited a 
consistent direction of changes, suggesting that minor alleles were associated with a 
decreased 1-hr glucose. It is notable that 3 out of 10 SNPs in the ADIPOR2 gene were in 
strong linkage disequilibrium with r2 ranging from 0.81 to 0.89. However, rs12342 which 
was in strong linkage disequilibrium with rs929434 and rs1029629, exhibited a conflict 
in direction of increased 1-hr glucose when compared to the associations of rs929434 and 
rs1029629. Although we are not fully able to explain this discrepancy among the SNPs 
which were in strong linkage disequilibrium, it may be due to the wide variability of 
phenotype within individuals. When genotypes (i.e., major/major, major/minor, 
minor/minor) were analyzed by two groups (i.e., non-carrier of risk allele [major/major] 
vs. carrier of risk allele [major/minor and minor/minor]) in the SNP rs12342, a significant 
association with 1-hr glucose was not observed. For this reason, it is possible that the 
current association is false. Collectively, in contrast to the glucose response curve, these 
trends with 1-hr glucose were concordant with the changes in traditional phenotypes from 
a previous study (Richardson et al., 2006). 
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An interesting finding from our current study was an association between KCNQ1 
SNP (rs2237892) and the 1-hr glucose. In addition to the associations between rs2237892 
and traditional diabetes risk factors including prediabetes status, insulin resistance, 
impairment of insulin secretion, and β-cell function, this SNP was associated with a novel 
glycemic marker, 1-hr glucose. Consistent with associations of traditional clinical 
markers, major allele C in rs2237892 was associated with elevated 1-hr glucose levels. 
Based on the physiological characterization of the candidate SNPs we selected, it is likely 
that genetic variants in KCNQ1 impact various physiological features including glycemic 
controls by insulin efficiency and secretion. 
In addition, we have further identified genetic variants in insulin-like growth 
factor 2 mRNA binding protein 2 (IGF2BP2), glucokinase (GCK), CRY2, prospero 
homeobox 1 (PROX1), hematopoietically expressed homeobox (HHEX), and fatty acid 
desaturase 1 (FADS1). Briefly, IGF2BP2 is a paralog of IGF2BP1, which regulates 
translation of insulin-like growth factor 2. A cluster of IGF2BP1 genetic variants were 
found to be associated with type 2 diabetes risk including decreased first-phase insulin 
secretion and reduced β-cell function (Grarup et al., 2007). Minor allele T in rs4402960 
was considered a risk allele, as odds exhibited 1.11-1.14 (Scott et al., 2007). GCK gene 
plays an important role in regulating glucose cycling in several tissues, including the liver 
and pancreas (Li et al., 2009). For the SNP rs4607517, odds of type 2 diabetes was 1.07 
(95% CI=1.05-1.10), suggesting that the minor allele A was the risk allele (Dupuis et al., 
2010). PROX1 gene plays a crucial role in the development of β-cell and acts as a novel 
co-regulator of bile acid synthesis and gluconeogenesis (Song, Li, & Chiang, 2006). 
Dupuis et al. (2010) showed that the major allele C of rs340874 was associated with 
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development of type 2 diabetes. Note that allele C was considered a minor allele in our 
study. HHEX gene encodes a transcription factor that is involved in Wnt signaling, which 
is an important pathway for cell growth and development (Foley & Mercola, 2005). In 
general, the major allele C of rs1111875 is considered a risk allele by exhibiting odds of 
1.13 for type 2 diabetes (Saxena et al., 2007). Lastly, FADS1 encodes fatty acid 
desaturase 1, which catalyzes the biosynthesis of highly unsaturated fatty acids, 
suggesting that increased activity of these enzymes may lower circulating triglyceride 
concentrations (Keane & Newsholme, 2008). For the SNP 174550 in FADS1, the major 
allele T was associated with increased risk for type 2 diabetes (Dupuis et al., 2010). Note 
that allele T was considered a minor allele in our study. Taken together, we confirmed 
consistent patterns of protective or deleterious alleles for elevated 1-hr glucose in the 
aforementioned SNPs when compared to previous findings. 
To our knowledge, this is the first study to examine genetic determinants of novel 
glycemic markers, which include the glucose response curve and 1-hr glucose during an 
OGTT. Moreover, we explored the genetic associations of 3 KCNQ1 SNPs (rs151290, 
rs2239892, and rs2239895) with diabetes-related phenotypes. The AIR registry is 
composed of Latino participants who reside in the Phoenix-Arizona area. We observed 
that the prevalence of prediabetes and type 2 diabetes (35% and 12%, respectively) is 
similar to the reported U.S prevalence in the Latino population (Cowie et al., 2009).  
Given that Latinos are disproportionately impacted by obesity and type 2 diabetes 
(Lawrence et al, 2009), our previous and current studies are crucial since we provided 
heritability estimates of diabetes-related phenotypes including novel glycemic markers 
(i.e., glucose response curve and 1-hr glucose) in the AIR registry as well as performed 
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physiological characterization of candidate genes/SNPs that were previously associated 
with type 2 diabetes (Dupuis et al., 2010; Gloyn et al., 2003; Grarup et al., 2007; Saxena 
et al., 2007; Zeggini et al., 2007, 2008). In order to expand our previous study and 
broaden our knowledge of the pathogenesis of type 2 diabetes in this population, current 
study included 3 SNPs in the KCNQ1 gene which has shown relatively higher effect size 
for the development of type 2 diabetes compared to other potential genetic variants (Hu et 
al., 2009; Qi et al., 2009; van Vliet-Ostaptchouk et al., 2012). In addition, we have 
attempted to characterize candidate SNPs measured by examining the association with 
novel glycemic biomarkers (i.e., glucose response curve and 1-hr glucose). Despite these 
strengths, we acknowledge potential limitations that should be considered. First, the 
number of subjects (≤ 626 participants’ DNA samples are currently available for 
genotyping) for the genetic analysis in this study may not be enough to examine the 
stringently significant association between candidate SNPs and phenotypic markers of 
type 2 diabetes risk (Lin & Sullivan, 2009). Therefore, we previously mentioned that, for 
the purpose of exploration, we used a nominal P value of 0.05 as our threshold for 
statistical significance in this study. Larger cohorts of Latino population are warranted to 
confirm theses SNPs associated with novel glycemic markers (glucose response curve 
and 1-hr glucose). Second, our key outcome measures related to type 2 diabetes risk were 
obtained from the OGTT including glucose response curve, fasting, 1-hr, 2-hr glucose 
concentrations, and OGTT-derived indices (HOMA-IR, Matsuda index, insulinogenic 
index, and disposition index). For this reason, we acknowledge that poor reproducibility 
of the OGTT is a limitation (Libman, Barinas-Mitchell, Bartucci, Robertson, & 
Arslanian, 2008; Mooy et al., 1996) and further studies will need to include more 
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comprehensive and sophisticated phenotyping measure to determine insulin 
sensitivity/secretion and β-cell function. 
In summary, we set out to determine whether there are associations between 
candidate genetic variants in type 2 diabetes susceptibility genes and clinical phenotypes 
including both traditional and novel markers. Moreover, we included KCNQ1 SNPs that 
were strongly associated with type 2 diabetes risk mainly in Caucasian and East Asian in 
order to replicate/confirm the findings in a Latino population.  Although there remain 
some discrepancies in the direction of increased risk in multiple SNPs/genes (i.e., 
ADIPOR2), the majority of associations with the glucose response curve and 1-hr 
glucose were concordant with changes in the traditional clinical risk markers from the 
previous GWAS and/or candidate study. These discrepancies may stem from the power 
of the analysis (i.e., sample size matter), or inherent population differences. Our data lead 
us towards a better understanding of the genetic background of novel glycemic markers 
as well as KCNQ1 genetic influences on the risk of type 2 diabetes in the Latino 
population.  
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CHAPTER 6: CONCLUSION 
In this dissertation, we introduced novel glycemic markers, which included the 
glucose response curve and 1-hr glucose level during an OGTT, as efficient and accurate 
tools for identifying type 2 diabetes risk in Latino youth. Since we did not know whether 
these novel glycemic markers were influenced by environmental or genetic factors, we 
further examined the associations between type 2 diabetes susceptibility genetic variants 
including KCNQ1 SNPs and novel glycemic markers. 
First, we demonstrated that the shape of the plasma glucose response during an 
OGTT differentiates type 2 diabetes risk factors in Latino adolescents (Kim et al., 2012). 
Our data showed that youth with a biphasic response harbors metabolically healthier 
characteristics including lower glucose area under the curve and HbA1c, higher whole-
body insulin sensitivity (Matsuda index) and insulin secretion (insulinogenic index), and 
better β-cell function relative to the insulin sensitivity (disposition index) than individuals 
with a monophasic response. Interestingly, two types of glucose response curves 
exhibited no difference in fasting and 2-hr glucose levels, which have traditionally been 
used as a diagnosis tool for the development of prediabetes or type 2 diabetes (The 
Expert Committee on the, Diagnosis, & Classification of Diabetes, Mellitus, 1997; 2003). 
These data extend previous studies in adults (Abdul-Ghani, Lyssenko, Tuomi, DeFronzo, 
& Groop, 2010; Fuchigami, Nakano, Oba, & Metori, 1994; Kanauchi, M., Kimura, 
Kanauchi, K., & Saito, 2005; Trujillo-Arriaga, & Roman-Ramos, 2008; Tschritter et al., 
2003; Tura et al., 2011) and suggest that the glucose response curve may be an early 
indicator of type 2 diabetes risk in youth. Recently, one study tested the reproducibility of 
emerging parameters of the insulin and glucose response on the OGTT, including the 
glucose response curve, and reported that agreement on the shape classification within 
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individuals between three separate OGTTs occurred in around 40% (Kramer et al., 2014). 
Given the fact that OGTT harbors poor reproducibility in terms of identifying 
hyperglycemia, future studies need to test whether the shape of the glucose response 
curve is an inherent (i.e., reproducible biological process). Further, longitudinal studies to 
examine whether the shape of glucose response during an OGTT prospectively predicts 
the development of type 2 diabetes by comparing with traditional glycemic markers such 
as HbA1c, fasting and 2-hr glucose are warranted. 
In order to examine whether there are common biologic or genetic pathways 
linking the phenotypic characteristics of the glucose response curve, we further 
performed the genetic association analysis of this novel markers in conjunction with type 
2 diabetes susceptibility SNPs. In order to improve statistical power for the genetic 
association analysis, we included a total of 667 participants (20.4% children, and 79.6% 
adults) who participated in the AIR registry. It is important to note that we confirmed the 
utility of this marker for differentiating type 2 diabetes risk across age groups in the 
Latino population prior to testing genetic associations (data not published). Briefly, a 
total of 584 participants were available to be classified by either monophasic or biphasic 
glucose response curve phenotypes. A monophasic glucose response curve (n=435) was 
the preponderant phenotype compared to the biphasic glucose response curve (n=149). 
Similar with our published youth study (Kim et al., 2012), a monophasic glucose 
response was associated with a more deleterious anthropometric and metabolic profile, 
including higher BMI, fat mass, waist and hip circumferences, triglyceride, blood 
pressures, HbA1c, and lower HDL, Matsuda index, insulinogenic index, and disposition 
index (all P < 0.05). Overall, our data revealed that the pattern of plasma glucose 
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response during an OGTT differentiates the risk for type 2 diabetes in the Latino 
population across age groups. 
When the associations between candidate genetic variants (n=59; representing 31 
genes/loci) and the glucose response curve were examined, we identified 15 SNPs 
nominally associated with this marker. These identified SNPs represented 8 unique genes 
as follows: ADIPOR2, FTO, NOTCH2, GCKR, SLC30A8, TCF7L2, CRY2, and 
MTNR1B. We further confirmed that directions of increased prevalence for the 
monophasic response (i.e., increased risk for type 2 diabetes) of these SNPs were 
concordant with either previous GWAS findings or our own (DeMenna et al., 2014; 
Dupuis et al., 2010; Richardson et al., 2006; Saxena et al., 2007; Scott et al., 2007; 
Zeggini et al., 2008, 2007). Therefore, based on the associations between the glucose 
response curve and multiple SNPs, we obtained the information about the biological 
contributions to this marker. Our data suggests that the shape of the mono phasic 
response is linked with energy homeostasis, regulation of glucose and lipid metabolism, 
and β-cell function. 
In addition to the glucose response curve, we further tested the utility of the 1-hr 
glucose level during an OGTT as another novel glycemic marker among 201 obese 
Latino youth who were followed for up to 8 years (mean 4.7 ± 2.7 years) (Kim et al, 
2013). We demonstrated that participants with 1-hr glucose ≥155 mg/dL at baseline 
exhibited a significantly lower β-coefficient for disposition index obtained from the 
FSIVGTT, indicating greater deterioration of β-cell function over time. Moreover, when 
data was restricted to NGT participants, we also observed that those with 1-hr glucose 
concentrations ≥155 mg/dL at baseline were 2.5 times more likely to develop prediabetes 
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over time. Importantly, our findings were also independent of traditional glycemic 
indicators (i.e., fasting and 2-hr glucose). These data extend previous cross-sectional 
studies in youth (Tfayli et al., 2011) and support the potential prospective utility of 1-hr 
glucose concentrations during an OGTT to identify youth at a higher risk for developing 
type 2 diabetes.  
Furthermore, we also compared the predictive power of 1-hr glucose to traditional 
glycemic indicators including HbA1c, fasting, and 2-hr glucose for identifying 
progression to prediabetes in obese Latino youth (Kim et al., 2014). Of the 116 obese 
normoglycemic Latino youth at baseline, 49.1% of the study participants experienced 
progression to prediabetes at least more than one time while 52.9% maintained their NGT 
status throughout each follow-up. When the area under the ROC curve (i.e., predictive 
power) was estimated, we observed that 1-hr glucose is the single best predictor for 
identifying future prediabetes compared to HbA1c, fasting, and 2-hr glucose. In a series 
of studies involving the 1-hr glucose level, we also attempted to find which genetic 
components were involved in this biomarker. Much larger cohorts followed over longer 
periods to definitively test the utility of 1-hr glucose concentrations to predict the 
development of overt type 2 diabetes in youth are warranted. 
Prior to testing genetic determinants of 1-hr glucose, we confirmed the utility of 
1-hr glucose level for differentiating type 2 diabetes risk across age groups in the AIR 
registry, which were used in the genetic association analysis (data not published). In 
order to improve statistical power to detect the genetic associations, we analyzed this 
marker as a continuous variable (instead of dichotomously; above or below 1-hr glucose 
of 155 mg/dL). Briefly, 1-hr concentrations obtained from the OGTT were found to 
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increase alongside BMI, fat mass, waist and hip circumference, blood pressures, lipid 
profile, HbA1c, fasting and 2-hr glucose, and HOMA-IR (all P < 0.05). Additionally, 1-
hr glucose concentrations were negatively and significantly correlated with Matsuda 
index, insulinogenic index, and disposition index (data not published). Overall, our data 
confirmed the utility of 1-hr glucose level during an OGTT to identify Latino youth and 
adults at a higher risk for type 2 diabetes. 
When the genetic determinants of 1-hr glucose were tested by using 59 genetic 
variants which represented 31 genes/loci, we identified 18 SNPs nominally associated 
with this marker. The identified SNPs represented 9 unique genes as follows: IGF2BP2, 
GCK, CRY2, KCNQ1, ADIPOR2, PROX1, HHEX, LOC100420392, and FADS1. We 
further confirmed that directions of the elevated 1-hr glucose level (i.e., increased risk for 
type 2 diabetes) for these SNPs were concordant with previous findings from GWAS or 
candidate SNP studies (Dupuis et al., 2010; Morris et al., 2012; Richardson et al., 2006; 
Saxena et al., 2007). Therefore, based on the associations between the 1-hr glucose and 
multiple SNPs/genes, we were able to gather the biological information on this marker. 
Our data suggests that an elevated 1-hr glucose during an OGTT was affected by the 
genes which were known as type 2 diabetes risk including energy homeostasis, regulation 
of glucose (including glucose cycling in liver or pancreas tissues) and lipid metabolism, 
β-cell function, and cell growth and development. 
Lastly, in order to expand our knowledge of the pathogenesis of type 2 diabetes in 
the Latino population, we further genotyped 3 KCNQ1 SNPs (rs151290, rs2237892, 
rs2237895) and explored genetic association analysis with diabetes-related phenotypes in 
the AIR registry. Of them, 2 SNPs (rs151290 and rs2237892) exhibited nominal (P < 
124 
0.05) associations with multiple phenotypes. Consistent direction of increased risk in 
total cholesterol, LDL, DBP, FPG, prediabetes status, insulinogenic index, and 
disposition index was observed when the SNP rs151290 was analyzed. Similarly, 
rs2237892 was also found to be associated with consistent direction of elevated risk in 
SBP, FPG, 2-hr glucose, HbA1c, prediabetes status, insulinogenic index, and disposition 
index. In general, our data suggest that major allele C for both SNPs is considered a risk 
allele and our findings were concordant with previous findings (Hu et al., 2009; Qi et al., 
2009; van Vliet-Ostaptchouk et al., 2012). The results of this study are promising since 
genetic variants in the KCNQ1 are not fully understood in relation to type 2 diabetes risk 
in Latino individuals despite its relatively high effect size compared to other candidate 
SNPs in other ethnicities (Hu et al., 2009; Qi et al., 2009; van Vliet-Ostaptchouk et al., 
2012). Larger cohorts of the Latino population are warranted to replicate theses SNPs 
associated with the susceptibility to type 2 diabetes.  
In summary, in order to find more accurate identification parameters for the risk 
of type 2 diabetes in a Latino population, we tested the utility of novel glycemic markers, 
which include the glucose response curve and 1-hr glucose level during an OGTT. 
Furthermore, we described the genetic determinants of these novel glycemic markers and 
explored the biological pathways that are possibly involved in the glucose response curve 
and 1-hr glucose level.  
 
  
125 
REFERENCES 
Abdul-Ghani, M. A., Abdul-Ghani, T., Ali, N., & DeFronzo, R. A. (2008). One-hour 
plasma glucose concentration and the metabolic syndrome identify subjects at 
high risk for future type 2 diabetes. Diabetes Care, 31(8), 1650-1655. doi: 
10.2337/dc08-0225 
Abdul-Ghani, M. A., Jenkinson, C. P., Richardson, D. K., Tripathy, D., & DeFronzo, R. 
A. (2006). Insulin secretion and action in subjects with impaired fasting glucose 
and impaired glucose tolerance: results from the Veterans Administration Genetic 
Epidemiology Study. Diabetes, 55(5), 1430-1435.  
Abdul-Ghani, M. A., Lyssenko, V., Tuomi, T., DeFronzo, R. A., & Groop, L. (2009). 
Fasting versus postload plasma glucose concentration and the risk for future type 
2 diabetes: results from the Botnia Study. Diabetes Care, 32(2), 281-286. doi: 
10.2337/dc08-1264 
Abdul‐ Ghani, M. A., Lyssenko, V., Tuomi, T., DeFronzo, R. A., & Groop, L. (2010). 
The shape of plasma glucose concentration curve during OGTT predicts future 
risk of type 2 diabetes. Diabetes/metabolism Research and Reviews, 26(4), 280-
286.doi: 10.1002/dmrr.1084 
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. (2007). What is the 
best predictor of future type 2 diabetes? Diabetes Care, 30(6), 1544-1548. doi: 
10.2337/dc06-1331 
Almasy, L., & Blangero, J. (1998). Multipoint quantitative-trait linkage analysis in 
general pedigrees. The American Journal of Human Genetics, 62(5), 1198-1211. 
Alyass, A., Almgren, P., Akerlund, M., Dushoff, J., Isomaa, B., Nilsson, P., … Meyre, D. 
(2015). Modelling of OGTT curve identifies 1 h plasma glucose level as a strong 
predictor of incident type 2 diabetes: results from two prospective 
cohorts. Diabetologia, 58(1), 87-97. 
American Diabetes, Association. (2010). Diagnosis and classification of diabetes 
mellitus. Diabetes Care, 33(Suppl 1), S62-69. doi: 10.2337/dc10-S062 
Arslanian, S. (2002). Type 2 diabetes in children: clinical aspects and risk 
factors. Hormone Research, 57(1), 19-28. 
Arslanian, S. A., Bacha, F., Saad, R., & Gungor, N. (2005). Family history of type 2 
diabetes is associated with decreased insulin sensitivity and an impaired balance 
between insulin sensitivity and insulin secretion in white youth. Diabetes 
Care, 28(1), 115-119. 
126 
Bacha, F., Lee, S., Gungor, N., & Arslanian, S. A. (2010). From pre-diabetes to type 2 
diabetes in obese youth: pathophysiological characteristics along the spectrum of 
glucose dysregulation. Diabetes Care, 33(10), 2225-2231. doi: 10.2337/dc10-
0004 
Ball, G. D., Huang, T. T. K., Gower, B. A., Cruz, M. L., Shaibi, G. Q., Weigensberg, M. 
J., & Goran, M. I. (2006). Longitudinal changes in insulin sensitivity, insulin 
secretion, and β-cell function during puberty. The Journal of Pediatrics, 148(1), 
16-22. doi: 10.1016/j.jpeds.2005.08.059 
Bardini, G., Dicembrini, I., Cresci, B., & Rotella, C. M. (2010). Inflammation markers 
and metabolic characteristics of subjects with 1-h plasma glucose levels. Diabetes 
Care, 33(2), 411-413. 
Bergman, R. N., Ader, M., Huecking, K., & Van Citters, G. (2002). Accurate assessment 
of β-cell function the hyperbolic correction. Diabetes, 51(suppl 1), S212-S220. 
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981). Physiologic evaluation of factors 
controlling glucose tolerance in man: measurement of insulin sensitivity and beta-
cell glucose sensitivity from the response to intravenous glucose. Journal of 
Clinical Investigation, 68(6), 1456-1467.  
Bervoets, L., Mewis, A., & Massa, G. (2014). The Shape of the Plasma Glucose Curve 
During an Oral Glucose Tolerance Test as an Indicator of Beta Cell Function and 
Insulin Sensitivity in End-Pubertal Obese Girls. Hormone and Metabolic 
Research. 
Bianchi, C., Miccoli, R., Trombetta, M., Giorgino, F., Frontoni, S., Faloia, E., … Del 
Prato, S. (2013). Elevated 1-hour postload plasma glucose levels identify subjects 
with normal glucose tolerance but impaired β-cell function, insulin resistance, and 
worse cardiovascular risk profile: the GENFIEV study. The Journal of Clinical 
Endocrinology & Metabolism, 98(5), 2100-2105. 
Boerwinkle, E., Chakraborty, R., & Sing, C. F. (1986). The use of measured genotype 
information in the analysis of quantitative phenotypes in man. Annals of Human 
Genetics, 50(2), 181-194. 
Broedl, U. C., Lehrke, M., Fleischer-Brielmaier, E., Tietz, A. B., Nagel, J. M., Goke, B., 
… Parhofer, K. G. (2006). Genetic variants of adiponectin receptor 2 are 
associated with increased adiponectin levels and decreased triglyceride/VLDL 
levels in patients with metabolic syndrome. Cardiovascular Diabetology, 5(11). 
Brunetti, A., Chiefari, E., & Foti, D. (2014). Recent advances in the molecular genetics of 
type 2 diabetes mellitus. World Journal of Diabetes, 5(2), 128-40. 
127 
Burns, S. F., Bacha, F., Lee, S. J., Tfayli, H., Gungor, N., & Arslanian, S. A. (2011). 
Declining beta-cell function relative to insulin sensitivity with escalating OGTT 
2-h glucose concentrations in the nondiabetic through the diabetic range in 
overweight youth. Diabetes Care, 34(9), 2033-2040. doi: 10.2337/dc11-0423 
Cecil, J. E., Tavendale, R., Watt, P., Hetherington, M. M., & Palmer, C. N. (2008). An 
obesity-associated FTO gene variant and increased energy intake in children. New 
England Journal of Medicine, 359(24), 2558-2566. 
Chan, C. L., McFann, K., Newnes, L., Nadeau, K. J., Zeitler, P. S., & Kelsey, M. (2014). 
Hemoglobin A1c assay variations and implications for diabetes screening in obese 
youth. Pediatric Diabetes, 15(8), 557-563. doi: 10.1111/pedi.12132 
Chimienti, F., Devergnas, S., Favier, A., & Seve, M. (2004). Identification and cloning of 
a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory 
granules. Diabetes, 53(9), 2330-7. 
Chimienti, F., Devergnas, S., Pattou, F., Schuit, F., Garcia-Cuenca, R., Vandewalle, B., 
… Seve, M. (2006). In vivo expression and functional characterization of the zinc 
transporter ZnT8 in glucose-induced insulin secretion. Journal of Cell Science, 
119(20), 4199-4206. 
Chu, C. A., Fujimoto, Y., Igawa, K., Grimsby, J., Grippo, J. F., Magnuson, M. A., … 
Shiota, M. (2004). Rapid translocation of hepatic glucokinase in response to 
intraduodenal glucose infusion and changes in plasma glucose and insulin in 
conscious rats. American Journal of Physiology-Gastrointestinal and Liver 
Physiology, 286(4), G627-G634. doi: 10.1152/ajpgi.00218.2003 
Church, C., Lee, S., Bagg, E. A., McTaggart, J. S., Deacon, R., Gerken, T., … Cox, R. D. 
(2009). A mouse model for the metabolic effects of the human fat mass and 
obesity associated FTO gene. PLoS genetics, 5(8), e1000599. 
Civitarese, A. E., Jenkinson, C. P., Richardson, D., Bajaj, M., Cusi, K., Kashyap, S., … 
Ravussin, E. (2004). Adiponectin receptors gene expression and insulin sensitivity 
in non-diabetic Mexican Americans with or without a family history of Type 2 
diabetes. Diabetologia, 47(5), 816-820. 
Cohen, S. S., Gammon, M. D., North, K. E., Millikan, R. C., Lange, E. M., Williams, S. 
M., … Matthews, C. E. (2011). ADIPOQ, ADIPOR1, and ADIPOR2 
polymorphisms in relation to serum adiponectin levels and BMI in black and 
white women. Obesity, 19(10), 2053-2062. 
128 
Conwell, L. S., Trost, S. G., Brown, W. J., & Batch, J. A. (2004). Indexes of insulin 
resistance and secretion in obese children and adolescents a validation 
study. Diabetes Care, 27(2), 314-319. 
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., … 
Geiss, L. S. (2009). Full accounting of diabetes and pre-diabetes in the US 
population in 1988–1994 and 2005–2006. Diabetes Care, 32(2), 287-294. 
Cubeddu, L. X., & Hoffmann, I. S. (2010). One-hour postload plasma glucose levels, a 
predictor of additional risk for diabetes: prevalence, mechanisms, and associated 
cardiovascular and metabolic risk factors in Hispanics. Metabolic Syndrome and 
Related Disorders, 8(5), 395-402. 
Dabelea, D., Bell, R. A., D'Agostino Jr, R. B., Imperatore, G., Johansen, J. M., Linder, 
B., ... & Waitzfelder, B. (2007). Incidence of diabetes in youth in the United 
States. JAMA: the journal of the American Medical Association, 297(24), 2716-
2724.  
Damcott, C. M., Pollin, T. I., Reinhart, L. J., Ott, S. H., Shen, H., Silver, K. D., … 
Shuldiner, A. R. (2006). Polymorphisms in the Transcription Factor 7-Like 2 
(TCF7L2) Gene Are Associated With Type 2 Diabetes in the Amish Replication 
and Evidence for a Role in Both Insulin Secretion and Insulin Resistance. 
Diabetes, 55(9), 2654-2659. . doi: 10.2337/db06-0338 
Debard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio-Liondore, B., … Vidal, 
H. (2004). Expression of key genes of fatty acid oxidation, including adiponectin 
receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia, 47(5), 
917-925. 
DeFronzo, R. A. (2009). From the triumvirate to the ominous octet: a new paradigm for 
the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773-795. doi: 
10.2337/db09-9028 
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas 
under two or more correlated receiver operating characteristic curves: a 
nonparametric approach. Biometrics, 44(3), 837-845.  
DeMenna, J., Puppala, S., Chittoor, G., Schneider, J., Kim, J. Y., Shaibi, G. Q., … 
Coletta, D. K. (2014). Association of common genetic variants with diabetes and 
metabolic syndrome related traits in the Arizona Insulin Resistance registry: a 
focus on Mexican American families in the Southwest. Human Heredity, 78(1), 
47-58. 
129 
Dina, C., Meyre, D., Gallina, S., Durand, E., Körner, A., Jacobson, P., … Froguel, P. 
(2007). Variation in FTO contributes to childhood obesity and severe adult 
obesity. Nature Genetics, 39(6), 724-726. 
Dupuis, J., Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., Jackson, A. U., … 
Elliott, A. (2010). New genetic loci implicated in fasting glucose homeostasis and 
their impact on type 2 diabetes risk. Nature Genetics, 42(2), 105-116. 
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, 
G. K., ... & Hamman, R. F. (1997). Predictors of progression from impaired 
glucose tolerance to NIDDM: an analysis of six prospective studies. 
Diabetes, 46(4), 701-710. 
Ek, A. E., Rossner, S. M., Hagman, E., & Marcus, C. (2014). High prevalence of 
prediabetes in a Swedish cohort of severely obese children. Pediatric Diabetes. 
doi: 10.1111/pedi.12136 
Elbein, S. C., Chu, W. S., Das, S. K., Yao-Borengasser, A., Hasstedt, S. J., Wang, H., … 
Kern, P. A. (2007). Transcription factor 7-like 2 polymorphisms and type 2 
diabetes, glucose homeostasis traits and gene expression in US participants of 
European and African descent. Diabetologia, 50(8), 1621-1630. DOI: 
10.1007/s00125-007-0717-x 
Elder, D. A., Woo, J. G., & D'Alessio, D. A. (2010). Impaired beta-cell sensitivity to 
glucose and maximal insulin secretory capacity in adolescents with type 2 
diabetes. Pediatric Diabetes, 11(5), 314-321. doi: 10.1111/j.1399-
5448.2009.00601.x 
Ershow, A. G. (2009). Environmental influences on development of type 2 diabetes and 
obesity: challenges in personalizing prevention and management. Journal of 
Diabetes Science and Technology, 3(4), 727-734. 
Fagot-Campagna, A. (2000). Emergence of type 2 diabetes mellitus in children: 
epidemiological evidence. Journal of Pediatric Endocrinology and 
Metabolism,13(Supplement), 1395-1402. 
Fetita, L. S., Sobngwi, E., Serradas, P., Calvo, F., & Gautier, J. F. (2006). Consequences 
of fetal exposure to maternal diabetes in offspring. The Journal of Clinical 
Endocrinology & Metabolism, 91(10), 3718-3724. doi: 10.1210/jc.2006-0624 
Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J. C., & Rüther, 
U. (2009). Inactivation of the Fto gene protects from obesity. Nature,458(7240), 
894-898. 
130 
Foley, A. C., & Mercola, M. (2005). Heart induction by Wnt antagonists depends on the 
homeodomain transcription factor Hex. Genes & Development, 19(3), 387-396. 
Ford, E. S., Li, C., & Zhao, G. (2010). Prevalence and correlates of metabolic syndrome 
based on a harmonious definition among adults in the US*. Journal of 
Diabetes, 2(3), 180-193. 
Fredriksson, R., Hagglund, M., Olszewski, P. K., Stephansson, O., Jacobsson, J. A., 
Olszewska, A. M., … Schioth, H. B. (2008). The obesity gene, FTO, is of ancient 
origin, up-regulated during food deprivation and expressed in neurons of feeding-
related nuclei of the brain. Endocrinology, 149(5), 2062-2071. 
Fuchigami, M., Nakano, H., Oba, K., & Metori, S. (1994). [Oral glucose tolerance test 
using a continuous blood sampling technique for analysis of the blood glucose 
curve]. Nihon Ronen Igakkai zasshi. Japanese Journal of Geriatrics, 31(7), 518-
524. 
Gamboa-Meléndez, M. A., Huerta-Chagoya, A., Moreno-Macías, H., Vázquez-Cárdenas, 
P., Ordóñez-Sánchez, M. L., Rodríguez-Guillén, R., … Tusié-Luna, M. T. (2012). 
Contribution of common genetic variation to the risk of type 2 diabetes in the 
Mexican Mestizo population. Diabetes, 61(12), 3314-3321. 
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., … 
Booker, L. (2007). Annual incidence and relative risk of diabetes in people with 
various categories of dysglycemia: a systematic overview and meta-analysis of 
prospective studies. Diabetes Research and Clinical Practice, 78(3), 305-312. 
doi: 10.1016/j.diabres.2007.05.004 
Giannini, C., Weiss, R., Cali, A., Bonadonna, R., Santoro, N., Pierpont, B., … Caprio, S. 
(2012). Evidence for early defects in insulin sensitivity and secretion before the 
onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes, 
61(3), 606-614. doi: 10.2337/db11-1111 
Gibson, N. J. (2006). The use of real-time PCR methods in DNA sequence variation 
analysis. Clinica Chimica Acta, 363(1), 32-47. 
Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., … 
Frayling, T. M. (2003). Large-scale association studies of variants in genes 
encoding the pancreatic β-cell KATP channel subunits Kir6. 2 (KCNJ11) and 
SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 
diabetes. Diabetes, 52(2), 568-572. 
Goran, M. I., Bergman, R. N., Avila, Q., Watkins, M., Ball, G. D., Shaibi, G. Q., … Cruz, 
M. L. (2004). Impaired glucose tolerance and reduced β-cell function in 
131 
overweight Latino children with a positive family history for type 2 diabetes. The 
Journal of Clinical Endocrinology & Metabolism, 89(1), 207-212. 
Goran, M. I., Bergman, R. N., Cruz, M. L., & Watanabe, R. (2002). Insulin resistance and 
associated compensatory responses in african-american and Hispanic children. 
Diabetes Care, 25(12), 2184-2190.  
Goran, M. I., & Gower, B. A. (2001). Longitudinal study on pubertal insulin 
resistance. Diabetes, 50(11), 2444-2450. 
Goran, M. I., Lane, C., Toledo-Corral, C., & Weigensberg, M. J. (2008). Persistence of 
Pre-Diabetes in Overweight and Obese Hispanic Children Association With 
Progressive Insulin Resistance, Poor β-Cell Function, and Increasing Visceral 
Fat. Diabetes, 57(11), 3007-3012. doi: 10.2337/db08-0445 
Grant, S. F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., 
… Stefansson, K. (2006). Variant of transcription factor 7-like 2 (TCF7L2) gene 
confers risk of type 2 diabetes. Nature Genetics, 38(3), 320-323. 
Grarup, N., Rose, C. S., Andersson, E. A., Andersen, G., Nielsen, A. L., Albrechtsen, A., 
… Pedersen, O. (2007). Studies of Association of Variants Near the HHEX, 
CDKN2A/B, and IGF2BP2 Genes With Type 2 Diabetes and Impaired Insulin 
Release in 10,705 Danish Subjects Validation and Extension of Genome-Wide 
Association Studies. Diabetes, 56(12), 3105-3111. doi: 10.2337/db07-0856 
Grarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014). Genetic susceptibility to 
type 2 diabetes and obesity: from genome-wide association studies to rare variants 
and beyond. Diabetologia, 57(8), 1528-1541. 
Gungor, N., Bacha, F., Saad, R., Janosky, J., & Arslanian, S. (2005). Youth Type 2 
Diabetes Insulin resistance, β-cell failure, or both?. Diabetes Care,28(3), 638-644. 
Haffner, S. M., Gonzalez, C., Miettinen, H., Kennedy, E., & Stern, M. P. (1996). A 
prospective analysis of the HOMA model: the Mexico City Diabetes Study. 
Diabetes Care, 19(10), 1138-1141. 
Haffner, S. M., Miettinen, H., Gaskill, S. P., & Stern, M. P. (1995). Decreased insulin 
secretion and increased insulin resistance are independently related to the 7-year 
risk of NIDDM in Mexican-Americans. Diabetes, 44(12), 1386-1391. 
Hara, K., Horikoshi, M., Kitazato, H., Yamauchi, T., Ito, C., Noda, M., … Kadowaki, T. 
(2005). Absence of an association between the polymorphisms in the genes 
encoding adiponectin receptors and type 2 diabetes. Diabetologia,48(7), 1307-
1314. 
132 
Haupt, A., Thamer, C., Staiger, H., Tschritter, O., Kirchhoff, K., Machicao, F., … 
Fritsche, A. (2009). Variation in the FTO gene influences food intake but not 
energy expenditure. Experimental and Clinical Endocrinology & Diabetes: 
Official Journal, German Society of Endocrinology [And] German Diabetes 
Association,117(4), 194-197. 
Horowitz, M., Edelbroek, M. A. L., Wishart, J. M., & Straathof, J. W. (1993). 
Relationship between oral glucose tolerance and gastric emptying in normal 
healthy subjects. Diabetologia, 36(9), 857-862. 
Horowitz, M., Harding, P. E., Maddox, A. F., Wishart, J. M., Akkermans, L. M. A., 
Chatterton, B. E., & Shearman, D. J. C. (1989). Gastric and oesophageal 
emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. 
Diabetologia, 32(3), 151-159. 
Hu, C., Wang, C., Zhang, R., Ma, X., Wang, J., Lu, J., … Jia, W. (2009). Variations in 
KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese 
population. Diabetologia, 52(7), 1322-1325. 
Imamura, M., & Maeda, S. (2011). Genetics of type 2 diabetes: the GWAS era and future 
perspectives [Review]. Endocrine Journal, 58(9), 723-739. 
Ingelsson, E., Langenberg, C., Hivert, M. F., Prokopenko, I., Lyssenko, V., Dupuis, J., 
…Stumvoll, M. (2010). Detailed physiologic characterization reveals diverse 
mechanisms for novel genetic Loci regulating glucose and insulin metabolism in 
humans. Diabetes, 59(5), 1266-1275. 
Jacobsson, J. A., Schiöth, H. B., & Fredriksson, R. (2012). The impact of intronic single 
nucleotide polymorphisms and ethnic diversity for studies on the obesity gene 
FTO. Obesity Reviews, 13(12), 1096-1109. 
Jonsson, A., Ladenvall, C., Ahluwalia, T. S., Kravic, J., Krus, U., Taneera, J., … 
Lyssenko, V. (2013). Effect of common genetic variants associated with type 2 
diabetes and glycemic traits on α-and β-cell function and insulin action in 
man. Diabetes, 62(8), 2978-2983. doi: 10.2337/db12-1627 
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to 
insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846. doi: 
10.1038/nature05482 
Kanauchi, M., Kimura, K., Kanauchi, K., & Saito, Y. (2005). Beta‐ cell function and 
insulin sensitivity contribute to the shape of plasma glucose curve during an oral 
glucose tolerance test in non‐ diabetic individuals. International journal of 
Clinical Practice, 59(4), 427-432. doi: 10.1111/j.1368-5031.2005.00422.x 
133 
Keane, D., & Newsholme, P. (2008). Saturated and unsaturated (including arachidonic 
acid) non-esterified fatty acid modulation of insulin secretion from pancreatic 
beta-cells. Biochemical Society Transactions, 36(pt 5), 955-958. 
Kelly, L. A., Lane, C. J., Weigensberg, M. J., Koebnick, C., Roberts, C. K., Davis, J. N., 
… Goran, M. I. (2007). Parental History and Risk of Type 2 Diabetes in 
Overweight Latino Adolescents A longitudinal analysis. Diabetes Care, 30(10), 
2700-2705. doi: 10.2337/dc07-0050 
Kilpeläinen, T. O., Qi, L., Brage, S., Sharp, S. J., Sonestedt, E., Demerath, E., … Jansson, 
J. O. (2011). Physical activity attenuates the influence of FTO variants on obesity 
risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS 
Medicine, 8(11), e1001116. 
Kim, J. Y., Coletta, D. K., Mandarino, L. J., & Shaibi, G. Q. (2012). Glucose response 
curve and type 2 diabetes risk in Latino adolescents. Diabetes Care, 35(9), 1925-
1930. doi: 10.2337/dc11-2476 
Kim, J. Y., Goran, M. I., Toledo-Corral, C. M., Weigensberg, M. J., Choi, M., & Shaibi, 
G. Q. (2013). One-hour glucose during an oral glucose challenge prospectively 
predicts β-cell deterioration and prediabetes in obese Hispanic youth. Diabetes 
care, 36(6), 1681-1686. 
Kim, J. Y., Goran, M. I., Toledo‐ Corral, C. M., Weigensberg, M. J., & Shaibi, G. Q. 
(2014). Comparing glycemic indicators of prediabetes: a prospective study of 
obese Latino Youth. Pediatric diabetes. 
Kramer, C. K., Vuksan, V., Choi, H., Zinman, B., & Retnakaran, R. (2014). Emerging 
parameters of the insulin and glucose response on the oral glucose tolerance test: 
reproducibility and implications for glucose homeostasis in individuals with and 
without diabetes. Diabetes Research and Clinical Practice,105(1), 88-95. 
Kume, K., Zylka, M. J., Sriram, S., Shearman, L. P., Weaver, D. R., Jin, X., … Reppert, 
S. M. (1999). mCRY1 and mCRY2 are essential components of the negative limb 
of the circadian clock feedback loop. Cell, 98(2), 193-205. 
Kuo, C. K., Lin, L. Y., Yu, Y. H., Chang, C. H., & Kuo, H. K. (2010). A family history 
of diabetes mellitus is associated with poor glycemic control and increased 
metabolic risks among people with diabetes: data from the National Health and 
Nutrition Examination Survey 1999-2004. Internal Medicine, 49(6), 549-555. 
Lawrence, J. M., Mayer-Davis, E. J., Reynolds, K., Beyer, J., Pettitt, D. J., D'Agostino, 
R. B., … Hamman, R. F. (2009). Diabetes in Hispanic American Youth 
Prevalence, incidence, demographics, and clinical characteristics: the SEARCH 
for Diabetes in Youth Study. Diabetes Care, 32(Supplement 2), S123-S132.  doi: 
10.2337/dc09-S204 
134 
Lee, J. M., Wu, E. L., Tarini, B., Herman, W. H., & Yoon, E. (2011). Diagnosis of 
diabetes using hemoglobin A1C: Should recommendations in adults be 
extrapolated to adolescents?. The Journal of Pediatrics, 158(6), 947-952. doi: 
10.1016/j.jpeds.2010.11.026 
Lewy, V. D., Danadian, K., Witchel, S. F., & Arslanian, S. (2001). Early metabolic 
abnormalities in adolescent girls with polycystic ovarian syndrome. The Journal 
of Pediatrics, 138(1), 38-44. doi: 10.1067/mpd.2001.109603 
Li, X., Shu, Y. H., Xiang, A. H., Trigo, E., Kuusisto, J., Hartiala, J., … Watanabe, R. M. 
(2009). Additive effects of genetic variation in GCK and G6PC2 on insulin 
secretion and fasting glucose. Diabetes, 58(12), 2946-2953. doi: 10.2337/db09-
0228 
Libman, I. M., Barinas-Mitchell, E., Bartucci, A., Robertson, R., & Arslanian, S. (2008). 
Reproducibility of the oral glucose tolerance test in overweight children. The 
Journal of Clinical Endocrinology & Metabolism, 93(11), 4231-4237. doi: 
10.1210/jc.2008-0801 
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., … Bogardus, 
C. (1993). Insulin resistance and insulin secretory dysfunction as precursors of 
non-insulin-dependent diabetes mellitus: prospective studies of Pima 
Indians. New England Journal of Medicine, 329(27), 1988-1992. doi: 
10.1056/NEJM199312303292703 
Lin, D. Y., & Sullivan, P. F. (2009). Meta-analysis of genome-wide association studies 
with overlapping subjects. The American Journal of Human Genetics,85(6), 862-
872. 
Liu, J., Wang, F., Wu, Y., Huang, X., Sheng, L., Xu, J., ... & Sun, T. (2013). Meta-
analysis of the effect of KCNQ1 gene polymorphism on the risk of type 2 
diabetes. Molecular Biology Reports, 40(5), 3557-3567. 
Love-Osborne, K. A., Sheeder, J., Svircev, A., Chan, C., Zeitler, P., & Nadeau, K. J. 
(2013). Use of glycosylated hemoglobin increases diabetes screening for at-risk 
adolescents in primary care settings. Pediatric Diabetes, 14(7), 512-518. doi: 
10.1111/pedi.12037 
Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M., Almgren, P., 
… Eriksson, K. F. (2007). Mechanisms by which common variants in the 
TCF7L2 gene increase risk of type 2 diabetes. Journal of Clinical 
Investigation, 117(8), 2155-2163. doi:10.1172/JCI30706 
135 
Manco, M., Miraglia Del Giudice, E., Spreghini, M. R., Cappa, M., Perrone, L., Brufani, 
C., … Caprio, S. (2012). 1-Hour plasma glucose in obese youth. Acta 
Diabetologica, 49(6), 435-443. doi: 10.1007/s00592-012-0384-3 
Manco, M., Panunzi, S., Macfarlane, D. P., Golay, A., Melander, O., Konrad, T., … 
Cardiovascular Risk, Consortium. (2010). One-hour plasma glucose identifies 
insulin resistance and beta-cell dysfunction in individuals with normal glucose 
tolerance: cross-sectional data from the Relationship between Insulin Sensitivity 
and Cardiovascular Risk (RISC) study. Diabetes Care, 33(9), 2090-2097. doi: 
10.2337/dc09-2261 
Marini, M. A., Succurro, E., Frontoni, S., Mastroianni, S., Arturi, F., Sciacqua, A., … 
Sesti, G. (2012). Insulin sensitivity, β-cell function, and incretin effect in 
individuals with elevated 1-hour postload plasma glucose levels. Diabetes 
Care,35(4), 868-872.  
Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in 
girls. Archives of Disease in Childhood, 44(235), 291-303.  
Marshall, W. A., & Tanner, J. M. (1970). Variations in the pattern of pubertal changes in 
boys. Archives of Disease in Childhood, 45(239), 13-23.  
Matschinsky, F. M. (1996). A lesson in metabolic regulation inspired by the glucokinase 
glucose sensor paradigm. Diabetes, 45(2), 223-241. 
Matsuda, M., & DeFronzo, R. A. (1999). Insulin sensitivity indices obtained from oral 
glucose tolerance testing: comparison with the euglycemic insulin clamp. 
Diabetes Care, 22(9), 1462-1470. 
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, 
R. C. (1985). Homeostasis model assessment: insulin resistance and β-cell 
function from fasting plasma glucose and insulin concentrations in man. 
Diabetologia, 28(7), 412-419. 
Matthews, J. N., Altman, D. G., Campbell, M. J., & Royston, P. (1990). Analysis of serial 
measurements in medical research. BMJ, 300(6719), 230-235. 
McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. New England Journal of 
Medicine, 363(24), 2339-2350. 
McCarthy, M. I., & Zeggini, E. (2009). Genome-wide association studies in type 2 
diabetes. Current Diabetes Reports, 9(2), 164-171. 
Mooy, J. M., Grootenhuis, P. A., De Vries, H., Kostense, P. J., Popp-Snijders, C., Bouter, 
L. M., & Heine, R. J. (1996). Intra-individual variation of glucose, specific insulin 
136 
and proinsulin concentrations measured by two oral glucose tolerance tests in a 
general Caucasian population: the Hoorn Study. Diabetologia, 39(3), 298-305. 
Morbiducci, U., Di Benedetto, G., Gaetano, L., Kautzky-Willer, A., Pacini, G., & Tura, 
A. (2014). Predicting the Metabolic Condition After Gestational Diabetes 
Mellitus from Oral Glucose Tolerance Test Curves Shape. Annals of Biomedical 
Engineering, 42(5), 1112-1120. 
Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segré, A. V., Steinthorsdottir, 
V., … Fontanillas, P. (2012). Large-scale association analysis provides insights 
into the genetic architecture and pathophysiology of type 2 diabetes. Nature 
Genetics, 44(9), 981. 
Müssig, K., Staiger, H., Machicao, F., Kirchhoff, K., Guthoff, M., Schäfer, S. A., … 
Fritsche, A. (2009). Association of type 2 diabetes candidate polymorphisms in 
KCNQ1 with incretin and insulin secretion. Diabetes, 58(7), 1715-1720. 
Musso, G., Gambino, R., Pacini, G., Pagano, G., Durazzo, M., & Cassader, M. (2009). 
Transcription Factor 7–like 2 polymorphism modulates glucose and lipid 
homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. 
Hepatology, 49(2), 426-435. DOI: 10.1002/hep.22659 
Nolfe, G., Spreghini, M. R., Sforza, R. W., Morino, G., & Manco, M. (2012). Beyond the 
morphology of the glucose curve following an oral glucose tolerance test in obese 
youth. European Journal of Endocrinology, 166(1), 107-114. 
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014). Prevalence of childhood 
and adult obesity in the United States, 2011-2012. JAMA, 311(8), 806-814. doi: 
10.1001/jama.2014.732 
Ogden, C. L., Flegal, K. M., Carroll, M. D., & Johnson, C. L. (2002). Prevalence and 
trends in overweight among US children and adolescents, 1999-2000. 
JAMA, 288(14), 1728-1732. 
Parra, E. J., Below, J. E., Krithika, S., Valladares, A., Barta, J. L., Cox, N. J., … Cruz, M. 
(2011). Genome-wide association study of type 2 diabetes in a sample from 
Mexico City and a meta-analysis of a Mexican-American sample from Starr 
County, Texas. Diabetologia, 54(8), 2038-2046. 
Peters, K. E., Beilby, J., Cadby, G., Warrington, N. M., Bruce, D. G., Davis, W. A., … 
Hung, J. (2013). A comprehensive investigation of variants in genes encoding 
adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association 
with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic 
syndrome. BMC Medical Genetics, 14(1), 15. 
137 
Phillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994). Understanding oral 
glucose tolerance: comparison of glucose or insulin measurements during the oral 
glucose tolerance test with specific measurements of insulin resistance and insulin 
secretion. Diabetic Medicine,11(3), 286-292. 
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008). Type 2 diabetes: new genes, 
new understanding. Trends in Genetics, 24(12), 613-621. doi: 
10.1016/j.tig.2008.09.004 
Qi, Q., Li, H., Loos, R. J., Liu, C., Wu, Y., Hu, F. B., … Lin, X. (2009). Common 
variants in KCNQ1 are associated with type 2 diabetes and impaired fasting 
glucose in a Chinese Han population. Human Molecular Genetics,18(18), 3508-
3515. 
Reinehr, T., Wabitsch, M., Kleber, M., De Sousa, G., Denzer, C., & Toschke, A. M. 
(2009). Parental diabetes, pubertal stage, and extreme obesity are the main risk 
factors for prediabetes in children and adolescents: a simple risk score to identify 
children at risk for prediabetes. Pediatric Diabetes, 10(6), 395-400. doi: 
10.1111/j.1399-5448.2008.00492.x 
Retnakaran, R., Qi, Y., Goran, M. I., & Hamilton, J. K. (2009). Evaluation of proposed 
oral disposition index measures in relation to the actual disposition 
index. Diabetic Medicine, 26(12), 1198-1203. 
Richardson, D. K., Schneider, J., Fourcaudot, M. J., Rodriguez, L. M., Arya, R., Dyer, T. 
D., … Jenkinson, C. P. (2006). Association between variants in the genes for 
adiponectin and its receptors with insulin resistance syndrome (IRS)-related 
phenotypes in Mexican Americans. Diabetologia, 49(10), 2317-2328. 
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. 
(1988). The natural history of impaired glucose tolerance in the Pima 
Indians. New England Journal of Medicine, 319(23), 1500-1506. doi: 
10.1056/NEJM198812083192302 
Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., … Kumari, M. 
(2012). Large-scale gene-centric meta-analysis across 39 studies identifies type 2 
diabetes loci. The American Journal of Human Genetics, 90(3), 410-425. 
Saxena, R., Hivert, M. F., Langenberg, C., Tanaka, T., Pankow, J. S., Vollenweider, P., 
… Böttcher, Y. (2010). Genetic variation in GIPR influences the glucose and 
insulin responses to an oral glucose challenge. Nature Genetics, 42(2), 142-148. 
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H., … 
Camarata, J. (2007). Genome-wide association analysis identifies loci for type 2 
diabetes and triglyceride levels. Science, 316(5829), 1331-1336. 
138 
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., … 
Boehnke, M. (2007). A genome-wide association study of type 2 diabetes in Finns 
detects multiple susceptibility variants. Science, 316(5829), 1341-1345. 
Scuteri, A., Sanna, S., Chen, W. M., Uda, M., Albai, G., Strait, J., ... & Abecasis, G. R. 
(2007). Genome-wide association scan shows genetic variants in the FTO gene 
are associated with obesity-related traits. PLoS genetics, 3(7), e115. 
Shaibi, G. Q., Coletta, D. K., Vital, V., & Mandarino, L. J. (2013). The Design and 
Conduct of a Community‐ Based Registry and Biorepository: A Focus on 
Cardiometabolic Health in Latinos. Clinical and Translational Science, 6(6), 429-
434. 
Singer, J. D. (1998). Using SAS PROC MIXED to fit multilevel models, hierarchical 
models, and individual growth models. Journal of Educational and Behavioral 
Statistics, 23(4), 323-355. 
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., … Caprio, S. 
(2002). Prevalence of impaired glucose tolerance among children and adolescents 
with marked obesity. New England Journal of Medicine, 346(11), 802-810. doi: 
10.1056/NEJMoa012578 
Song, K. H., Li, T., & Chiang, J. Y. (2006). A prospero-related homeodomain protein is a 
novel co-regulator of hepatocyte nuclear factor 4α that regulates the cholesterol 
7α-hydroxylase gene. Journal of Biological Chemistry, 281(15), 10081-10088. 
Stern, M. P., Williams, K., & Haffner, S. M. (2002). Identification of persons at high risk 
for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Annals of 
Internal Medicine, 136(8), 575-581.  
Tfayli, H., Lee, S., & Arslanian, S. (2010). Declining beta-cell function relative to insulin 
sensitivity with increasing fasting glucose levels in the nondiabetic range in 
children. Diabetes Care, 33(9), 2024-2030. doi: 10.2337/dc09-2292 
Tfayli, H., Lee, S. J., Bacha, F., & Arslanian, S. (2011). One-hour plasma glucose 
concentration during the OGTT: what does it tell about beta-cell function relative 
to insulin sensitivity in overweight/obese children? Pediatric Diabetes, 12(6), 
572-579. doi: 10.1111/j.1399-5448.2011.00745.x 
The expert committee on the diagnosis and classification of diabetes mellitus (1997). 
Report of the expert committee on the diagnosis and classification of diabetes 
mellitus. Diabetes Care, 20(7), 1183-1197.  
The expert committee on the diagnosis and classification of diabetes mellitus (2003). 
139 
Report of the expert committee on the diagnosis and classification of diabetes 
mellitus. Diabetes Care, 26(Suppl. 1), S5-S20.  
Thomsen, S. K., & Gloyn, A. L. (2014). The pancreatic β cell: recent insights from 
human genetics. Trends in Endocrinology & Metabolism, 25(8), 425-434. 
Trujillo-Arriaga, H. M., & Román-Ramos, R. (2008). Fitting and evaluating the glucose 
curve during a quasi continuous sampled oral glucose tolerance test. Computers in 
Biology and Medicine, 38(2), 185-195. doi: 10.1016/j.compbiomed.2007.09.004 
Tschritter, O., Fritsche, A., Shirkavand, F., Machicao, F., Häring, H., & Stumvoll, M. 
(2003). Assessing the shape of the glucose curve during an oral glucose tolerance 
test. Diabetes Care, 26(4), 1026-1033. 
Tura, A., Morbiducci, U., Sbrignadello, S., Winhofer, Y., Pacini, G., & Kautzky-Willer, 
A. (2011). Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose 
tolerance test: any relationship with the degree of glucose tolerance? American 
Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 300(4), R941-R948. doi: 10.1152/ajpregu.00650.2010 
Ullrich, S., Su, J., Ranta, F., Wittekindt, O. H., Ris, F., Rösler, M., … Lang, F. (2005). 
Effects of IKs channel inhibitors in insulin-secreting INS-1 cells. Pflügers Archiv 
: European Journal of Physiology., 451(3), 428-436. 
Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G., … 
Maeda, S. (2008). SNPs in KCNQ1 are associated with susceptibility to type 2 
diabetes in East Asian and European populations. Nature Genetics,40(9), 1098-
1102. 
Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. (2002). Impaired glucose tolerance 
and impaired fasting glycaemia: the current status on definition and intervention. 
Diabetic Medicine, 19(9), 708-723.  
Vallon, V., Grahammer, F., Volkl, H., Sandu, C. D., Richter, K., Rexhepaj, R., … Lang, 
F. (2005). KCNQ1-dependent transport in renal and gastrointestinal 
epithelia. Proceedings of the National Academy of Sciences of the United States of 
America, 102(49), 17864-17869. 
van Vliet-Ostaptchouk, J. V., van Haeften, T. W., Landman, G. W., Reiling, E., 
Kleefstra, N., Bilo, H. J., … M't Hart, L. (2012). Common variants in the type 2 
diabetes KCNQ1 gene are associated with impairments in insulin secretion during 
hyperglycaemic glucose clamp. PloS One, 7(3), e32148. 
Vaxillaire, M., Dechaume, A., Vasseur-Delannoy, V., Lahmidi, S., Vatin, V., Leprêtre, 
F., … Froguel, P. (2006). Genetic analysis of ADIPOR1 and ADIPOR2 candidate 
140 
polymorphisms for type 2 diabetes in the Caucasian population. Diabetes, 55(3), 
856-861. 
Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., … 
Grarup, N. (2010). Twelve type 2 diabetes susceptibility loci identified through 
large-scale association analysis. Nature Genetics, 42(7), 579-589. 
Wåhlén, K., Sjölin, E., & Hoffstedt, J. (2008). The common rs9939609 gene variant of 
the fat mass-and obesity-associated gene FTO is related to fat cell 
lipolysis. Journal of Lipid Research, 49(3), 607-611. 
Wareham, N. J., Byrne, C. D., Hales, C. N., & Phillips, D. I. W. (1995). The 30 minute 
insulin incremental response in an oral glucose tolerance test as a measure of 
insulin secretion. Diabetic Medicine, 12(10), 931-931. 
Weigensberg, M. J., Ball, G. D., Shaibi, G. Q., Cruz, M. L., & Goran, M. I. (2005). 
Decreased β-cell function in overweight Latino children with impaired fasting 
glucose. Diabetes Care, 28(10), 2519-2524. 
Weiss, R., & Gillis, D. (2008). Patho‐ physiology and dynamics of altered glucose 
metabolism in obese children and adolescents. International Journal of Pediatric 
Obesity, 3(S1), 15-20. doi: 10.1080/17477160801896499 
Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. 
(2005). Predictors of changes in glucose tolerance status in obese youth. Diabetes 
Care, 28(4), 902-909. 
West, B. T. (2009). Analyzing longitudinal data with the linear mixed models procedure 
in SPSS. Evaluation & the Health Professions, 32(3), 207-228. doi: 
10.1177/0163278709338554 
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999). The natural history of 
insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 
diabetes mellitus. Journal of Clinical Investigation,104(6), 787. doi: 
10.1172/JCI7231 
Williams, J. T., & Blangero, J. (2004). Power of variance component linkage analysis—
II. Discrete traits. Annals of Human Genetics, 68(6), 620-632. 
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., … Kadowaki, T. 
(2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic 
effects. Nature, 423(6941), 762-769. 
141 
Yamauchi, T., Kamon, J., Minokoshi, Y. A., Ito, Y., Waki, H., Uchida, S., … Kadowaki, 
T. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by 
activating AMP-activated protein kinase. Nature Medicine, 8(11), 1288-1295. 
Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., … Kasuga, M. 
(2008). Variants in KCNQ1 are associated with susceptibility to type 2 diabetes 
mellitus. Nature Genetics, 40(9), 1092-1097. 
Yeckel, C. W., Weiss, R., Dziura, J., Taksali, S. E., Dufour, S., Burgert, T. S., … Caprio, 
S. (2004). Validation of insulin sensitivity indices from oral glucose tolerance test 
parameters in obese children and adolescents. The Journal of Clinical 
Endocrinology & Metabolism, 89(3), 1096-1101. 
Zeger, S. L., Liang, K. Y., & Albert, P. S. (1988). Models for longitudinal data: a 
generalized estimating equation approach. Biometrics, 1049-1060. 
Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., … Marvelle, 
A. F. (2008). Meta-analysis of genome-wide association data and large-scale 
replication identifies additional susceptibility loci for type 2 diabetes. Nature 
Genetics, 40(5), 638-645. 
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., 
… Hattersley, A. T. (2007). Replication of genome-wide association signals in 
UK samples reveals risk loci for type 2 diabetes. Science,316(5829), 1336-1341. 
  
142 
APPENDIX A 
DESCRIPTIVE CHARACTERISTICS OF ADULT PARTICIPANTS IN THE AIR REGISTRY 
BY GLUCOSE RESPONSE PHENOTYPE 
  
143 
Data are means ± SD, n (%), NGT=normal glucose tolerance; Prediabetes, impaired fasting glucose and 
impaired glucose tolerance; BMI=body mass index; WC=waist circumference; HC=hip circumference; 
SBP=systolic blood pressure; DBP=diastolic blood pressure; TRG=triglyceride; HDL=high-density 
lipoprotein; LDL=low-density lipoprotein; VLDL=very low-density lipoprotein; ALT, alanine 
aminotransferase; AST, aspartate aminotransferase; FPI, fasting plasma insulin; FPG, fasting plasma 
glucose; AUC, area under the curve; HOMA-IR, homeostatis assessment of insulin resistance; 
Variables Monophasic (n=327) Biphasic (n=101) P-value 
Gender (Male/Female) 131 (40%) / 196 (60%) 31 (31%) / 70 (69%) 0.101 
NGT/Prediabetes 170 (59%) / 118 (41%) 68 (73%) / 25 (27%) 0.019 
Age (year) 38.04 ± 9.79 34.77 ± 7.51 <0.001 
BMI (kg/m2) 30.12 ± 5.81 28.84 ± 4.78 0.061 
Fat mass (kg) 24.75 ± 10.96 22.90 ± 9.06 0.145 
WC (cm) 99.18 ± 13.97 96.23 ± 11.81 0.069 
HC (cm) 108.56 ± 11.97 107.38 ± 9.27 0.467 
SBP (mmHg) 120.41 ± 14.64 116.27 ± 14.74 0.009 
DBP (mmHg) 76.86 ± 9.21 74.17 ± 9.76 0.008 
TRG (mg/dL) 140.07 ± 83.64 124.11 ± 71.09 0.074 
HDL (mg/dL) 43.68 ± 10.99 46.86 ± 12.21 0.014 
LDL (mg/dL) 108.81 ± 28.57 108.06 ± 27.40 0.973 
VLDL (mg/dL) 22.02 ± 10.93 20.29 ± 11.06 0.122 
Cholesterol (mg/dL) 176.51 ± 34.81 174.50 ± 33.51 0.652 
ALT (U/L) 27.80 ± 18.05 23.21 ± 14.80 0.007 
AST (U/L) 23.89 ± 9.92 23.76 ± 10.62 0.817 
FPI (uIU/mL) 9.12 ± 6.62 8.61 ± 4.96 0.526 
FPG (mg/dL) 95.34 ± 13.79 91.63 ± 9.45 0.010 
HbA1c (%) 5.63 ± 0.33 5.48 ± 0.29 <0.001 
2-hr glucose (mg/dL) 136.89 ± 46.12 124.35 ± 35.10 0.025 
Glucose AUC (mg*dL-1*h-1) 18782.29 ± 5650.37 15521.07 ± 4847.83 <0.001 
Insulin AUC (µU*mL-1*h-1) 9156.63 ± 5569.05 8161.23 ± 5954.13 0.043 
Matsuda index 4.97 ± 3.45 5.90 ± 3.87 0.037 
HOMA-IR 2.20 ± 1.66 2.02 ± 1.37 0.377 
Insulinogenic index 1.19 ± 1.01 1.48 ± 1.01 0.005 
Disposition index 5.07 ± 4.52 7.70 ± 5.95 <0.001 
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Variables Monophasic (n=435) Biphasic (n=149) P-value 
Gender (Male/Female) 181 (42%) / 254 (58%) 53 (36%) / 96 (64%) 0.209 
NGT/Prediabetes 253 (64%) / 141 (36%) 103 (73%) / 38 (27%) 0.061 
Age (year) 32.63 ± 12.74 28.98 ± 10.56 0.001 
BMI (kg/m2) 29.19 ± 6.41 27.63 ± 5.35 0.012 
Fat mass (kg) 23.42 ± 11.73 20.58 ± 9.71 0.018 
WC (cm) 96.66 ± 15.83 92.81 ± 13.36 0.013 
HC (cm) 107.18 ± 12.81 105.21 ± 10.49 0.127 
SBP (mmHg) 118.79 ± 14.17 116.05 ± 14.02 0.034 
DBP (mmHg) 75.16 ± 9.41 73.05 ± 10.31 0.012 
TRG (mg/dL) 130.01 ± 79.17 115.01 ± 65.60 0.023 
HDL (mg/dL) 43.51 ± 10.78 45.95 ± 11.02 0.011 
LDL (mg/dL) 103.21 ± 28.87 98.95 ± 29.65 0.115 
VLDL (mg/dL) 20.67 ± 10.71 18.93 ± 10.30 0.072 
Cholesterol (mg/dL) 169.12 ± 35.63 163.30 ± 35.97 0.069 
ALT (U/L) 25.64 ± 17.29 21.16 ± 13.06 0.001 
AST (U/L) 23.52 ± 9.79 22.90 ± 10.18 0.355 
FPI (uIU/mL) 9.51 ± 6.83 8.76 ± 5.20 0.210 
FPG (mg/dL) 94.49 ± 12.44 91.08 ± 8.61 0.001 
HbA1c (%) 5.61 ± 0.32 5.46 ± 0.29 <0.001 
2-hr glucose (mg/dL) 132.40 ± 43.23 121.54 ± 32.09 0.007 
Glucose AUC (mg*dL-1*h-1) 18189.20 ± 5183.01 15099.44 ± 4253.96 <0.001 
Insulin AUC (µU*mL-1*h-1) 9645.36 ± 6085.70 8383.93 ± 5755.68 0.016 
Matsuda index 4.94 ± 3.51 5.76 ± 3.63 0.006 
HOMA-IR 2.24 ± 1.65 2.02 ± 1.32 0.706 
Insulinogenic index 1.32 ± 1.11 1.68 ± 1.16 <0.001 
Disposition index 5.27 ± 4.32 8.61 ± 6.76 <0.001 
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APPENDIX D 
Variables <155 mg/dl (n=101) ≥155 mg/dl (n=57) P 
Gender (Male/Female) 47 (47%) / 54 (53%) 26 (46%) / 31 (54%) 0.522 
NGT/Prediabetes 91 (90%) / 10 (10%) 29 (53%) / 26 (47%) <0.001 
Mono/Biphasic response 57 (58%) / 42 (42%) 51 (59%) / 6 (11%) <0.001 
Age (year) 16.61 ± 2.67 16.12 ± 2.66 0.276 
BMI (kg/m2) 25.30 ± 6.33 27.15 ± 7.40 0.118 
Fat mass (kg) 17.17 ± 11.38 20.43 ± 13.01 0.151 
WC (cm) 87.01 ± 16.86 89.81 ± 17.53 0.321 
HC (cm) 101.58 ± 12.98 103.53 ± 14.40 0.407 
SBP (mmHg) 113.74 ± 11.01 115.02 ± 13.31 0.601 
DBP (mmHg) 69.79 ± 9.03 70.75 ± 9.15 0.509 
TRG (mg/dL) 90.08 ± 46.18 113.67 ± 57.21 0.003 
HDL (mg/dL) 43.88 ± 8.82 42.61 ± 10.58 0.303 
LDL (mg/dL) 81.28 ± 24.13 91.04 ± 21.48 0.006 
VLDL (mg/dL) 15.14 ± 7.71 19.00 ± 9.53 0.003 
Cholesterol (mg/dL) 140.16 ± 28.72 153.05 ± 25.76 0.003 
ALT (U/L) 17.06 ± 7.91 21.13 ± 15.21 0.113 
AST (U/L) 21.25 ± 8.08 23.33 ± 10.89 0.216 
FPI (uIU/mL) 9.72 ± 7.02 10.45 ± 6.47 0.380 
FPG (mg/dL) 89.96 ± 6.12 93.42 ± 6.33 0.001 
HbA1c (%) 5.47 ± 0.30 5.55 ± 0.29 0.095 
2-hr glucose (mg/dL) 105.84 ± 19.51 139.22 ± 26.97 <0.001 
Glucose AUC (mg*dL-1*h-1) 14116.07 ± 1723.98 18533.16 ± 1945.73 <0.001 
Insulin AUC (µU*mL-1*h-1) 8874.23 ± 5158.57 13016.87 ± 8360.60 0.001 
Matsuda index 5.72 ± 3.78 3.91 ± 2.65 <0.001 
HOMA-IR 2.10 ± 1.47 2.44 ± 1.59 0.213 
Insulinogenic index 1.94 ± 1.34 1.53 ± 1.22 0.020 
Disposition index 8.99 ± 6.47 4.32 ± 2.93 <0.001 
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Variables <155 mg/dL (n=189) ≥155 mg/dL (n=262) P-value 
Gender (Male/Female) 64 (34%) / 125 (66%) 101 (39%) / 161 (61%) 0.179 
NGT/Prediabetes 166 (88%) / 22 (12%) 73 (37%) / 127 (63%) <0.001 
Mono/Biphasic response 109 (59%) / 77 (41%) 214 (90%) / 24 (10%) <0.001 
Age (year) 34.27 ± 8.32 40.20 ± 10.01 <0.001 
BMI (kg/m2) 28.91 ± 5.20 30.98 ± 5.96 <0.001 
Fat mass (kg) 23.13 ± 9.72 26.11 ± 11.32 0.005 
WC (cm) 96.09 ± 13.08 101.31 ± 13.74 <0.001 
HC (cm) 107.41 ± 11.47 109.93 ± 11.77 0.021 
SBP (mmHg) 115.91 ± 12.70 123.01 ± 15.90 <0.001 
DBP (mmHg) 73.82 ± 8.37 78.67 ± 9.99 <0.001 
TRG (mg/dL) 116.84 ± 65.03 151.57 ± 85.54 <0.001 
HDL (mg/dL) 46.70 ± 12.61 42.56 ± 9.82 <0.001 
LDL (mg/dL) 104.43 ± 25.84 111.82 ± 28.55 0.020 
VLDL (mg/dL) 18.91 ± 9.03 24.10 ± 11.90 <0.001 
Cholesterol (mg/dL) 170.47 ± 31.03 180.52 ± 35.09 0.003 
ALT (U/L) 23.04 ± 14.46 30.40 ± 19.54 <0.001 
AST (U/L) 23.06 ± 9.81 25.14 ± 10.81 0.023 
FPI (uIU/mL) 7.91 ± 5.24 10.27 ± 7.26 0.006 
FPG (mg/dL) 89.09 ± 6.73 100.43 ± 17.04 <0.001 
HbA1c (%) 5.49 ± 0.27 5.70 ± 0.35 <0.001 
2-hr glucose (mg/dL) 107.37 ± 21.43 162.70 ± 52.07 <0.001 
Glucose AUC (mg*dL-1*h-1) 14111.26 ± 1722.69 21092.66 ± 4917.30 <0.001 
Insulin AUC (µU*mL-1*h-1) 7515.18 ± 5059.99 10281.22 ± 5907.72 <0.001 
Matsuda index 6.37 ± 3.75 4.10 ± 3.07 <0.001 
HOMA-IR 1.75 ± 1.78 2.55 ± 1.83 <0.001 
Insulinogenic index 1.58 ± 1.16 1.00 ± 0.76 <0.001 
Disposition index 8.57 ± 5.77 3.15 ± 2.03 <0.001 
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Variables <155 mg/dL (n=290) ≥155 mg/dL (n=319) P-value 
Gender (Male/Female) 111 (38%) / 179 (62%) 127 (40%) / 192 (60%) 0.380 
NGT/Prediabetes 257 (89%) / 32 (11%) 102 (40%) / 153 (60%) <0.001 
Mono/Biphasic response 166 (58%) / 119 (42%) 265 (90%) / 30 (10%) <0.001 
Age (year) 28.12 ± 10.89 35.90 ± 12.99 <0.001 
BMI (kg/m2) 27.65 ± 5.87 30.29 ± 6.40 <0.001 
Fat mass (kg) 21.05 ± 10.70 25.09 ± 11.83 <0.001 
WC (cm) 92.92 ± 15.12 99.25 ± 15.12 <0.001 
HC (cm) 105.38 ± 12.31 108.78 ± 12.51 0.001 
SBP (mmHg) 115.16 ± 12.16 121.57 ± 15.75 <0.001 
DBP (mmHg) 72.41 ± 8.81 77.26 ± 10.29 <0.001 
TRG (mg/dL) 107.52 ± 60.43 144.71 ± 82.38 <0.001 
HDL (mg/dL) 45.72 ± 11.50 42.57 ± 9.94 0.001 
LDL (mg/dL) 96.31 ± 27.54 108.00 ± 28.52 <0.001 
VLDL (mg/dL) 17.59 ± 8.76 23.16 ± 11.66 <0.001 
Cholesterol (mg/dL) 159.91 ± 33.48 175.67 ± 35.19 <0.001 
ALT (U/L) 20.96 ± 12.88 28.74 ± 19.15 <0.001 
AST (U/L) 22.43 ± 9.28 24.81 ± 10.83 0.003 
FPI (uIU/mL) 8.56 ± 5.99 10.31 ± 7.08 0.011 
FPG (mg/dL) 89.39 ± 6.53 99.14 ± 15.86 <0.001 
HbA1c (%) 5.48 ± 0.28 5.67 ± 0.34 <0.001 
2-hr glucose (mg/dL) 106.85 ± 20.77 158.34 ± 49.22 <0.001 
Glucose AUC (mg*dL-1*h-1) 14112.94 ± 1720.15 20633.88 ± 4633.32 <0.001 
Insulin AUC (µU*mL-1*h-1) 8008.43 ± 5127.97 10837.62 ± 6555.15 <0.001 
Matsuda index 6.13 ± 3.77 4.06 ± 2.98 <0.001 
HOMA-IR 1.88 ± 1.30 2.53 ± 1.78 <0.001 
Insulinogenic index 1.71 ± 1.24 1.11 ± 0.89 <0.001 
Disposition index 8.72 ± 6.02 3.38 ± 2.28 <0.001 
